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Abstract 
Abebe, W. M. (2018). Bovine lumpy skin disease: epidemiology, economic impact 
and control opportunities in Ethiopia. PhD thesis, Wageningen University, the 
Netherlands. 
 
 Lumpy skin disease (LSD) is a serious pox disease of cattle caused by LSD 
virus of the genus Capripoxvirus, subfamily Chordopoxvirinae and family Poxviridae. 
It is economically an important disease due to its effect on productivity, fertility, 
animal survival, hide quality, and trade. LSD is an endemic disease in Ethiopia having 
serious  consequences on both national and household incomes. This PhD study has 
been undertaken with the main aim to generate information on LSD epidemiology,  
vaccination effect and financial consequences to support the formulation of a 
disease control strategy. An LSD outbreak occurred at least once in all of the regional 
states and city administrations in Ethiopia between 2000 and 2015. The average 
incidence of LSD outbreaks at district level was 5.58 per 16 years (0.35 per year). The 
trend of LSD outbreaks increased over the study period. Outbreaks were frequent at 
the end of the long rainy season and more numerous in areas with relatively high 
rain fall. The true animal level and herd level sero-prevalences were estimated as 
26.5% (95% CI: 24.7-28.3) and 51.0% (95% CI: 46.8-55.1), respectively. Adult age 
(OR=2.44, (95% CI: 1.67-3.55)), contact with other animals (OR=0.41 (95% CI: 0.23-
0.74)), and presence of water bodies (OR=1.61 (95% CI: 1.03-2.52)) were identified 
as the most important risk factors at individual animal level in relation to LSD sero-
positivity. The transmission rate between animals in the crop-livestock production 
system was 0.072 (95% CI: 0.068-0.076) per day, whereas the transmission rate 
among animals in intensive production system was 0.076 (95% CI: 0.068-0.085) per 
day. The reproduction ratio (R) of LSD between animals in the crop-livestock 
production system was 1.07 and in the intensive production system it was 1.09. 
Kenyan sheep pox virus strain vaccine (KS1 O-180) significantly reduces the severity 
of the disease. The vaccine efficacy for susceptibility was estimated to be 0.46 (i.e. a 
susceptibility effect of 0.54) while the infectivity effect of the vaccine was 1.83. The 
LSD field outbreak economic impact assessment revealed a total economic loss of 
USD 1176 per affected herd (USD 489 in the subsistence and USD 2735 in the 
commercial farm type). The financial analysis showed a positive net profit of USD 
136 per herd (USD 56 in the subsistence and USD 283 in the commercial farm type) 
to LSD vaccine investment. Generally, this PhD research provides insight into the 
epidemiology, economic impact and control opportunities of LSD in Ethiopia that can 
support policy makers to formulate control strategy for the disease, which is 
currently lacking in the country. 
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1.1 Animal disease   
  Livestock plays an important role in human societies as a source of food, raw 
materials, energy, recreation, companionship and income. In the developing world, 
they also provide organic fertilizer and draft power for crop production and are used 
as transport and store of wealth (Otte et al., 2004; Bender et al., 2006; Randolph et 
al., 2007). However, livestock has been threatened by diseases since farming began 
(Otte et al., 2004; Bender et al., 2006). Animal diseases reduce production and 
productivity of animals through death, condemnation at slaughter, and by reducing 
feed conversion, milk yield, weight gain, reproductive capacity and work capacity for 
ploughing and transport (FAO, 2009). In developing countries, livestock are at risk for 
a greater range of serious diseases compared to developed countries. In African 
countries including Ethiopia, transboundary animal diseases such as contagious 
bovine pleuropneumonia (CBPP), foot and mouth disease (FMD), and lumpy skin 
disease (LSD) do regularly occur and threaten assets and income of cattle owners 
(FAO, 2009; AU-IBAR, 2014). Diseases often cause most damage when they occur as 
an epidemic. Major outbreaks of transboundary animal diseases have been observed 
in the past, such as  FMD in the United kingdom (Thompson et al., 2002), classical 
swine fever in The Netherlands (Meuwissen et al., 1999) and highly pathogenic avian 
influenza in Asia and Europe (Otte et al., 2004). These outbreaks have shown the 
worldwide impact of animal disease in causing significant societal damage by 
disrupting trade and local and regional economies as well as exacerbating poverty 
(Otte et al., 2004; FAO, 2009; Oxford-Analytica, 2012). 
  Little attention, however, has been paid to transboundary animal diseases 
that prevail in less developed countries, such as LSD. Until recently, LSD has been 
restricted to Africa and Middle East countries, and currently, the disease has become 
a threat for European and Asian countries by moving beyond its usual territory. The 
disease’s economic impact is considerable for livestock industry in affected regions 
and nations (Tuppurainen et al., 2017). Studying and understanding the occurrence, 
transmission dynamics, consequences for production and the economy, factors 
associated with the spread, and cost effectiveness of the available intervention 
measures are essential prerequisites to formulate an appropriate control strategy 
for such a neglected transboundary animal disease. 
 
1.2 Lumpy skin disease 
1.2.1 Characterization and aetiology 
Lumpy skin disease (LSD) is a serious viral cattle disease characterized by 
fever, nodular lesions, and lymphadenopathy (Weiss, 1968; Woods, 1990; Quinn et 
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al., 2002; Radostits et al., 2007; Awad et al., 2010; OIE, 2010; Tuppurainen and Oura, 
2012). LSD is caused by lumpy skin disease (Neethling) virus (LSDV), a DNA virus of 
the family Poxviridea, subfamily Chordopoxvirinae and of the genus Capripoxvirus. 
The term Neethling has been added to distinguish LSDV  from bovine herpes virus 2 
which causes pseudo-lumpy skin disease. LSDV has a close antigenic relationship and 
resemblance to sheep pox and goat pox viruses. These three capripox viruses share 
a common major antigen on their outer membrane and this similarity is the reason 
behind the use of sheep pox vaccine against LSD (Woods, 1990; Quinn et al., 2002; 
Radostits et al., 2007; Babiuk et al., 2008b). So far, LSDV is known to have only one 
serotype. LSDV is stable between pH 6.6 and 8.6, and it remains viable in the 
environment and dried scabs for several weeks at ambient temperature. The virus 
survives at refrigeration temperatures for 6 months, in skin nodules kept at –80°C 
for 10 years, in air-dried hides for at least 18 days, in necrotic skin nodules over 33 
days, and for up to 35 days in desiccated crust (Weiss, 1968; Woods, 1990; OIE, 
2013). LSDV is susceptible to direct sunlight but can persist for many months under 
dark environmental conditions. It is also sensitive to temperature of 55°C/2 hours or 
65°C/30 minutes, highly alkaline or acidic pH, ether (20%), chloroform, formalin (1%), 
detergents containing lipid solvents, iodine compounds (1:33 dilution), phenol (2%), 
Virkon® (2%), sodium hypochlorite (2-3%), and quaternary ammonium compounds 
(0.5%) (OIE, 2013).  
LSDV mainly affects cattle but LSD is also observed in domestic Asian water 
buffaloes (Ali et al., 1990; FAO, 2015). In wildlife, clinical disease has been suspected 
in springbok (Antidorcas marsupialis) in Namibia, oryx (Oryx gazelle) in South Africa 
and Arabian oryx (Oryx leucoryx) in Saudi Arabia (Greth et al., 1992; OIE, 2013). LSDV 
has been isolated on two separate occasions from springbok antelope in South Africa 
(Le Goff et al., 2009). Experimentally, LSDV has been shown to infect impala 
(Aepyceros melampus), giraffe (Giraffe camelopardalis), Grant’s gazelle (Gazella 
thomsonii), goats and sheep (Young et al., 1970; Davies, 1991). Antibodies against 
LSDV have been found in greater kudu (Tragelaphus strepsiceros), waterbuck (Kobus 
ellipsiprymnus), impala, reedbuck (Redunca arundinum), giraffe, springbok, eland 
(Taurotragus oryx), black wildebeest (Connochaetes gnou), blue wildebeest 
(Connochaetes taurinus), and African buffalo (Syncerus caffer), though their 
epidemiological role in the maintenance and transmission of the virus is not known 
(Hedger and Hamblin, 1983; Barnard, 1997; Fagbo et al., 2014).  
The clinical signs of LSD have been described under both field and 
experimental conditions. The incubation period after experimental inoculation is 7-
14 days while it is 2-4 weeks in field outbreaks (Carn and Kitching, 1995a; Radostits 
et al., 2007). LSD outbreaks present a wide array of signs ranging from inapparent to 
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severe disease. Clinical signs that can be exhibited by infected cattle include but are 
not limited to fever of 40.0-41.5°C, inflammatory and oedematous swellings of the 
limbs and abdomen or brisket, cutaneous and mucosal eruption of nodules, enlarged 
and oedematous regional lymph nodes, drop in milk yield, emaciation, keratitis, and 
abortion. The nodules are circumscribed areas of 1-5 cm or more in diameter 
involving the full thickness of the skin and often the subcutis. They can form plaques 
that can reach more than 10 cm in diameter. The nodular lesions become necrotic 
and ulcerate. Some lesions may develop into 'sit-fasts'. Lesions are distributed on all 
parts of the body from the head to the tail, but most common on the head, neck, 
udder and perineum. Extensive skin lesions, mouth and respiratory lesions and limb 
oedema may cause a prolonged anorexia and disinclination to move which in turn 
may lead to body condition deterioration and finally to death (Woods, 1990; Davies, 
1991; Quinn et al., 2002; Kumar, 2011; OIE, 2013). 
 
1.2.2 Occurrence and transmission 
LSD first appeared in 1929 in Northern Zambia from where it has spread to 
other parts of Africa and out of the continent (Woods, 1988; Babiuk et al., 2008b). 
The disease is reported throughout Africa except Libya, Algeria, Morocco and Tunisia 
which are still considered free of LSD (Tuppurainen and Oura, 2012). LSD has been 
also reported in most of the Middle East countries following the 1989 outbreak in 
Israel, which was the first confirmed report outside the African continent (WAHIS; 
Tuppurainen and Oura, 2012; FAO, 2015; Tuppurainen et al., 2017; Shimshony and 
Economides, 2006). In recent years, LSD has been reported in central Asian countries 
(Azerbaijan, Iran and Kazakhstan) and in European countries (Turkey, Cyprus, 
Greece, Russian Federation, Armenia, Bulgaria, Macedonia, Serbia, Montenegro, and 
Albania) (WAHIS; FAO, 2015; Tuppurainen et al., 2017). The spread of the disease in 
Africa took half a century and thus has been slow (Woods, 1990). However, the 
spread in most of the Middle East countries, Asia and Europe is rapid. The current 
fast spread of the disease is attributed to uncontrolled animal movement across 
borders and collapse of veterinary services in the politically unstable Middle East 
region  (FAO, 2015; Tuppurainen et al., 2017). 
  Morbidity of the disease varies from 5% to 45% depending on the immune 
status of the host and the level of exposure to the pathogen (Woods, 1988; Babiuk 
et al., 2008b; OIE, 2013; Tuppurainen et al., 2017), but 2-20% is more common 
(Davies, 1991). The presence and role of innate resistance towards LSD morbidity has 
been repeatedly shown in both naturally and experimentally infected cattle (Weiss, 
1968; Woods, 1990). LSD mortality is generally low (usually less than 5%) but may 
sometimes reach 20% (Von Backstrom, 1945; Woods, 1988; Quinn et al., 2002; OIE, 
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2010) but also 40-75% has been reported (Davies, 1991). Recovered animals develop 
lifelong immunity. The build-up of a susceptible population in the absence of a 
regular vaccination scheme can lead to recurrence of the disease in an area (Woods, 
1990). Usually LSD epidemics recur with an interval of five or six years in 
unvaccinated cattle populations (Woods, 1988). 
LSDV is not considered to be a very contagious virus. Though the virus sheds 
through many body secretions and excretions of infected animals, direct contact 
between cattle plays little part in transmission of LSDV. However, cattle can become 
infected by sharing drinking troughs with severely infected animals and ingestion of 
feed contaminated with saliva from infected animals (Weiss, 1968; Woods, 1988; 
Woods, 1990; Radostits et al., 2007; Tuppurainen and Oura, 2012; OIE, 2013). LSDV 
infected bulls shed LSDV in their semen for prolonged periods (Irons et al., 2005) and 
the testis and epididymis are sites of persistence of LSDV (Annandale et al., 2010). 
However, there is no confirmation on the ability of transmission of LSDV through 
semen and inducing clinical disease after natural mating or artificial insemination 
(Philpott, 1993; Osuagwuh et al., 2007). Recently, Annandale et al. (2014) 
demonstrated LSDV transmission followed by clinical disease using semen spiked 
with a very high virus titre, a titre that has never been detected in semen of naturally 
infected bulls. Since the shedding of LSDV in bodily secretions is low (Babiuk et al., 
2008b), it is unlikely that similar infection rates would be achieved in herds where 
natural mating or artificial insemination practiced (Annandale et al., 2014). This 
transmission route is therefore regarded as minor. Lately, intra-uterine transmission 
of LSDV from an infected pregnant cow to its foetus has been reported (Rouby and 
Aboulsoud, 2016). 
  The transmission of LSDV from infected to susceptible cattle is assumed to be 
predominantly via biting and blood-feeding arthropod vectors. Intravenously feeding 
arthropods are most responsible for the transmission of LSDV (Carn and Kitching, 
1995b). The mosquito Aedes aegypti has been shown to transmit LSDV mechanically 
from infected to susceptible animals, under experimental conditions (Chihota et al., 
2001). Ixodid ticks have also shown to be capable of transmitting LSDV (Tuppurainen 
et al., 2011). Experimental studies have demonstrated mechanical transmission of 
LSDV by Rhipicephalus appendiculatus and Amblyomma hebraeum to cattle 
(Tuppurainen et al., 2011; Tuppurainen et al., 2013b; Lubinga et al., 2015), and 
vertical (transovarian) transmission by Rhipicephalus decoloratus ticks to its larvae, 
which in turn transmit the virus to their bovine hosts (Tuppurainen et al., 2013a). 
Even though transmission of LSDV in a natural setting by specific vectors has not yet 
been proven clearly, epidemiologic observations strongly suggest that several 
mosquito and fly species could play a major role. LSDV has been isolated from 
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Anopheles stephensi, Culex quinquefasciatus, Culicoides nubeculosus, Biomyia 
fasciata and Stomoxys calcitrans immediately post-feeding on infected cattle, 
though the ability of these species to transmit the virus to susceptible cattle still 
needs to be demonstrated (Weiss, 1968; Woods, 1988; Chihota et al., 2003; OIE, 
2013).  
  A number of animal and environmental factors are associated with the 
occurrence and spread of LSD: abundance of arthropod vectors, susceptibility of the 
cattle population, animal movement, wild animals including birds, and rain fall 
pattern (Woods, 1990). Except animals that have recovered from LSD, all breeds, 
sexes and ages of cattle are susceptible to the virus infection (Von Backstrom, 1945; 
Weiss, 1968; Radostits et al., 2007). The severity of LSD depends on the strain of 
capripoxvirus, the route of virus inoculation and the species, breed, production 
stage, age,  and immune status of the host (Carn and Kitching, 1995b; Quinn et al., 
2002; Babiuk et al., 2008a; OIE, 2010; Gari et al., 2011; EFSA AHAW Panel, 2015). Bos 
taurus is more susceptible to LSDV infection than Bos indicus both in number 
affected and in severity of the disease. Within Bos taurus, the fine-skinned Channel 
Island breeds, the Jersey and Guernsey, Friesian and Ayrshire cattle develop more 
severe disease (Davies, 1991; Radostits et al., 2007; OIE, 2013). Zebu breeds which 
are indigenous to Africa are generally less susceptible to LSDV (Davies, 1991). 
Commonly, very young calves, cows at the peak of lactation and malnourished 
animals are at more risk to develop sever clinical disease (Von Backstrom, 1945; 
Hunter and Wallace, 2001; OIE, 2010; Tuppurainen et al., 2011; Tuppurainen and 
Oura, 2012). 
  Cattle movement is one of the most important factors in the dissemination of 
LSD whether by trek routes or along roads and railways. Nomadism, communal 
grazing and watering points (odds ratio (OR) = 4.1), and introduction of new animals 
to a herd (OR = 8.5) are risks for the introduction and spread of LSD (Woods, 1990; 
Gari et al., 2010; Tuppurainen et al., 2017). Although there is concern that wildlife 
might serve as a reservoir of LSDV, to date no affected wildlife has been found in 
natural outbreaks (Woods, 1990; Radostits et al., 2007) and it is generally assumed 
they do not play an important role in the maintenance and spread of the virus. The 
red-billed oxpecker (Buphagus erythorhynus) and the egret (Bubulcus ibis) birds are 
suspected to pick up LSDV through their beaks while they are perching and pecking 
skin lesions of infected animals and subsequently transmit it mechanically (Woods, 
1990). 
  A warm and humid agro-climate and high densities of vector populations are 
considered risk factors for the occurrence of LSD (Woods, 1988; Yeruham et al., 
1995; Gari et al., 2010). Extensive LSD outbreaks are commonly noticed during the 
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wet season and often associated with heavy rain fall and the associated high level of 
insect activity. In dry seasons, outbreaks tend to be more restricted along water 
courses in low-lying areas (Weiss, 1968; Woods, 1990; Hunter and Wallace, 2001; 
Radostits et al., 2007). In dry areas, outbreaks subside and disease tends to disappear 
at the end of the rainy season. Cold and dry weather causes a sharp reduction in the 
transmission of LSD which might be associated with reduction of the density of 
arthropod vectors (Woods, 1990; Davies, 1991). Possibly as a consequence, LSD 
epidemics are often interspersed with quiescent periods in which there are no 
apparent clinical cases. Resurgence of LSD is often associated with the onset of rains 
and the build-up of large numbers of arthropod vectors in the environment (Woods, 
1988).  
 
1.2.3 Diagnosis 
  Experienced animal health practitioners can diagnose LSD with a high degree 
of certainty. Generalized skin nodules in cattle in an endemic area are highly 
suggestive of LSD (FAO; Quinn et al., 2002; Gelaye et al., 2017). Diagnosis of LSD is 
often based on characteristic clinical signs. However, sometimes, LSD might be 
difficult to diagnose as only few skin lesions or transient fever can be present and it 
may easily be confused with skin lesions due to other diseases such as pseudo-lumpy 
skin disease, bovine dermatophilosis, onchocerciosis, besnoitiosis, demodex 
infection, insect bite, and urticaria. Thus, laboratory diagnosis is needed for the 
confirmation that clinical signs are indeed due to LSDV infections, which is most 
rapidly done by a polymerase chain reaction (PCR) method (FAO; Awad et al., 2010; 
OIE, 2010; Gelaye et al., 2017). A variety of molecular tests using capripoxvirus-
specific primers are considered sensitive and specific for LSDV identification (Le Goff 
et al., 2009; Lamien et al., 2011; Gelaye et al., 2013; OIE, 2016). Confirmation can 
also be performed by electron microscopy and virus isolation using cell culture 
(Babiuk et al., 2008b). Virus isolation on primary or secondary bovine dermis cells or 
lamb testis cells culture is considered to be the most sensitive (OIE, 2016). Presence 
of capripoxvirus antigen can be demonstrated in tissue culture using 
immunoperoxidase or immunofluorescent staining and the virus can be neutralized 
using specific antisera (OIE, 2010). Serological assay methods including virus 
neutralization, indirect enzyme linked immunosorbent assay (iELISA), western 
blotting, agar gel immunodiffusion test and the indirect fluorescent antibody test are 
also used to diagnose LSD (Quinn et al., 2002; Awad et al., 2010; OIE, 2010). Virus 
neutralisation test is the most specific serological test, though it lacks sensitivity to 
detect infected animals with low levels of neutralising antibody. The Western blot 
test is sensitive and specific to detect capripoxvirus antibodies, but it is expensive 
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and difficult to carry out (OIE, 2016). Serum/virus neutralization tests and electron 
microscopy examination are widely used as gold standard methods for the detection 
of capripoxvirus infection (Tuppurainen and Oura, 2012).  
 
1.2.4 Prevention and control 
  LSD spreads into uninfected areas principally by means of wind-borne vectors 
or movement of infected cattle. Therefore, restriction of cattle movement from 
infected to uninfected areas and also vaccination are important control measures 
(Davies, 1991; Radostits et al., 2007). In endemic regions vaccination is the best 
method of control. Five live attenuated vaccines based on a South African 
(Neethling) strain of LSDV, Gorgon goat pox virus (Iraq) strain, Kenyan sheep and 
goat pox virus strain (currently confirmed to be LSDV), Romanian sheep pox strain 
and Yugoslavian RM 65 sheep pox strain have been used for the control of LSD (FAO; 
Quinn et al., 2002; Bhanuprakash et al., 2012; Tuppurainen et al., 2014; OIE, 2016). 
All strains of Capripoxvirus from cattle, sheep and goat origin, share a common major 
antigen that makes it possible to use sheep pox or goat pox vaccine against LSDV 
infection in cattle (Kitching et al., 1986; Kitching, 2003). Protection following 
vaccination is claimed to be lifelong, however, as immunity wanes local LSDV 
replication will occur at the site of inoculation after challenge (Woods, 1990; OIE, 
2010). Calves from naturally infected and vaccinated dams receive passive immunity 
(by colostrum), which persists for six months (Woods, 1990; Sarma, 2004).  
  Though vaccination is considered a viable means to control LSDV, incomplete 
protection and adverse reactions following its use have been reported since long 
time (Weiss, 1968; Carn, 1993; Abutarbush, 2014). There is an increasing number of 
vaccine failure reports from various countries associated with the use of 
capripoxvirus vaccines. Adverse clinical reactions related to the use of the Kenyan 
sheep and goat pox vaccine have been observed in dairy cattle of Israel (Yeruham et 
al., 1994), and incomplete protection in dairy herds of Oman (Kumar, 2011) and 
vaccinated cattle in Ethiopia (Ayelet et al., 2013; Gari et al., 2015). In the Middle East, 
RM65 vaccine is incriminated for its adverse reactions and incomplete protection in 
vaccinated cattle (Brenner et al., 2009; Abutarbush et al., 2016). Though the 
Neethling strain vaccine is also known to cause a local reaction at the injection site 
(Weiss, 1968) and adverse reactions following administration (Abutarbush et al., 
2016), it is claimed to provide a better protection from LSDV infection compared to 
sheep pox virus and goat pox virus based vaccines (Ben-Gera et al., 2015). 
  In countries where LSD appears for the first time, all infected and in-contact 
animals should be stamped-out as soon as possible to avoid the establishment of the 
disease (Davies, 1991; Tuppurainen and Galon, 2016; Tuppurainen et al., 2017). 
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However, stamping-out as the sole control measure is less effective and should be 
complemented by other control measures such as vaccination (Tuppurainen and 
Galon, 2016; Tuppurainen et al., 2017). Quarantine and movement control measures 
are considered helpful (FAO, 2016) but not very effective (Coetzer and Tuppurainen, 
2014; Al-Salihi, 2014). Efficient insect control may reduce the rate of LSDV 
transmission but cannot totally stop it (Al-Salihi, 2014; Tuppurainen and Galon, 
2016). 
  
1.2.5  Economic importance  
  Lumpy skin disease is of economic importance to farmers in regions where it 
is endemic and is a major constraint to international trade in cattle and their 
products. The disease is associated with cessation or temporary reduction in milk 
production, temporary or permanent sterility in bulls and cows, low weight gain, 
damage to hides and death due to secondary bacterial infections, costly control and 
eradication measures and compulsory animal movement restrictions (Woods, 1988; 
Chihota et al., 2003; Babiuk et al., 2008a; OIE, 2010; Tuppurainen and Oura, 2012; 
Elhaig et al., 2017). Secondary infection causes debility and loss of weight, and 
mastitis (Woods, 1990). Healing is slow and affected cattle often remain debilitated 
for several months. The economic importance of the disease relates to the prolonged 
convalescence (Murphy et al., 1999). Abortion losses (up to 10%) (Coetzer and 
Tuppurainen, 2014) are not uncommon in the early stages of the disease. Anorexia 
due to mouth lesions, lameness, pneumonia, cellulitis, and infected lesions cause 
considerable economic losses in affected herds. The most important losses arise 
from morbidity, not from mortality (Woods, 1990; Davies, 1991). Though the 
assessment made so far on the economic significance of the disease is limited, 
published works indicate 40–65% milk production loss in intensive milk producing 
herds (Hunter and Wallace, 2001; Kumar, 2011), and a loss of USD 6.43 per head for 
local Zebu and USD 58 per head for Holstein–Friesian crossbred cattle in infected 
herds (Gari et al., 2011). Also a total loss of USD 667,786 in feedlots in and around 
Adama (Alemayehu et al., 2013) and a loss of £486 (about USD 800) per animal in a 
farm (Abutarbush, 2014) due to morbidity and mortality of the disease have been 
reported. The disease is categorized as a notifiable disease by the World 
Organization for Animal Health (OIE) because of its substantial economic impact 
(Tuppurainen and Oura, 2012).  
 
1.3 Problem statement  
  Ethiopia is an agrarian country whose economy is dominated by arable 
agriculture and livestock production. It has a huge livestock population, particularly 
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cattle (about 57 million) (CSA, 2015), but the benefits derived from it are far below 
its potential. Livestock production contributes 35.6% of the agricultural GDP, 16.5% 
of the national GDP (Metaferia et al., 2011), and 12% of the annual foreign exchange 
earnings (NBE, 2014). While low performance is attributable to a number of issues, 
animal diseases are among the top ranks (APHRD, 2010, 2012). Diseases, especially 
LSD, limit the productivity (meat, milk, draft power, hides and manure) and 
international trade of livestock and their products. They are not only bottlenecks for 
the livestock sector developments in Ethiopia but also threaten food security and 
exacerbate poverty. LSD is among the well-known animal diseases impairing the 
Ethiopian farming community to get optimal benefit from their livestock (Rashid and 
Shank, 1994; APHRD, 2010; Gari et al., 2011; APHRD, 2012). 
  In Ethiopia, LSD was first observed in the year 1981 in the North western parts 
of the country (Mebratu et al., 1984). However, it has now (2017) spread to almost 
all regions and agro-ecological zones of the country with sero-prevalence ranging 
from 23-31% at animal level and 26-64% at herd level (Gari et al., 2010; Gari et al., 
2012). The disease has a major economic impact on livestock industry of the nation, 
as  it causes a loss of USD 6.43 and USD 58.00 per head for local Zebu and Holstein–
Friesian crossbred cattle, respectively (Gari et al., 2011) and a total loss of USD 
667,786 in feedlots in and around Adama due to mortality and rejection (Alemayehu 
et al., 2013). Although the disease is endemic and causing significant economic losses 
in the livestock sector, so far, little is known about its spatiotemporal distribution, 
transmission dynamics, predisposing factors, financial loss at herd level and 
efficiency of the prevention and control strategies of the disease practiced in 
Ethiopia. Undertaking research on these issues is crucial for developing effective LSD 
prevention and control strategies, and enhancement of the optimal contribution of 
the cattle population to the economies and health of the nation. 
 
1.4 Aim and outline of the thesis 
  The main aim of the studies described in this thesis was to generate 
knowledge on LSD epidemiology, financial consequence and effect of vaccination as 
a control means that can be used by policy makers to formulate and optimize the 
LSD control strategy in Ethiopia. The specific aims were: 
(1) to determine the spatial and temporal distribution, and forecast the future 
pattern of LSD outbreaks;  
(2) to estimate the sero-prevalence and identify the associated risk factors of LSD;  
(3) to understand LSD epidemic dynamics by quantifying transmission parameters;  
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(4) to assess the efficacy of Kenyan sheep pox virus strain vaccine (KS1 O-180) 
against a natural infection of LSD under field conditions by estimating its effect 
on the transmission and severity of the disease; and  
(5) to estimate the direct economic losses of LSD (mortality loss, milk loss, draft 
loss) and indirect costs (medication and labour cost) per affected herd, and 
therewith assess the cost effectiveness of vaccination as a means for LSD 
control.  
The findings may make an important contribution towards the prevention and 
control of the disease and alleviating its economic consequences. 
  This thesis is organized into seven chapters, including this general 
introduction (Chapter 1) and a general discussion (Chapter 7). The specific objectives 
were the guide for the outline of the thesis addressed in Chapters 2-6. In Chapter 2, 
LSD outbreaks time series of the period 2000 to 2015 are described and analysed. 
The geographical distribution and seasonal pattern of the outbreaks, and the relation 
between outbreaks and rainfall pattern were assessed. Furthermore, prediction of 
the original time series data pattern and forecasting of the number of LSD outbreaks 
expected from January 2016 to December 2018 was done. Chapter 3 concerns a 
cross-sectional study based on multistage cluster sampling in which sero-prevalence 
is estimated and associated risk factors are identified. Chapter 4 presents dynamics 
of LSD outbreaks and transmission parameters between animals using data from 
field observations. Transmission parameters were estimated using a SIR epidemic 
model based on data from field observations. Chapter 5 describes the efficacy 
assessment of KS1 O-180 vaccine against natural LSD occurrence under field 
conditions and the vaccine impact on the transmission and severity of the disease. 
Chapter 6 is based on a questionnaire survey to assess LSD induced morbidity and 
mortality at animal and herd level, herd owners’ perception of LSD impact, financial 
losses from morbidity and mortality, control cost per affected individual animal or 
herd, and cost effectiveness of vaccination. In the general discussion, Chapter 7, 
results from Chapters 2-6 are amalgamated to discuss the policy implication of the 
findings. The chapter ends with suggestions for future research outlook and main 
conclusions of the thesis. 
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Abstract 
Lumpy skin disease (LSD) is an infectious viral disease of cattle caused by a 
virus of the genus Capripoxvirus. LSD was reported for the first time in Ethiopia in 
1981 and subsequently became endemic. This time series study was undertaken with 
the aims of identifying the spatial and temporal distribution of LSD outbreaks and to 
forecast the future pattern of LSD outbreaks in Ethiopia. A total of 3811 LSD 
outbreaks were reported in Ethiopia between 2000 and 2015. In this period, LSD was 
reported at least once in 82% of the districts (n=683), 88% of the administrative 
zones (n=77), and all of the regional states or city administrations (n=9 and n=2) in 
the country. The average incidence of LSD outbreaks at district level was 5.58 per 16 
years (0.35 year-1). The incidence differed between areas, being the lowest in hot dry 
lowlands and highest in warm moist highland. The occurrence of LSD outbreaks was 
found to be seasonal. LSD outbreaks generally have a peak in October and a low in 
May. The trend of LSD outbreaks indicates a slight, but statistically significant 
increase over the study period. The monthly precipitation pattern is the reverse of 
LSD outbreak pattern and they are negatively but non-significantly correlated at lag 
0 (r = -0.05, p = 0.49, Spearman rank correlation) but the correlation becomes 
positive and significant when the series are lagged by 1 to 6 months, being the 
highest at lag 3 (r = 0.55, p < 0.001). The forecast for the period 2016-2018 revealed 
that the highest number of LSD outbreaks will occur in October for all the three years 
and the lowest in April for the year 2016 and in May for 2017 and 2018. Generally, 
LSD occurred in all major parts of the country. Outbreaks were high at the end of the 
long rainy season. Understanding temporal and spatial patterns of LSD and 
forecasting future occurrences are useful for indicating periods when particular 
attention should be paid to prevent and control the disease.  
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2.1 Introduction 
Lumpy skin disease (LSD) is an infectious viral disease of cattle caused by 
LSD virus of the genus Capripoxvirus and the disease often occurs as epidemics. It 
has spread from Zambia, where it was first observed in 1929 to most African 
countries (except Libya, Morocco, Algeria and Tunisia), Middle Eastern countries, 
and more recently also to European countries (Davies, 1991; Tuppurainen and Oura, 
2012; Tuppurainen et al., 2015; Tasioudi et al., 2016; WAHIS, 2016). LSD can occur in 
diverse ecological zones from the very dry semi-desert, the wet and dry areas to the 
high altitude temperate areas (Davies, 1991). 
LSD was introduced in Ethiopia, for the first time, through north-west 
(Gojjam and Gondar) in 1981 with subsequent introductions in the West (Wollega) 
in 1982 from Sudan and in the central part (Shewa) in 1983 (Mebratu et al., 1984). 
After the introduction, the disease initially spread eastwards, later to all directions 
and currently it has affected all regions and agro-climatic zones of the country 
(Mebratu et al., 1984; Gari et al., 2010; APHRD, 2012b). The spread of LSD was 
enhanced by uncontrolled cattle movements, communal grazing and watering, and 
pastoralism (Gari et al., 2010; Tuppurainen and Oura, 2012). The poor animal health 
situation, inefficient prevention and control efforts in combination with late 
detection of the disease have further contributed to the spread of LSD in Ethiopia 
(APHRD, 2012b; Tuppurainen and Oura, 2012). 
In general, the temporal pattern of disease occurrence can be described 
with short-term, cyclical and seasonal, and long-term trends; time series analysis is 
a frequently used method to assess these temporal patterns (Thrusfield, 2007). The 
cyclical trends are associated with regular, periodic fluctuations in the level of 
disease occurrence. A seasonal trend is a special case of a cyclical trend, where the 
periodic fluctuations in disease incidence are related to particular seasons 
(Thrusfield, 2007). Seasonal variation in the occurrence of infectious diseases is a 
common phenomenon in both temperate and tropical climates. Seasonal changes in 
vector abundance are well-known causes of seasonality of vector-borne infections. 
A good knowledge on the seasonal variation of disease outbreaks has paramount 
importance for the understanding of the dynamics of the disease and in designing 
better control strategies (Grassly and Fraser, 2006). 
Field observations and experimental studies indicate that blood feeding 
arthropods are involved as passive vectors in the transmission of LSD virus (Chihota 
et al., 2001; Tuppurainen and Oura, 2012). The spread of LSD has been frequently 
associated with epidemics (Carn, 1993). Epidemics of LSD occurred during the rainy 
season in which the arthropod vector populations are abundant while LSD incidence 
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sharply drops during the dry and cold weather seasons (Woods, 1988; Davies, 1991; 
Wainwright et al., 2013). Seasonal variation in the incidence of LSD outbreaks is 
common in Ethiopia in which it occurs most frequently between September and 
December (Ayelet et al., 2014). Resurgence of the disease has been consistently 
associated with the high rainfall, emergence of large numbers of vectors and a low 
level of herd immunity (Woods, 1988; Hunter and Wallace, 2001). Epidemics of LSD 
were reported to recur at intervals of 5 or 6 years (Woods, 1988). The reoccurrence 
of the disease in provisionally free area is possible when the infection is introduced 
into the population and the reproduction ratio (R), the average number of secondary 
cases caused by a single typical infectious individual, becomes greater than one 
(Dibble et al., 2016). 
Animal disease monitoring data is of fundamental importance to know the 
disease status of a country. In Ethiopia, the disease monitoring is mainly passive as 
most of the disease outbreaks reported to the federal veterinary services are based 
on clinical observations (APHRD, 2012a). Monitoring of livestock diseases in the field 
is the responsibility of regional animal health services, regional veterinary 
laboratories and district animal health personnel. Disease investigations are 
generally conducted in response to reports of health problems from livestock 
owners. There is a regular follow up of disease outbreaks but the monthly livestock 
disease reporting rate is less than 47% which is below the required OIE standards of 
at least 80% (APHRD, 2010). 
Assessing the spatial and temporal patterns is a prerequisite for guiding 
successful surveillance and control efforts in a country. Therefore, the objectives of 
this study were to evaluate the spatial and temporal distribution of LSD outbreaks 
and to forecast future patterns of outbreaks in Ethiopia based on data reported over 
the period 2000-2015. 
 
2.2 Materials and methods 
2.2.1 Study area 
Ethiopia is located in Eastern Africa bordering with Sudan, Eritrea, Djibouti, 
Somalia, Kenya, and South Sudan. It is a federation of nine member regional states 
(Tigray, Afar, Amhara, Oromia, Benshangul-Gumuz, Gambella, Southern Nations 
Nationalities and Peoples Region (SNNP), Harari, and Somali) and two city 
administrations (Addis Ababa and Dire Dawa). The regional states and city 
administrations are further divided into zones and the zones into woredas (districts), 
and the woredas into kebeles. As a whole there are about 15,000 kebeles (5000 
urban dwellers associations in towns and 10,000 peasant associations in rural areas) 
in the country (Tadesse et al., 2010; Mbogo, 2012; GoE, 2016). The country’s territory 
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presents a diverse topography, ranging from 116 meters below sea level at the Dallol 
Depression, in the East, to 4620 m above sea level on the Ras Dashen in the North 
and covers an area of approximately 1.1 million km2. Ethiopia is broadly divided into 
three climatic zones: ''Kolla'' (the hot lowland zone below 1500 m); ''Weyna Dega'' 
(mid highland zone between 1500 and 2400 m); and ''Dega'' (the cool highlands zone 
above 2400 m). Average daily temperature ranges from 20oC to 30oC.  Rainfall ranges 
from 200 mm to 2000 mm per year. Ethiopia receives heavy rainfall in June, July and 
August and occasional showers in February and March. In general, the highlands of 
Ethiopia receive more rain than the lowlands (Tadesse et al., 2010; GoE, 2016). 
The total cattle population of the country is estimated to be about 57 million 
heads, mostly  local breeds (98.7%); the remaining are hybrid (1.2%) and exotic 
breeds (0.1%) (CSA, 2015). The livestock production system practiced in the country 
is usually extensive. In the highland and mid highland, it is highly integrated with crop 
production where cattle are primarily kept for traction purpose and to provide milk 
and meat as by-products. In the lowland, where no or little farming is practiced, 
pastoralists and agro-pastoralists keep cattle to provide mainly milk (Gari et al., 2012; 
CSA, 2015).  
 
2.2.2 Outbreak and weather data 
LSD is a notifiable disease and it is required that all occurrences of this 
disease be reported. LSD outbreak data were obtained from the Federal Veterinary 
Services Directorate of Ethiopia for the period 2000-2015. The records contained 
information on place, time, number of cases, number of deaths and number of 
animals at risk for each month. The reporting format enables calculation of the 
temporal and spatial distribution of LSD. An outbreak is defined as one or more 
bovines showing LSD symptoms in a specified geographical area (usually Kebele). 
During the 16 years period, no significant changes in operation of the veterinary 
organization that could have affected the level of reporting from the field were 
noted. 
The LSD outbreak incidence was established at district (woredas, n = 683) 
level using the 16 years outbreak data. The mean LSD outbreak incidence in a district 
was calculated by summing all reported LSD outbreaks in a district over the study 
period and divide it by 16. The geographical distribution of LSD outbreaks over the 
16 years was mapped by administrative zone using GIS software QGIS 2.2 (QGIS 
developer team, Open Source Geospatial Foundation, 2014). The spread of the 
epidemic was also shown using spmap (South Platte Mapping and Analysis Program, 
Stata 14) by superimposing the yearly outbreak data onto Ethiopian Woreda 2008 
shape files in Microsoft power point program.  
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The monthly mean precipitations for the period 1999-2013 were obtained 
from the Global weather data for SWAT website. From a meteorological point of 
view, three seasons can be distinguished in Ethiopia; ‘Belg’ (February to May), 
‘Kiremt’ (June to September) and ‘Bega’ (October to January). ‘Kiremt’ is the main 
rainy season in which the magnitude of rainfall is highest as compared to the other 
seasons for many parts of the country (NMA, 2013). 
 
2.2.3 Data analysis 
Data on the number of LSD outbreaks reported each month during the 16-
year study period were analysed to detect temporal trends and seasonal effects. A 
simple inspection of the graph of the original LSD outbreak time series was employed 
to appreciate the presence of a clear long-term trend or seasonal effect. The 
existence of a long-term trend in LSD outbreaks was modelled by linear regression 
(Stata version 14) using the number of LSD outbreaks (or trend component of the 
outbreak) as dependent variable and month of the outbreaks as explanatory 
variable. Spectral analysis with SAS 9.4 was performed to detect seasonality and 
cyclical patterns in the LSD outbreak time series.  
Decomposition of LSD outbreak time series was performed using package 
‘TTR’ in R software, to identify and estimate the three components of the temporal 
additive model: seasonality, long-term trend, and irregularity (Coghlan, 2015).  
The time series were also seasonally differenced (i.e. deducting the 12 
months earlier observation value from each observation value) first followed by first 
order trend differencing (i.e. deducting the preceding observation value from each 
observation value) according to the procedure described by Allard (1998) and 
Coghlan (2015) to make the series stationary (diff function in R). Next 
autocorrelation analysis (Autocorrelation function in R) was used to assess the 
seasonality of the differenced time series. The autocorrelation function (ACF) 
enables to test the significance of seasonality in a time series by examining the ACF 
correlogram at lags of 12 month intervals (Courtin et al., 2000). The ACF estimates 
the correlation between the number of outbreaks reported in a given month and the 
number of outbreaks reported in each of the previous 1 to 192 months. The 
autocorrelations and partial autocorrelations values of various lags were used for the 
selection of terms to be included in the initial autoregressive integrated moving 
average (ARIMA) model (autocorrelations and partial autocorrelations functions in 
R).  
The Holt-Winters exponential smoothing technique as described by Coghlan 
(2015) was applied to make short term (36 months) forecasts using package 
‘forecast’ in R software. The possibility of improving the predictive model was 
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evaluated by making a correlogram and carrying out the Ljung-Box test on the in-
sample forecast errors for evidence of non-zero autocorrelations at lags 1 to 20. In 
this method the estimates of the parameters alpha, beta, and gamma represents the 
level, the slope of the trend component, and the seasonal component, respectively 
at the current time point. All the three parameters have values between 0 and 1. 
Parameter values that are close to 0 indicate that relatively little weight is placed on 
the most recent observations while forecasting future values. 
Exponential smoothing methods are useful for making forecasts, but it does 
not take into account the correlations between successive values of the time series. 
However, a better predictive model can be made by taking correlations in the data 
into account. ARIMA models include an explicit statistical model for the irregular 
component of a time series that allows for non-zero autocorrelations in the irregular 
component. An ARIMA (1, 1, 1) x (1, 1, 1)12 model (EmelK; Coghlan, 2015) seemed a 
plausible model for the LSD outbreak stationary time series and this model was used 
to forecast the expected numbers of LSD outbreaks for a 36 month (January 2016 to 
December 2018) future time using the “forecast.Arima()” function in the “forecast” 
R package. Finally, it was investigated whether or not successive forecast errors of 
an ARIMA (1, 1, 1) x (1, 1, 1)12 models were correlated by making a correlogram and 
carrying out the Ljung-Box test.  
The association between monthly rainfall and monthly LSD outbreaks was 
tested with Spearman rank test (Stata version 14). 
 
2.3 Results 
2.3.1 Geographical distribution and incidence of LSD outbreaks 
During the period 2000-2015, LSD has been reported from all regional states 
(n=9) and city administrations (n=2) of Ethiopia. About 82% of the districts (n=683) 
and 88% of the administrative zones (n=77) in the country reported at least one LSD 
outbreak in this time period. In total 3811 LSD outbreaks were reported in Ethiopia 
during the study period (Appendix 2.1: Table S1). Most of these outbreaks were from 
Oromia (54.5%), Amhara (27.9%), SNNP (10.1%) and Tigray regional states (3.6%) 
(Appendix 2.2: Figure S1). 
The average incidence of LSD outbreaks at district level was 5.58 over all 16 
years or 0.35 per year. The lowest incidences were observed in the eastern lowland 
(Afar and Somali), southern lowland (Liben), south-west (Benchi Maji) and North 
(North western zone of Tigray) areas whereas the highest number of outbreaks were 
documented in the north-west, central, West and south-western parts of the country 
(Figure 2.1).  
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Figure 2.1. Zonal distribution of LSD outbreaks per 16 district years in Ethiopia over 
 the period 2000–2015. 
 
The data shows that LSD affects districts for one or two years and then 
spreads to other nearby districts/areas with a susceptible cattle population. In this 
fashion the disease moves from one geographical area to the other and circulates in 
the country (Appendix 2.2: Figure S2). The reoccurrence of the disease in the study 
districts varies from 1 year to 13 years, with average length of 4.54 years and median 
4 years. The time between outbreaks was shorter in districts geographically located 
in the West, south-west and central part of the country.  
 
2.3.2 LSD outbreak time series description and analysis 
The monthly distribution of LSD outbreaks is presented in Figure 2.2, 
Appendix 2.1: Table S1 and Appendix 2.2: Figure S3. It showed a slight increase in the 
number of monthly outbreaks which was statistically significant (P < 0.05) (Figure 
2.2). The seasonality in the numbers of outbreaks is apparent, which tend to be 
higher in the months following the long rainy season compared to other seasons 
(Figure 2.2). The undecomposed and undifferenced original LSD outbreak time series 
was found seasonal by spectral analysis techniques (Figure 2.3). 
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Figure 2.3. Spectral density estimates of  LSD outbreaks by month, the vertical reference line 
at the 12 month period shows the seasonality of the disease. 
 
The trend, seasonal and irregular components of the LSD outbreak time 
series were estimated by decomposing the time series (Figure 2.4). The estimated 
trend component shows a decrease from about 20 outbreaks in 2002 to about 6 
outbreaks in 2006, followed by a substantial increase to about 41 outbreaks in 2009, 
decrease to about 16 outbreaks at the end of 2013 and finally increase to about 26 
outbreaks in 2014. Though the LSD outbreak pattern from the trend component 
appears to have a cycle with a periodicity of 5-7 years (peaks in 2002, 2009 and 2014) 
(Figure 2.4) it was not established by spectral analysis. Linear regression on the trend 
component of the decomposed time series shows a statistically significant (p < 0.001) 
increase in monthly LSD outbreak numbers between 2000 and 2015. 
The seasonal pattern of LSD outbreaks is clearly indicated in Figure 2.3 and 
2.4. Seasonal factors were estimated for each month over the 16 year period as the 
seasonal component of the decomposed LSD time series. The largest seasonal factor 
is recorded for October (about 16.8) and the lowest for May (about -12.1), indicating 
that number of LSD outbreaks peaks in October and has a low (trough) in May (Figure 
2.4 and 2.5). In general the number of LSD outbreaks was above average for the 
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months September to January and below average for February to August (Figure 
2.5).  
The rainfall season of Ethiopia is indicated in Figure 2.2 and 2.5. The 
precipitation is above average from April to September and below average from 
October to March. The rainfall is high in July and August and low in December to 
February. The precipitation pattern is the reverse of LSD outbreak pattern (Figure 
2.5), resulting in a negative correlation coefficient (r = -0.05, p=0.49, Spearman rank 
correlation) at lag 0 and positive correlation coefficients when the series were lagged 
by 1 to 6 months, the correlation at lag 3 being the highest (r = 0.55, p < 0.001). 
Figure 2.4.  Decomposition of the time series of the number of LSD outbreaks (top panel) into 
three  components: trend, seasonality and  random. 
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Figure 2.5. Seasonal indices of  monthly LSD outbreak between 2000 and 2015 and mean 
rainfall between 1999 and 2013 in Ethiopia. 
 
2.3.3 LSD outbreak times series forecasting 
For forecasting with Holt-Winters exponential smoothing, the three 
parameters: alpha, beta, and gamma which are important for forecasting future 
values were 0.56, 0.00, and 0.32, respectively. The original LSD outbreak times series 
and the forecasted values plotted using Holt’s exponential smoothing is shown in 
Appendix 2.2: Figure S4. The future times, from January 2016 to December 2018 
were also forecasted with Holt-Winters’ exponential methods (Appendix 2.2: Figure 
S5). However, the correlogram and Ljung-Box test showed the presence of significant 
(P = 0.002) autocorrelations of the in-sample forecast errors at lags 1-20. This 
indicates that Holt-Winters exponential smoothing could not provide an adequate 
forecast. 
The LSD outbreak time series was differenced for trend and seasonality, and 
the resulting series of first order differences appeared to be stationary in mean and 
variance. The ACF correlogram of first differenced LSD time series indicates 
significant autocorrelation at lag 1 (-0.349), 12 (-0.468), and 13 (0.273) (Appendix 
2.2: Figure S6A). This demonstrates the seasonality of the series because the current 
monthly value is related to the value of 12 months earlier. The partial correlogram 
also shows that the partial autocorrelations at lags 1 (-0.349), 9 (-0.199), 12 (-0.487) 
and 15 (0.185) exceed the significance bounds (Appendix 2.2: Figure S6B). Hence, the 
ARIMA model (1, 1, 1) x (1, 1, 1)12 was used for making forecasts for the number of 
LSD outbreaks from January 2016 to December 2018 (Figure 2.6). The correlogram 
for the forecasted value shows that none of the sample autocorrelations for lags 1-
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20 exceed the significance bounds, and the p-value for the Ljung-Box test is 0.107, 
so it can be concluded that there is little evidence for non-zero autocorrelations in 
the forecast errors at lags 1-20. Based on the forecast, the highest numbers of LSD 
outbreaks are expected in October for all predicted years and the lowest in April for 
2016 and May for 2017 and 2018 (Appendix 2.1: Table S2). 
 
Figure 2.6. The original LSD outbreak time series  (2000 – 2015) and predicted for 
the next three years (2016-2018) using ARIMA (1,1,1) x (1,1,1)12 model. The black 
line represents the original LSD outbreak time series and the blue line the  forecasted 
value. The dark grey shaded area indicate the 80% confidence interval and the light 
grey 95% confidence interval of the predicted values. 
 
2.4 Discussion 
In the current study, LSD has been recorded from all regional states and city 
administrations in Ethiopia. A previous retrospective study that covered a period 
from January 2007 to December 2011 reported no outbreaks from Dire Dawa city 
administration and Harari regional state (Ayelet et al., 2014). The present study, 
however, showed that they are affected by the disease. 
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Our spatial analysis have shown that distribution of incidence of LSD 
outbreaks vary among areas (Figure 2.1). The highest LSD incidences were in warm 
moist highland and the lowest in hot dry lowland areas. This indicate that the parts 
of the country which receive relatively high rain fall for a reasonable period of time 
is conducive for the replication and survival of blood feeding arthropods and then 
for the spread of the disease in the geographical areas (Ecotravelworldwide; Woods, 
1990; Gari et al., 2010; Ayelet et al., 2014). The LSD outbreak incidence indicated for 
the different zones should be treated consciously because under reporting might 
result in an underestimated incidence.  
In this study, it became clear that the occurrence of LSD in an area/districts 
is sporadic. However, endemicity of the disease is maintained in the country because 
the outbreaks in different districts/area do not occur at the same time (Appendix 
2.2: Figure S2). The average time to reoccurrence was 4.54 years, in line with the 5 
yearly reoccurrence of LSD epidemic in unvaccinated populations (Woods, 1990). 
The reoccurrence was variable across the study districts. Some districts reported 
outbreaks after one year of quiescence, whereas others reported an outbreak after 
a much longer period (up to 13 years), which is in line with Gari et al. (2010). This 
indicates that the disease is not endemic in a district/an area but it occurs in an 
outbreak (epidemic) form after some years. The reoccurrence is only possible after 
the seroprevalence (herd immunity) dropped below the critical value and 
reproduction ratio (R) is above one. How long it will take depends on the rate at 
which LSD is introduced into the district/area (spark rate) and how far the R has 
increased above one (Dibble et al., 2016). The time between outbreaks was shorter 
in the West and south-west (where rainfall occurs for extended periods of time) and 
central (where live animal from different parts of the country cross through to the 
central market) parts of the country.  
LSD outbreaks do also not occur at random in time and we demonstrated 
the seasonality by spectral analysis (Figure 2.3) and estimated a significant 
autocorrelation between LSD outbreaks at lag 12, 24, 36, etc., indicating the 
seasonality of the disease. The seasonal pattern of the disease is also clearly 
indicated in Figure 2.4. The seasonal LSD outbreak variation might be related to the 
variation in temperature and rainfall between seasons leading to varying arthropod 
densities in the environment. Seasonal variations in vector abundance, including 
mosquitoes, ticks, and flies, are well known causes of seasonality for vector borne 
diseases (Grassly and Fraser, 2006). Identification of temporal patterns can indicate 
times when particular attention should be paid to control the disease (Thrusfield, 
2007). 
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The trend of LSD outbreaks from January 2000 to December 2015 indicates 
a slight, but statistically significant increase over the period (Figure 2.2 and 2.4). This 
might be attributed to the absence of a specific national strategy for LSD control or 
eradication (APHRD, 2012a) and the increased tendency of using irrigation for crop 
cultivation that create favourable environmental conditions for vector borne 
diseases in the country. The implication of the trend component is that the disease 
will continue to persist if the environmental circumstances and the poor disease 
control activities continue. 
The positive and significant cross correlations between precipitation and 
increased LSD outbreaks at lag 3 (r = 0.55, p < 0.001) suggests that the rainfall in the 
previous months are an important factor for the occurrence of LSD outbreaks. The 
time delay for LSD outbreaks to occur might be justified by the time required for the 
build-up of arthropod population following the rains (Linthicum et al., 1983; Stewart 
Ibarra et al., 2013), incubation period (2-4 weeks (Radostits et al., 2007)) of the virus 
within the cattle host and delay in reporting.  
Based on the 2000-2015 reports, the number of LSD outbreaks to occur in 
each month from 2016 to 2018 was forecasted. The forecast suggests that high 
number of LSD outbreak will occur from August to January and this is comparable 
with the available LSD outbreak time series data. The reappearance of the 
seasonality in the original time series again in the forecasts is an indication of the 
forecast is reasonable (Allard, 1998). The wide confidence interval (Figure 2.6) 
indicates the need of  frequent updating of the model by incorporating the latest 
outbreak reports (Allard, 1998). The confidence interval was even wider when Holt-
Winters’ exponential methods were used (Appendix 2.2: Figure S5). The wider 
confidence interval is related to a limitation of this method, i.e. it  does not take the 
correlations between successive values of the time series into account. The ARIMA 
model, taking the correlations in the data into account, therefore, is the preferred 
model to get a reasonable forecast  in this study (Coghlan, 2015). The forecasting 
process can be continued to any point in the future, but will become less reliable for 
predictions further in time (EmelK). This means we can only gain advantage from the 
use of short term forecasts. The forecasted results of this study, therefore, will alert 
and help policy makers to focus on the unusual situations to decide whether any 
disease control intervention is required to halt the occurrence of the disease in the 
future.  
Currently, Ethiopia has no a well-designed control strategy for LSD (APHRD, 
2012a). The animal health authority undertake reactive vaccination campaign using 
Kenyan sheep pox vaccine when an LSD outbreak is reported somewhere in the 
country. Vaccination is the only measure taken for LSD control. However, research 
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findings indicate that the vaccine used in Ethiopia is not fully protective (Ayelet et 
al., 2013) which might be the reason for the increase in incidence of LSD outbreaks 
observed over the current study period. Because there is no regular vaccination 
program against LSD this might attribute to a drop of herd immunity below the 
critical point and for the reoccurrence of the disease. We now understood that LSD 
does not establish endemicity in an area, but it recurs as epidemic in, at average, 
every 5 years. Therefore, outbreaks might be prevented by bringing the herd 
immunity above the critical level through vaccination and by prohibiting the 
entrance of infected animals to the provisionally free area. Vaccination should be 
undertaken regularly ahead of the onset of the main rainy season with a high  
coverage. The vaccine currently in use shall be replaced by more competent 
homologous (Neethling virus) vaccine(Ben-Gera et al., 2015). It is widely agreed that 
vaccination is the most manageable and realistic approach to control the disease in 
endemic and resource poor countries. However, to be more effective, the 
vaccination should be complemented by other additional measures such as 
movement control.  
 
2.5 Conclusion 
LSD is wide spread and well established in Ethiopia. It occurred in all regional 
states and city administrations in the time period between 2000 and 2015. LSD does 
not establish endemicity in a  district, but it does in the country as a whole. It recurs 
in a district as epidemic, on average in 5 years period. The average incidence of LSD 
outbreaks at district level was 5.58 over all 16 years. The trend of LSD outbreaks 
increased over time. Outbreaks are seasonal and occurred more often in the months 
following the long rainy season. The results of the spatiotemporal analysis and the 
forecasted value may serve as a guide for the routine surveillance of LSD in the 
country. 
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Table S2. 36 month forecast of the number of LSD outbreaks based on ARIMA (1, 1, 1) x (1, 1, 
1)12. 
 
Month Point 
Forecast 
Lo 80 Hi 80 Lo 95 Hi 95 
Jan 2016  7.18 -6.66 21.02 -13.99 28.35 
Feb 2016   1.95 -14.69 18.60 -23.50 27.41 
Mar 2016    4.63 -13.20 22.47 -22.64 31.91 
Apr 2016     1.85 -16.58 20.29 -26.34 30.05 
May 2016     2.32 -16.46 21.11 -26.40 31.05 
Jun 2016       5.76 -13.25 24.77 -23.36 34.83 
Jul 2016 9.43 -9.75 28.61 -19.90 38.76 
Aug 2016 16.01 -3.30 35.33 -13.53 45.55 
Sep 2016  23.21 3.78 42.65 -6.50 52.93 
Oct 2016    36.57 17.03 56.10 6.68 66.45 
Nov 2016    34.15 14.51 53.78 4.11 64.18 
Dec 2016     20.39 0.66 40.13 -9.79 50.57 
Jan 2017       18.87 -1.25 38.99 -11.90 49.64 
Feb 2017        8.75 -11.63 29.13 -22.41 39.92 
Mar 2017        8.54 -12.03 29.11 -22.92 40.00 
Apr 2017 3.98 -16.75 24.71 -27.73 35.68 
May 2017 3.42 -17.45 24.29 -28.50 35.34 
Jun 2017   6.17 -14.83 27.17 -25.94 38.28 
Jul 2017     9.42 -11.70 30.54 -22.87 41.72 
Aug 2017    15.94 -5.30 37.17 -16.54 48.41 
Sep 2017     22.71 1.36 44.05 -9.94 55.35 
Oct 2017       36.32 14.86 57.77 3.50 69.13 
Nov 2017       33.49 11.92 55.06 0.51 66.47 
Dec 2017 19.40 -2.28 41.08 -13.75 52.55 
Jan 2018   18.02 -4.10 40.14 -15.81 51.85 
Feb 2018    7.99 -14.43 30.41 -26. 30 42.28 
Mar 2018     7.83 -14.81 30.48 -26.80 42.47 
Apr 2018      3.30 -19.53 26.13 -31.62 38.22 
May 2018      2.76 -20.23 25.76 -32.41 37.93 
Jun 2018        5.53 -17.62 28.67 -29.87 40.92 
Jul 2018 8.78 -14.50 32.07 -26.83 44.40 
Aug 2018 15.30 -8.12 38.72 -20.52 51.12 
Sep 2018  22.08 -1.48 45.64 -13.95 58.11 
Oct 2018    35.68 12.00 59.37 -0.54 71.91 
Nov 2018    32.86 9.05 56.68 -3.56 69.29 
Dec 2018     18.78 -5.16 42.73 -17.84 55.40 
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Appendix 2.2. Supplementary figures 
 
 
 
 
Figure S1. Distribution of LSD outbreaks (n = 3811) over regional states and city 
administrations in the period 2000-2015. 
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Figure S2. Animation of the spread of lumpy skin 
disease epidemics in Ethiopia, 2000-2015
Wassie Molla Abebe
Faculty of Veterinary Medicine / Quantitative Veterinary Epidemiology group
University of Gondar /Wageningen University & Research
Ethiopia / Wageningen, The Netherlands
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Figure S3. Annual course of LSD outbreaks in Ethiopia, 2000-2015. 
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Figure S4. The original LSD outbreak time series (black) and the predicted values (red) using 
Holt-Winters filtering. 
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Figure S5. LSD outbreak forecasts based on Holt-Winters analysis for January 2016 to 
December 2018. The forecasts are shown as a blue line, and the dark grey and light grey 
shaded areas show 80% and 95% prediction intervals, respectively. 
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Figure S6. ACF (A) and Partial ACF (B) correlogram after first order seasonal and trend 
differencing  of the original LSD outbreak time series.
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Under review
 
 
Abstract 
Lumpy skin disease (LSD) is an acute or inapparent viral disease of cattle 
endemic in many African and Middle East countries. LSD is one of the major 
transboundary livestock diseases in Ethiopia. A cross-sectional study using 
multistage cluster sampling was undertaken in central and north-western parts of 
Ethiopia with the objectives to estimate seroprevalence and to identify risk factors 
contributing to the occurrence of the disease. A total of 2386 cattle sera were 
sampled from 605 herds and 30 clusters (kebeles) located in 10 districts and tested 
for presence of LSD virus antibodies using virus neutralization test. The overall 
animal level and herd level apparent seroprevalences were 25.4% (95% CI: 23.7-27.2) 
and 48.9% (95% CI: 44.9, 52.9), respectively and varied significantly between 
districts. The true animal level and herd level prevalences were estimated as 26.5% 
(95% CI: 24.7-28.3) and 51.0% (95% CI: 46.8-55.1), respectively. At individual animal 
level adult age (OR=2.44 (95% CI: 1.67-3.55) compared to calf), contact with other 
animals (OR=0.41 (95% CI: 0.23-0.74), compared to no contact) and presence of 
water bodies (OR=1.61 (95% CI: 1.03-2.52), compared to no such bodies) were 
identified as the most important risk factors in relation to testing LSD positive. The 
putative risk factors altitude, breed, sex, and presence of animal trade route showed 
no significant association with LSD serostatus. The LSD seroprevalence is medium at 
animal level and high at herd level. Cattle population with many adult animals and 
live in wet areas are at most risk. The estimated magnitude of seroprevalence and 
the risk factors identified could be useful inputs for developing a plausible LSD 
control strategy plan for the country, which is lacking at the moment.  
 
Key words: Cattle, Capripoxvirus, Ethiopia, Lumpy skin disease, Risk factors, 
Seroprevalence   
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3.1 Introduction 
Lumpy skin disease (LSD) is an acute or inapparent viral disease of cattle 
characterized by fever, nodular lesions on the skin, mucous membranes and internal 
organs, lymphadenopathy, emaciation, oedema of the limb, and sometimes death 
(Quinn et al., 2002; Radostits et al., 2007; OIE, 2010; Tuppurainen and Oura, 2012). 
LSD is caused by Lumpy skin disease (Neethling) virus (LSDV), a DNA virus of the 
family Poxviridea, subfamily Chordopoxvirinae and of the genus Capripoxvirus. LSDV 
has close antigenic relationship and resemblance to sheep pox and goat pox viruses 
(Quinn et al., 2002; Radostits et al., 2007; Babiuk et al., 2008b). So far, LSDV is known 
to have only one serotype. It is remarkably stable and remains viable in the 
environment and dried scabs for several weeks at ambient temperature. The virus 
survives in air-dried hides for at least 18 days, necrotic skin nodules for up to 33 days 
or longer, and for up to 35 days in desiccated crust (OIE, 2013).   
LSD is endemic in many African and Middle East countries and in recent 
years it has spread to central Asia and South and Eastern Europe. There is a real 
threat that LSDV will spread further to Western Europe, and further east into Asia 
(Babiuk et al., 2008b; Tuppurainen and Oura, 2012; FAO, 2015; Tuppurainen et al., 
2017). 
The transmission of LSDV from infected to susceptible cattle is stated to be 
predominantly via biting and blood-feeding arthropod vectors. Intravenous feeding 
are considered the main route for the transmission of LSDV (Carn and Kitching, 
1995). Aedes aegypti (a species of mosquito) is capable to transmit LSDV 
mechanically (Chihota et al., 2001; Chihota et al., 2003; Tuppurainen and Oura, 
2012). As a consequence, LSD outbreaks usually occur during the rainy season when 
insect activity is high (Quinn et al., 2002; Zeynalova et al., 2016). Experimental 
studies on cattle have also demonstrated mechanical transmission of LSDV by 
Rhipicephalus appendiculatus and Amblyomma hebraeum, and transovarian 
transmission by Rhipicephalus decoloratus ticks (Tuppurainen et al., 2011; 
Tuppurainen et al., 2013a, b; Lubinga et al., 2015). Direct contact between cattle is 
considered to play a small part in transmission of LSDV. However, cattle can be 
infected by sharing a drinking trough with severely infected animals (Woods, 1988; 
Radostits et al., 2007; Tuppurainen and Oura, 2012).  
Except animals recovered from LSD, all types and ages of cattle are 
susceptible to the disease (Radostits et al., 2007). However, very young calves, 
lactating and malnourished animals are the most at risk. The disease is more severe 
in cows at the peak of lactation (Hunter and Wallace, 2001; OIE, 2010; Tuppurainen 
et al., 2011; Tuppurainen and Oura, 2012). The severity of LSD furthermore depends 
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on the breed, age, immune status, and the route of virus inoculation (Carn and 
Kitching, 1995; Quinn et al., 2002; Babiuk et al., 2008a; OIE, 2010; Gari et al., 2011; 
Tuppurainen et al., 2017). A warm and humid agro-climate, high density of vector 
populations, communal grazing and watering points, introduction of new animals to 
a herd and cattle movement are considered to be risk factors of LSD (Woods, 1988; 
Gari et al., 2010).  
LSD has become endemic in Ethiopia since it was reported for the first time 
in 1981 in north western part of the country (Mebratu et al., 1984). Studies 
undertaken in various parts of the country indicated prevalence that ranges from 
6.4% to 31% at animal level and up to 64% at herd level (Gari et al., 2010; Gari et al., 
2012; Abera et al., 2015). The disease has a major economic impact on livestock 
industry of the nation as it causes reduction in production, death, restriction to the 
global trade of live animals and animal products, costly control and eradication 
measures (Radostits et al., 2007; OIE, 2010; Gari et al., 2011; Tuppurainen and Oura, 
2012). Despite the high economic losses, so far, little is known about the magnitude 
of the occurrence and predisposing factors of LSD in the study areas. Hence, this 
study was undertaken with the aim to estimate the seroprevalence and to identify 
the risk factors that are contributing to the occurrence of lumpy skin disease. 
 
3.2 Materials and Methods 
3.2.1 Study area 
The study was carried out in the central and north-western parts of Ethiopia 
(Figure 3.1). In the central part, it was undertaken in Ada’a, Sebeta Hawas, Ambo, 
Dendi, Debrelibanos, Kuyu and Hidabu Abote districts in Oromia National Regional 
State. In the north-western part, the sample and the corresponding data were 
collected from Dejen, Gozamn and Jabitenan districts in Amhara National Regional 
State. These districts were selected because of their accessibility and their LSD 
outbreaks in the past. The main livelihood within these districts is crop–livestock 
mixed farming, which is based on limited communal and/or private grazing areas and 
the use of crop residue and stubble and which is characterized by smallholdings. 
Cattle kept in this system primarily provide draft power for crop production, milk for 
consumption, manure for soil fertility and fuel, and cash income. 
 
3.2.2 Study design and sampling 
A cross-sectional study with a two-stage sampling technique was carried out 
from January 2015 to May 2015. Cattle were selected by multistage cluster sampling 
in which kebele was the primary sampling unit and individual animal the secondary  
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Figure 3.1. Map of Ethiopia showing the study districts. 
 
sampling unit. Multistage cluster sampling was chosen for the practical reason that 
the population studied has a nested structure and due to lack of individual animal 
lists in the study area (Thrusfield, 2007). The sample size was calculated using the 
method described by Bennett et al. ( 1991), Tschopp et al. (2009) and Dohoo et al. 
(2012).    
The sample size to estimate the prevalence with a specified precision is 
given by: 
 𝑛𝑛 = 𝑔𝑔𝑔𝑔 = 𝑃𝑃(100−𝑃𝑃)𝐷𝐷
𝑆𝑆𝑆𝑆2
                                                                                          (1) 
Where n is the sample size, p is the prevalence as percentage, D is the design effect, 
SE is the precision (standard error), g is the average number of individuals sampled 
per cluster, and c is the number of clusters sampled. The design effect is given by 
formula 2 (Bennett et al., 1991): 
𝐷𝐷 = 1 + (𝑔𝑔 − 1) 𝐼𝐼𝐼𝐼𝐼𝐼                                                                                           (2) 
The intracluster correlation coefficient (ICC) is a measure of the relatedness of 
clustered data. Mathematically, it is given by: 
     𝐼𝐼𝐼𝐼𝐼𝐼 = 𝜎𝜎𝑢𝑢2
𝜎𝜎𝑢𝑢
2+𝜋𝜋2/3                                                                                                      (3)                                                                                          
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Where 𝜎𝜎𝑢𝑢2 is the between-cluster component of variance and π2/3 the within-cluster 
component of variance of the logistic distribution.  
Gari et al. (2012) reported ICC to be 0.2 for kebele and considering the 
possibility to collect maximally about 80 (g) serum samples by a team of 4 people per 
day in a kebele, D equals 17 (formula 2). Sampling 80 animals per cluster (kebele) 
with an expected disease prevalence of 27% (Gari et al., 2012) and a desired 
precision of 3.75% gave 30 clusters and thus a total sample size of around 2400. The 
clusters and the total sample size were more or less equally distributed among 10 
study districts. The list of kebeles was obtained from each district agricultural office. 
Kebeles within district and animals within kebeles were selected randomly. All cattle 
in a kebele were considered as one population (cluster) since they share common 
grazing and watering points. 
 
3.2.3 Potential risk factors 
Data on putative risk factors were obtained by interviewing the farmer 
(herd owner) at the time of blood sampling. The term “herd” here designates a group 
of animals owned by a household. The possible explanatory variables included: 
altitude (<2000, 2000-4000 and >4000 meter above sea level), contact with other 
animals (yes, no), free animal movement (yes, no), presence of water bodies (river, 
pond, lake, dam, swampy and irrigated lands) (yes, no), animal trade route in the 
study area (yes, no), and animal characteristics: breed, age and sex. Individual 
animals were categorized as calf (0.5 ≤ 1 year), young (1-4 years) and adult (≥4 years), 
breed as Holstein-Friesian cross (HF cross) and local Zebu, sex as male or female.  
 
3.2.4 Sample collection and laboratory analysis 
Blood samples (6 ml) were collected from the jugular vein of each animal 
with a history of non-vaccination, using sterile disposable needles and plain 
vacutainer tubes. The samples were allowed to stand overnight and then the sera 
were decanted into cryovials. The sera were transported to the National Animal 
Health Diagnostic and Investigation Centre (NAHDIC) at Sebeta, Ethiopia in ice packs 
and stored at -20oC until testing for antibodies against LSDV using virus neutralization 
test (VNT).  
The VNT was performed using a constant-virus/varying-serum method (Gari 
et al., 2008; OIE, 2010). Briefly, each serum was tested in duplicate wells at serial 
dilutions of 1/5, 1/25, 1/125, 1/625 and 1/3125. Kenyan sheep pox virus (KS1) was 
used at 100 TCID50 per well in 96-well flat-bottomed tissue-culture microtiter plates. 
Vero cell was used as culturing host for the test to get consistent results (OIE, 2010). 
The plates were incubated at 37oC in an atmosphere containing 5% carbon dioxide 
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for 9 days. The presence of cytopathic effect (CPE) was examined using an inverted 
phase-contrast microscope as of day 4 and final reading was made at day 9. The 
serum was considered LSD positive, when CPE was inhibited either in both or in one 
of the duplicate wells at 1/25 or higher dilutions. 
 
3.2.5 Data management and analysis 
The collected data were entered in to Microsoft Excel spreadsheet, edited 
and analysed using STATA 14. The animal level and herd level true prevalences were 
obtained by adjusting the corresponding apparent seroprevalence (AP, as 
percentage) for 96% sensitivity (Se) and 100% specificity (SP) of virus neutralization 
test (VNT) (Babiuk et al., 2009) using formula 4 (Dohoo et al., 2012; Rogan and 
Gladen, 1978). True prevalence =  AP+SP−100
Se+SP−100
                                                                                                (4)                                   
Analysis of the association between animal LSD serostatus and potential risk factors 
and estimation of variance components were performed by first using univariable 
mixed effect logistic regression model with kebele as random effect (melogit STATA 
command). Variables with P values <0.25 were checked for multicollinearity 
between each other using tolerance (collinear at values <0.4) and variance inflation 
factor (VIF, collinear at VIF >10 (Dohoo et al., 2012)) tests. If variables were collinear 
one of them was removed. Next, all potential risk factors were fitted in a 
multivariable mixed effect logistic regression model and the final model was 
obtained by a backward stepwise elimination procedure while checking for 
confounding which was considered present if any of the remaining coefficients 
changed at least 25% after removing a non-significant (p >0.05) variable from the 
model. Interactions were tested for all combinations of the significant main effects. 
Finally, ICC, SE and Design effect were calculated using formula 1, 2 and 3 to 
understand the extent to which the observations between clusters are correlated 
and to assess the precision of the prevalence estimate. 
 
3.3 Results 
3.3.1 Seroprevalence 
Descriptive information about the target and study population is presented 
in Table 3.1. LSDV seropositive animals were detected in all kebeles. Of all animals 
sampled, 607 (25.4% (95% CI: 23.7- 27.2)) were tested positive while 296 herds 
(48.9% (95% CI: 44.9-52.9)) had at least one positive animal (Table 3.2). The highest 
animal level apparent prevalence was recorded in Gozamn district followed by 
Sebeta Hawas and Jabitenan whereas the lowest prevalence was in Debrelibanos 
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district (Table 3.2). The percentage of infected herds was highest in Ambo and lowest 
in Debrelibanos district (Table 3.2). Both animal and herd level prevalences varied 
significantly between the districts (p <0.001). Kebele level seroprevalence 
distribution is presented in Figure 3.2. 
The true overall animal level and herd level prevalences were estimated at 
26.5% (95% CI: 24.7-28.3) and 51.0% (95% CI: 46.8-55.1), respectively by considering 
96% sensitivity and 100% specificity of VNT. 
Figure 3.2. LSD seroprevalence of 30 kebeles in 10 districts of Ethiopia. 
 
3.3.2 Risk factors for LSD serostatus 
Results of the univariable mixed effect logistic regression are presented in 
Table 3.3. Accordingly, breed, age group, contact with other animals, free animal 
movement, and presence of water bodies were selected for the multivariable model 
(p <0.25).  
After removing the variable free animal movement due to collinearity with 
contact with other animals (VIF = 15.27), the final model showed age group ≥4 years, 
OR: 2.44 (95% CI: 1.67-3.55), contact with other animals OR: 0.41 (95% CI: 0.23-0.74) 
and presence of water bodies OR: 1.61 (95% CI: 1.03-2.52) as significant factors 
associated with LSD status (Table 3.4).  
 
3.3.3 Intracluster correlation coefficient  
The inter-kebele variance was estimated as 0.382 (Table 3.4) resulting in an 
ICC of 0.104 (Formula 3). The design effect is then 9.2 and the precision reached for 
the unadjusted prevalence estimate equals of 2.7%. 
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Table 3.1. Descriptive information about cattle, kebeles and number of serum samples 
collected per district in a study to lumpy skin disease in Ethiopia. 
 
 
Districts 
Cattle 
pop. in 
district 
No. of 
kebeles in 
district 
No. of 
kebeles 
sampled 
No. of serum 
samples 
collected 
Ada’a 101,088 25 3 239 
Ambo 370,000 35 3 245 
Debrelibanos 59,760 11 3 244 
Dejen 59,505 21 3 246 
Dendi 212,357 49 3 242 
Gozamn 185,799 25 3 235 
Hidabu Abote 79,636 20 3 269 
Jabitenan 237,677 37 3 209 
Kuyu 140,400 23 3 239 
Sebeta Hawas 151,400 39 3 218 
Overall 1,597,622 285 30 2386 
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3.4 Discussion 
In this cross-sectional study, the herd level prevalence was estimated at 
48.9% indicating that in half of the herds involved at least one LSD seropositive 
animal was present. This prevalence is close to the 44% herd level prevalence 
reported by Gari et al. (2012) and Hailu et al. (2014), but much higher than the 5.95% 
recorded by Abera et al. (2015). In the current study, 25.4% of the animals tested 
positive for LSDV antibody, leading to an estimated true prevalence of 26.5% in the 
target population. This is close to the seroprevalence of 27% reported by Gari et al. 
(2012), but considerably higher than the seroprevalence of 6.4% reported by Abera 
et al. (2015) in Western Wollega and the prevalence of 7.4% reported by Hailu et al. 
(2014) in a questionnaire based cross sectional study in north eastern Ethiopia. The 
difference in both herd and animal level prevalences might be due to the difference 
in efficiency and population densities of arthropod vectors, dissimilarity in the study 
area environment, a different study population, sampling period, and testing 
methods employed for the studies. The statistical methods used to compute the true 
prevalence might also contribute to the difference, though unadjusted apparent and 
true prevalences are close. In general, LSD seems to be endemic and widespread in 
mixed crop-livestock production area of Ethiopia, with all tested kebeles having at 
least one LSD positive animal. 
Among the risk factors studied, age, contact with other animals, and 
presence of water bodies were significantly associated with LSD serostatus. Adult 
animals have higher odds to be affected (OR = 2.44) compared to calves (reference). 
This is in agreement with Abera et al. (2015) who recorded higher odds in adult (OR 
= 3.41) and young (OR = 1.86) animals compared to calves. In Ethiopia, 63.5% of the 
cattle population is between 3-10 years of age and a large proportion of the animals 
is used for draft and milk production purposes (CSA, 2015). Therefore, the increased 
odds of being seropositive for young and adult animals might be attributed to stress 
and exhaustion related to lactation and heavy labour for milk and draft animals 
(Hunter and Wallace, 2001; OIE, 2010; Gari et al., 2011; Tuppurainen and Oura, 2012; 
Abera et al., 2015). On the other hand the low prevalence in calves might be related 
to the traditional calf management practices that segregate calves from the herd and 
this might lead to less exposure to vectors (Gari et al., 2011).  
Results indicate that animals living in an area with surface water bodies 
(rivers, dams, lakes, ponds, irrigated and marshy areas) present have 1.61 times 
higher odds than animals living in areas with no such bodies. Presence of surface 
water increases the breeding success and survival of various vectors (McMichael, 
2003) like for Aedes aegypti, which is seen as the vector for mechanical transmission 
3 Seroprevalence and risk factors of LSD 
 
 
70 
 
of LSD (Chihota et al., 2001; Kalluri et al., 2007; Al-Salihi, 2014). The present finding 
supports previous works indicating that river deltas and basins, irrigated lands, and 
water courses create ideal conditions for arthropod vector populations that could 
enhance LSDV transmission (Woods, 1988; Davies, 1991; Hunter and Wallace, 2001; 
Tuppurainen and Oura, 2012). Epidemiologic observations also showed that LSD 
incidence is highest in wet/warm weather and lowest in the dry season, which is 
possibly linked to variation in vector population density (FAO, 2013). 
Cattle in frequent contact with other animals and other animal species 
during extensive communal grazing and at watering places have two times lower 
odds to be infected by LSDV than animals herded separately. This is in contrast with 
other studies reporting that animals having a frequent contact with other animals at 
communal grazing and watering points are more at risk to acquire LSD (Gari et al., 
2010; Hailu et al., 2014). In the study areas, several animal species (bovine, ovine, 
caprine, and equine) are allowed to graze and stay together on the same communal 
pasture land during day time. The inverse relationship we found may be attributed 
to the presence of alternative blood meal source hosts for the arthropod vectors. 
Keeping the competent hosts (cattle) together with non-competent hosts (sheep, 
goat, donkey, mule, horse) at the same pasture land may decrease vector 
infection/contamination rates and thus the transmission to cattle, a dilution effect 
(Swaddle and Calos, 2008; Randolph and Dobson, 2012). 
In contrast to previous studies (Davies, 1991; Abera et al., 2015), breed did 
not play a significant role as risk factor for testing LSD positive. This could be 
explained by the distribution of the breeds among study areas. Most of the HF cross 
animals were in less affected districts such as Debrelibanos and Ada’a. The absence 
of significant association between altitude category and serostatus to LSD was 
observed in the current study unlike Gari et al. (2012) who reported a significantly 
higher animal level LSD seropositivity in the midland as compared to the highland 
and the lowland agro-climates, but it corroborates the findings of Abera et al. (2015). 
We did also find no association between sex and presence of trade routes with 
serostatus. This is in line with the previous reports by Gari et al. (2010) and Abera et 
al. (2015). 
In developing countries like Ethiopia, information on disease prevalence is 
usually obtained by means of cross-sectional surveys. Because of unavailability of 
individual animal sampling frame and a high travel costs cluster sampling was 
preferred over simple random sampling (Otte and Gumm, 1997). Kebele was 
considered as a cluster and the intrakebele correlation coefficient (0.104) was 
medium indicating a certain degree of variation in LSDV seroprevalence between 
kebeles. This ICC value implies that the within cluster (between individual animal) 
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variance is greater than the between cluster (kebele) variance. This finding is in line 
with the description that the estimate of ICC for most infectious diseases including 
LSD does not exceed 0.20 (Gari et al., 2012; Otte and Gumm, 1997). The design effect 
(D = 9.2) and the standard error (SE = 0.027) obtained indicate that the sample size 
used for the study was larger than what is needed to estimate the prevalence with a 
5% precision and 95% confidence interval. The design effect appeared to be lower 
than anticipated and therefore the sample size could have been smaller.  
 
3.5 Conclusion 
The LSD seroprevalence is medium at animal level and high at herd level. 
Adult age, contact with other animals, and presence of water bodies are important 
factors for the occurrence of LSD. The within cluster variance is greater than the 
between cluster variance and the estimated LSD design effect is lower than 
anticipated. In general, this study revealed useful epidemiological information for 
designing plausible LSD control strategy plan in the country, which is non-existent at 
the moment. Areas endowed with rivers, lakes, ponds, dams, irrigated and swampy 
areas, which support the presence of abundant blood feeding arthropods, and cattle 
populations with many adult animals could be priority areas for application of 
control measures to reduce the burden of the disease. 
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Abstract 
  Lumpy skin disease (LSD) is a severe disease of cattle caused by a 
Capripoxvirus and often caused epidemics in Ethiopia and many other countries. This 
study was undertaken to quantify the transmission between animals and to estimate 
the infection reproduction ratio in a predominantly mixed crop-livestock system and 
in intensive commercial herd types. The transmission parameters were based on a 
SIR epidemic model with environmental transmission and estimated using 
generalized linear models. The transmission parameters were estimated using a 
survival rate of infectious virus in the environment equal to 0.325 per day, a value 
based on the best fitting statistical model. The transmission rate parameter between 
animals was 0.072 (95% CI: 0.068-0.076) per day in the crop-livestock production 
system, whereas this transmission rate in intensive production system was 0.076 
(95% CI: 0.068-0.085) per day. The reproduction ratio (R) of LSD between animals in 
the crop-livestock production system was 1.07, whereas it was 1.09 between animals 
in the intensive production system. The calculated R provides a baseline against 
which various control options can be assessed for efficacy.  
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4.1 Introduction 
  Lumpy skin disease (LSD) is a severe viral disease of cattle, which often occurs 
as regional epidemics within a larger area in which it is endemic. It is caused by 
Lumpy skin disease virus (LSDV) which is of the genus Capripoxvirus of family 
Poxviridae. LSDV is one of the most important animal poxviruses because of the 
serious economic consequences in cattle (Davies, 1991; Carn, 1993). The disease is 
characterized by lachrymation, fever, nodular lesions on the skin and mucosal 
surfaces, lymph node enlargement, inflammatory and oedematous swelling of the 
legs and lameness (Davies, 1991; Tuppurainen and Oura, 2012). 
  The disease was reported for the first time in Zambia in 1929 and was 
confined to Africa until an outbreak occurred in Israel in 1989 (Davies, 1991). 
However, currently, the disease is found in most African and Middle East countries 
and recently it has spread to eastern and south eastern European countries. LSDV is 
clearly on the move in expanding its territory and increasingly becoming a risk for 
other Asian and European countries (Tuppurainen et al., 2015).  
  Though the mechanism of LSDV transmission has not yet been clearly 
established, it is hypothesized that the main mode of transmission of LSDV is via 
blood feeding arthropods (Carn and Kitching, 1995). Experimentally, female Aedes 
aegypti mosquitoes have been shown to transmit LSDV mechanically from infected 
to susceptible cattle (Chihota et al., 2001). The potential role of ixodid ticks in 
transmission of LSDV has also been demonstrated in transmission studies including 
mechanical transmission between cattle for Amblyomma hebraeum and 
Rhipicephalus appendiculatus, trans-stadial transmission for A. hebraeum, and 
transovarial transmission for Rhipicephalus (Boophilus) decoloratus (Tuppurainen et 
al., 2011; Lubinga et al., 2013; Tuppurainen et al., 2013b, a; Lubinga et al., 2014). 
Transmission of LSDV between infected and susceptible animals by direct contact is 
considered to be inefficient (Carn and Kitching, 1995; Magori-Cohen et al., 2012). 
  Data from infectious disease outbreaks are usually incomplete and highly 
dependent. Incomplete because the infection process is only partially observable, 
i.e. not all cases may be included due to under-reporting or because of asymptomatic 
cases, the number of susceptible animals may not be known exactly, individuals who 
enter or leave the study population may not be recorded accurately, there may be 
misdiagnosis of cases and flaws in data collection. Data such as daily or weekly case 
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numbers are obviously dependent (O’Neill, 2010 ; Becker and Britton, 1999). 
However, transmission under field conditions can be estimated from the number of 
infections that occurred during the study period or at certain intervals by 
mathematical modelling using exactly that dependence (Kroese and De Jong, 2001; 
Velthuis et al., 2002).  
  One parameter often used to characterize transmission is the basic 
reproduction ratio (R0) with the effective reproduction ratio (Re) being the parameter 
for the transmission after intervention. R0 is defined as the average number of 
secondary infections caused by one typical infectious individual in a fully susceptible 
population during its entire infectious period (Diekmann et al., 1990), whereas Re 
reflects the transmission parameter in a partially susceptible (previously exposed or 
vaccinated) population (Chowell and Nishiura, 2014). The reproduction ratio (R) is 
frequently used to describe the behaviour of transmission just after introduction of 
a disease. Whether an outbreak spreads or dies out depends on whether the 
reproduction ratio is greater than, or less than, 1 respectively. If R exceeds 1, a typical 
(i.e. average) infected animal infects on average more than one susceptible animal, 
and thus it may cause a major outbreak, while if R is smaller than 1 the disease will 
die out or it will at most produce a minor outbreak (Velthuis et al., 2002; van 
Roermund et al., 2010 ). 
  Despite a large number of LSD outbreaks in many African and Middle East 
countries, its dynamics are not well studied. Only one study, undertaken by Magori-
Cohen et al. (2012) in a dairy herd of Israel, reports an estimate for the reproduction 
ratio of LSDV (R0 = 15.7). Therefore, the current study was undertaken with the 
objectives to better understand the LSDV outbreak dynamics and to quantify the 
transmission rate parameter and the reproduction ratio between animals.  
 
4.2 Materials and methods 
4.2.1 Study area, farms and animals contact patterns 
  The study was carried out from 28 April 2014 to 1 February 2015 in the central 
and north-western parts of Ethiopia. In the north-western part, it involves the cattle 
population in Mota town and parts of the surrounding five Kebeles (Kebele is the 
smallest administrative unit in Ethiopia covering an approximate area of 53 km2) in 
Hulet Ejju Enessie district, and Debremarkos University dairy farm in Gozamn district. 
In the central part, the following herds were enrolled: Selale Dairy Development 
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Private Limited Company (Selale Dairy Dev’t PLC) in Wuchale district, Aser Dev’t PLC 
in Sululta district, Ambo University dairy farm in Ambo district, Holeta agricultural 
research centre farm (Holeta A.R.C) and Holeta special cattle breeding centre (Holeta 
S.C.B.C) in Welmera district, Selam children village dairy farm in Addis Ababa and 
Jenesis dairy farm in Ada’a district (Figure 4.1). Mota area (Mota town and parts of 
the surrounding five Kebeles) covers an area of about five km radius. The production 
system in the Mota area is mainly mixed crop-livestock while the other herds were 
commercial dairy herds. Most of the animals in the mixed crop-livestock type of 
herds were of local Zebu breed whilst the intensive herds consisted of Holstein-Zebu 
cross. Farms were categorized into small (<10 cattle), medium (10-50 cattle), large 
(51-300 cattle), very large (301-700 cattle) and extra-large (>700 cattle) based on the 
number of cattle they comprised. 
  The cattle contact network depends on a number of factors including housing 
system, size and nature of grazing lands, water points, cattle density, and frequency 
and duration of contacts. This study was undertaken at the family herd (group of 
animals owned by a family for subsistence) and commercial farm (group of animals 
owned by a private or public organization for commercial purpose) levels. All 
smallholder herds enrolled in the study were in the Mota area, but the intensive 
commercial farms were located in different areas. Since the smallholder herds in the 
subsistence crop-livestock system (Mota area) are managed extensively, they 
regularly mixed at shared pastures and watering points so that they had to be 
considered as one epidemiological unit. Animals in the intensive commercial farms, 
however, did not have direct contact with animals in other farms in their 
surroundings and most of them were located in districts far apart from each other. 
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Figure 4.1. Map of Ethiopia showing LSD transmission study districts. 
 
4.2.2 Period of the epidemic 
  To assess the association between LSD epidemics and the season of the 
outbreak (which has a strong relation with arthropod dynamics), the outbreak 
duration was categorized into three periods, Belg (period 1), Kiremt (period 2) and 
Bega (period 3) following the meteorological seasons of Ethiopia. Belg is a short rainy 
period from February to May over much of the Belg-growing areas. However, over 
the north-western parts of the country (where Mota area is located) this season is 
predominantly dry except for the month of May. Kiremt is the period from June to 
September; it is the main rainy season in which the major food crops of the country 
are produced. The magnitude of rainfall during Kiremt is higher as compared to the 
other seasons for many parts of the country. Bega is the period from October to 
January. It is normally a dry season characterized by cool nights and hot days over 
various parts of the country (NMA, 2013).  
 
4.2.3 Infection status of animals 
  Herds were visited every week to check whether or not animals showing 
symptoms of LSD were present. If so, the infection chain within the herd was 
monitored by visiting the affected herd twice a week throughout the study period 
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and the LSD status (susceptible, infected or recovered) of all animals was 
determined. At the start of the study all cattle were assumed to be susceptible. The 
start of the infectious period was considered to be the day following that on which 
an animal was first reported with clinical signs of LSD. Infected animals were 
assumed to stay infectious on average for 10 days taking the duration of viraemia as 
a proxy for period of infectivity (Woods, 1990; Carn and Kitching, 1995; Tuppurainen 
et al., 2005). An infected animal becomes most infective during the viraemic phase 
of the disease because the amount of virus in various body tissues and secretions 
and excretions of the animal become the highest in this phase (Woods, 1990). 
Animals that died before the infectious period was completed were considered 
infectious for the days they lived after being considered infectious.  
  The contribution of environment (E) to the transmission of LSDV was 
established by determining a per day survival rate of LSD virus shed into the 
environment by infected animals. This was done by fitting a GLM model to the 
collected data by varying the survival rate from 0.1 to 0.9 and selecting the best 
fitting model with the lowest AIC value.  
  Nodular samples were collected from few affected cattle in each herd to 
confirm the outbreak by using conventional and snapback real-time PCR (polymerase 
chain reaction) techniques following the procedure described by Gelaye et al. (2013).  
 
4.2.4 Estimation of the transmission parameters 
  The transmission parameters were estimated based on a SIR epidemic model 
in which individuals are either susceptible (S), infected and infectious (I) or recovered 
and immune or dead (R). During the study, the numbers of I and S observed in each 
herd were recorded at the start of each observation interval. Animals were 
registered as a new case (C) on the date they were reported with LSD and as 
infectious (I) on the next day. Transmission of LSDV between animals has been 
estimated from the relationship between the number of infectious animals at the 
start of the time interval and the number of newly infected animals at the end of the 
time interval. Every new infection is related to the number of animals that were 
infectious at the time of infection.  
  The transmission parameters were estimated by a generalized linear model 
(GLM) (Velthuis et al., 2003; Heffernan et al., 2005; Chowell et al., 2007; Bravo de 
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Rueda et al., 2015). The transmission dynamics of LSD between individuals are 
described by the change in the number of susceptible (S), infectious (I), and 
recovered (R) animals. Susceptible cattle become infected with a rate of 
β·St·(It+Et)/Nt. Here, β is the transmission rate which can be interpreted as the 
average number of new infections caused by a typical infectious animal in a fully 
susceptible population per unit of time, St is the number of susceptible animals, It 
the number of infectious animals, Et contribution of the environment to the 
transmission, and Nt is the total number of animals at time t, and they are assessed 
at the start of each observation period. The number of infectious contacts 
encountered by one individual in a period of length Δt follows a Poisson distribution 
with parameter (β·(It+Et)/Nt ∙ ∆𝑡𝑡). Hence, the probability of a susceptible animal 
escaping infection, during a period Δt is e-β·∆t·(It+Et)/Nt, and thus the probability to 
become infected is 1-e-β·∆t·(It+Et)/Nt . This implies that the number of new cases (C) in a 
period Δt follows a binomial distribution. Consequently, the relation between the 
expected number of cases per unit of time E(C), and It, Et, Nt, β, and St can be 
formulated as  E(Ct)=St·(1-e-β·∆t·(It+Et)/Nt).  The transmission parameter β (β = eb, 
where b is the regression coefficient of the intercept of the model) was estimated 
using a GLM with a complementary-log-log link function and log �∆t· It+Et
Nt
� as offset. 
Finally, we obtained R by multiplying β with the average length of the infectious 
period (Velthuis et al., 2003; van Roermund et al., 2010; Bravo de Rueda et al., 2015) 
times a factor of (1-E)-1 which incorporates the environmental contribution. 
  The Chi-square test was used to test the association of morbidity and 
mortality with production systems and GLM to compare transmission rates between 
the three meteorological periods, production systems and herd sizes.  
All analyses were carried out in Stata 14.  
 
4.3 Results 
4.3.1 Descriptive statistics 
  During the study period, a total of 14,319 individual animals from 2,446 herds 
were followed for LSD occurrence. 12,509 animals (in 2,438 herds) were kept in the 
crop-livestock system and 1,810 animals (in 8 herds) in the intensive production 
system (Table 4.1).   
  The number of animals and herds affected, morbidity and mortality due to 
LSD per production system are indicated in Table 4.1. The morbidity was significantly 
higher in the intensive (17.5%) compared to the crop-livestock (10.1%) system. The 
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mortality was also significantly higher in the intensive (4.0%) than in the crop-
livestock (0.7%) system (Table 4.1). 
   In the Mota area, the LSD outbreak started at the end of April 2014 but in the 
other study farms the outbreak started later and continued until the first week of 
February 2015. The epidemic curve of the LSD outbreak in the Mota area is 
presented in Figure 4.2. 
 
Figure 4.2. Epidemic curve of lumpy skin disease in Mota area, Ethiopia, in 2014. 
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4.3.2 Transmission of LSD between animals  
  The contribution of the environment to the transmission (E) and the number 
of C, I and S animals in the Mota area are listed for each day of the epidemic 
(Appendix 4.1). The transmission rate parameter between animals in the dominantly 
subsistent crop-livestock production system was 0.072 (95% CI: 0.068-0.076) per day 
(Table 4.2) whereas in the intensive production system it was 0.076 (0.068-0.085) 
per day (Table 4.3). The survival rate of infectious LSD virus in the environment was 
estimated as 0.325 per day based on the best fitting statistical model and this value 
was used to account for the indirect transmission (excluding the immediate or direct 
transmission) of the virus. The average LSD infectious periods for animals are 
indicated in Table 4.2 and 4.3 for both production systems. 
  Based on the survival rate of LSDV in the environment, the multiplication 
factor of R was 1.5. Then a reproduction ratio of 1.07 between animals was 
calculated in the crop-livestock production system in the Mota area (Table 4.2). R 
values between animals vary from 0.90 (Aser dairy farm) to 1.15 (Ambo university) 
in the eight intensive farms while the overall R value for intensive dairy farms was 
1.09 (Table 4.3). Major outbreaks have been observed in Ambo University, Holeta 
S.C.B.C, Holeta A.R.C, Selale Dairy Dev't PLC, Selam children village dairy herds and 
Mota area (Table 4.3, Appendix 4.2).  
  Transmission parameter rates (β) between animals for subsistence crop-
livestock production system in the Mota area showed significant differences 
between period two and three (P <0.05) (Table 2). However, the transmission rates 
did not significantly differ between production systems and herd sizes.  
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4.4 Discussion 
  The 10.1% and 17.5% animal level morbidity of LSD reported in the current 
study in the subsistence crop-livestock production system and intensive system, 
respectively, are within the range of what has been reported in previous works 
(Woods, 1988; Davies, 1991). Similarly, the mortality was higher in the intensive 
production system than in the crop-livestock system. These significant differences in 
morbidity and mortality between animals in the two systems might be explained by 
the breed of cattle raised in the two systems. In the intensive system, Holstein-
Friesian local cross was the dominant breed which is more susceptible and more 
severely affected by LSD than the local Zebu breed (Davies, 1991; OIE, 2010), which 
is the breed commonly found in the crop-livestock production system. The other 
reason might be related to the way we calculated the morbidity and mortality in both 
systems. In the crop-livestock system, all animals in the Mota area whether or not 
they were within an infected herd or not, were included in the denominator, 
whereas in the intensive system only the number of animals in infected herds were 
in the denominator to calculate the morbidity and mortality. 
  The infectious period and survival of the virus in the environment are 
important parameters in estimating the reproduction ratio but these parameters 
were not reported in any of the previous studies. However, information about these 
parameters is essential for formulating appropriate prevention and control 
strategies for LSD. In this study too we did not estimate the infectious period of an 
infected animal and the survival rate of the virus in the environment because the 
study set up did not allow us to do that; instead we parametrized the infectious 
period from information obtained in the literature and the survival rate by searching 
for the best fitting model. We set the infectious period to 10 days for an infected 
animal by taking into account the duration of virus isolation in blood for 10-12 days 
(Carn and Kitching, 1995; Tuppurainen et al., 2005). Furthermore, there is no clear 
information when infected animals become infectious, which is important to know 
for the quantification of transmission. Infectiousness may start before or after the 
onset of clinical disease, but for this study we set the start of the infectious period 
as 24 h after the onset of the disease considering that LSDV isolation from blood and 
skin samples were achieved in most of the cases after the affected animals showed 
fever (Tuppurainen et al., 2005). Regarding the survival rate of the virus in the 
environment, literature indicates that the virus survives in air-dried hides for at least 
18 days, in necrotic skin nodules for up to 33 days or longer, and for up to 35 days in 
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desiccated crust (OIE, 2013), but it is not clear whether the viruses surviving in these 
foci contribute to the transmission of LSD. Taking this information into consideration 
we fitted a model (by selecting the best fitting model) to our data and found a 
survival rate of 0.325 per day, which was used in the offset to incorporate the 
contribution of environment to the transmission of LSDV. The implication of this 
survival rate is that the infectivity is increased by almost 50%.  
  To our knowledge, this is the first field study in Ethiopia in which transmission 
rate parameters have been quantified. This knowledge is helpful to design sets of 
measures that efficiently eliminate the virus. In the study, LSDV transmission was 
modelled by considering it as direct transmission. It is widely believed that LSDV is 
transmitted from infected to susceptible hosts indirectly through mechanical 
arthropod vectors, though the importance of the different types of arthropod 
vectors in the transmission of LSD virus in field conditions is not fully understood 
(Carn and Kitching, 1995; Magori-Cohen et al., 2012). If a blood feeding arthropod 
feeds briefly on viraemic cattle and is interrupted, a subsequent immediate feeding 
on a second animal could result in virus transmission. The virus does not replicate 
within the vector (Goddard, 2008) which thus serves as a passive carrier to transmit 
the disease. The vector in this case serves only as a bridge for the transmission of 
LSDV from infected to susceptible cattle so that we did not incorporate the vectors 
in the transmission model.   
  During the outbreak, LSDV was transmitted between animals with a rate of 
0.072 per day in the crop-livestock production system. The transmission chain from 
which specific infected cattle to which susceptible cattle was not clearly identified 
due to the free movement and mixing up of animals in the area and mechanical 
transmission of the disease by arthropods vectors. Hence, the transmission rate 
between animals was calculated by considering the cattle population in the area as 
one population.  
  In the Mota area, the transmission rate of LSD was also estimated for different 
time periods and the results indicate a significant difference in daily transmission 
rates between periods. The per day transmission rate between animals was higher 
at the beginning of the outbreak (in period 1 and 2 compared to period 3). This was 
expected, because during these periods the susceptible population was not yet 
depleted and no specific measures were taken to reduce transmission. This result 
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indicates that starting implementation of control measures at early stage of the 
outbreak is necessary to halt the spread of the disease. We did not assess the 
periodic variation of transmission rate in farms of intensive production system due 
to the fact that the outbreaks in those farms were relatively short and it was not 
convenient to divide the time into different periods as in most occasions the 
outbreak fell in one period. 
  In this study, we estimated an R value of 1.07 between animals in the crop-
livestock area. The R values within the intensive farms were also in the range of 0.90 
to 1.15 with an overall value of 1.09. These R values are low compared with the R 
value of 15.7 reported for indirect transmission within a commercial dairy farm in 
Israel (Magori-Cohen et al., 2012). The difference might be explained by the method 
how R is calculated, different study population, the environmental difference and 
the production set up.  
  Knowledge of within herd transmission is necessary to assess the 
effectiveness of intervention measures and to design effective monitoring 
programmes (Stegeman et al., 1999; Graat et al., 2001; Hage et al., 2003 ). In this 
study, we estimated that R was greater than 1 between animals in the dominantly 
crop-livestock system and in some farms of the intensive production system. This 
sheds light on LSDV transmission and further work should focus on the effect of 
control measures that add to bring R below the threshold level. LSD control will be 
achieved if both reproduction ratios, among animals and between herds are less 
than 1; and also if R among animals is greater than 1, but R, between herds is below 
1. Infections with low R values are less difficult to control than those with a high R 
value (Hage et al., 2003 ). Our estimates of R provides a baseline against which 
various control options can be assessed for efficacy. In general, from this study it can 
be concluded that transmission of LSDV between animals in Ethiopia is low.  
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Appendixes 
Appendix 4.1. Number of newly infected (C),  infectious (I), susceptible  (S) animals,   contribution of 
the environment to the transmission (E) and total number of animals (N) of the epidemic during the 
2014  LSD outbreak in Mota area. 
       
Period 
Date of 
infection S I E C N 
1 29-4-2014 12508 1 0 0 12509 
1 30-4-2014 12508 1 0.325 0 12509 
1 1-5-2014 12508 1 0.430625 0 12509 
1 2-5-2014 12508 1 0.464953125 0 12509 
1 3-5-2014 12508 1 0.476109766 0 12509 
1 4-5-2014 12508 1 0.479735674 1 12509 
1 5-5-2014 12507 2 0.480914094 0 12509 
1 6-5-2014 12507 2 0.806297081 0 12509 
1 7-5-2014 12507 2 0.912046551 0 12509 
1 8-5-2014 12507 2 0.946415129 0 12509 
1 9-5-2014 12507 1 0.957584917 0 12509 
1 10-5-2014 12507 1 0.636215098 1 12509 
1 11-5-2014 12506 2 0.531769907 0 12509 
1 12-5-2014 12506 2 0.82282522 1 12509 
1 13-5-2014 12505 3 0.917418196 0 12509 
1 14-5-2014 12505 3 1.273160914 0 12509 
1 15-5-2014 12505 2 1.388777297 1 12509 
1 16-5-2014 12504 3 1.101352622 0 12509 
1 17-5-2014 12504 3 1.332939602 0 12509 
1 18-5-2014 12504 3 1.408205371 0 12509 
1 19-5-2014 12504 3 1.432666745 1 12508 
1 20-5-2014 12503 4 1.440616692 0 12508 
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1 21-5-2014 12503 3 1.768200425 1 12508 
1 22-5-2014 12502 4 1.549665138 0 12508 
1 23-5-2014 12502 3 1.80364117 1 12507 
1 24-5-2014 12501 4 1.56118338 1 12507 
1 25-5-2014 12500 5 1.807384599 1 12507 
1 26-5-2014 12499 5 2.212399995 0 12507 
1 27-5-2014 12499 5 2.344029998 0 12507 
1 28-5-2014 12499 5 2.386809749 0 12507 
1 29-5-2014 12499 5 2.400713169 1 12507 
1 30-5-2014 12498 5 2.40523178 1 12507 
1 31-5-2014 12497 6 2.406700328 0 12507 
1 1-6-2014 12497 5 2.732177607 0 12507 
2 2-6-2014 12497 5 2.512957722 0 12507 
2 3-6-2014 12497 4 2.44171126 0 12507 
2 4-6-2014 12497 3 2.093556159 1 12507 
2 5-6-2014 12496 3 1.655405752 0 12507 
2 6-6-2014 12496 3 1.513006869 1 12507 
2 7-6-2014 12495 4 1.466727233 0 12507 
2 8-6-2014 12495 4 1.776686351 0 12507 
2 9-6-2014 12495 3 1.877423064 0 12507 
2 10-6-2014 12495 2 1.585162496 0 12507 
2 11-6-2014 12495 2 1.165177811 1 12507 
2 12-6-2014 12494 3 1.028682789 1 12507 
2 13-6-2014 12493 4 1.309321906 1 12507 
2 14-6-2014 12492 5 1.72552962 1 12506 
2 15-6-2014 12491 5 2.185797126 0 12506 
2 16-6-2014 12491 5 2.335384066 1 12506 
2 17-6-2014 12490 5 2.383999821 2 12506 
2 18-6-2014 12488 7 2.399799942 2 12506 
2 19-6-2014 12486 9 3.054934981 0 12506 
2 20-6-2014 12486 9 3.917853869 0 12506 
2 21-6-2014 12486 9 4.198302507 2 12506 
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2 22-6-2014 12484 10 4.289448315 3 12506 
2 23-6-2014 12481 12 4.644070702 0 12505 
2 24-6-2014 12481 11 5.409322978 0 12505 
2 25-6-2014 12481 10 5.333029968 4 12505 
2 26-6-2014 12477 13 4.98323474 0 12505 
2 27-6-2014 12477 12 5.84455129 5 12505 
2 28-6-2014 12472 15 5.799479169 1 12505 
2 29-6-2014 12471 14 6.75983073 0 12505 
2 30-6-2014 12471 14 6.746944987 2 12505 
2 1-7-2014 12469 16 6.742757121 1 12505 
2 2-7-2014 12468 15 7.391396064 0 12505 
2 3-7-2014 12468 13 7.277203721 6 12505 
2 4-7-2014 12462 19 6.590091209 6 12505 
2 5-7-2014 12456 25 8.316779643 3 12505 
2 6-7-2014 12453 24 10.82795338 5 12505 
2 7-7-2014 12448 29 11.31908485 3 12504 
2 8-7-2014 12445 27 13.10370258 8 12504 
2 9-7-2014 12437 34 13.03370334 6 12504 
2 10-7-2014 12431 40 15.28595358 4 12504 
2 11-7-2014 12427 42 17.96793491 8 12504 
2 12-7-2014 12419 49 19.48957885 3 12504 
2 13-7-2014 12416 52 22.25911313 2 12503 
2 14-7-2014 12414 48 24.13421177 6 12503 
2 15-7-2014 12408 48 23.44361882 4 12503 
2 16-7-2014 12404 49 23.21917612 5 12503 
2 17-7-2014 12399 49 23.47123224 1 12502 
2 18-7-2014 12398 47 23.55315048 14 12502 
2 19-7-2014 12384 53 22.92977391 9 12502 
2 20-7-2014 12375 56 24.67717652 3 12502 
2 21-7-2014 12372 55 26.22008237 5 12502 
2 22-7-2014 12367 52 26.39652677 12 12501 
2 23-7-2014 12355 61 25.4788712 8 12501 
2 24-7-2014 12347 67 28.10563314 11 12501 
2 25-7-2014 12336 72 30.90933077 5 12500 
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2 26-7-2014 12331 73 33.4455325 11 12500 
2 27-7-2014 12320 78 34.59479806 12 12499 
2 28-7-2014 12308 89 36.59330937 6 12498 
2 29-7-2014 12302 82 40.81782555 4 12498 
2 30-7-2014 12298 77 39.9157933 6 12497 
2 31-7-2014 12292 79 37.99763282 6 12497 
2 1-8-2014 12286 80 38.02423067 4 12497 
2 2-8-2014 12282 72 38.35787497 10 12496 
2 3-8-2014 12272 74 35.86630936 7 12495 
2 4-8-2014 12265 70 35.70655054 6 12495 
2 5-8-2014 12259 71 34.35462893 9 12495 
2 6-8-2014 12250 69 34.2402544 10 12494 
2 7-8-2014 12240 68 33.55308268 12 12492 
2 8-8-2014 12228 74 33.00475187 12 12492 
2 9-8-2014 12216 82 34.77654436 6 12492 
2 10-8-2014 12210 82 37.95237692 15 12492 
2 11-8-2014 12195 91 38.9845225 6 12491 
2 12-8-2014 12189 93 42.24496981 10 12490 
2 13-8-2014 12179 92 43.95461519 10 12489 
2 14-8-2014 12169 96 44.18524994 7 12489 
2 15-8-2014 12162 96 45.56020623 16 12488 
2 16-8-2014 12146 103 46.00706702 14 12487 
2 17-8-2014 12132 107 48.42729678 10 12487 
2 18-8-2014 12122 104 50.51387145 4 12484 
2 19-8-2014 12118 96 50.21700822 6 12484 
2 20-8-2014 12112 95 47.52052767 15 12483 
2 21-8-2014 12097 95 46.31917149 14 12482 
2 22-8-2014 12083 101 45.92873074 22 12479 
2 23-8-2014 12061 115 47.75183749 13 12478 
2 24-8-2014 12048 118 52.89434718 5 12478 
2 25-8-2014 12043 117 55.54066283 6 12476 
2 26-8-2014 12037 107 56.07571542 14 12474 
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2 27-8-2014 12023 108 52.99960751 8 12473 
2 28-8-2014 12015 106 52.32487244 14 12473 
2 29-8-2014 12001 117 51.45558354 9 12472 
2 30-8-2014 11992 120 54.74806465 5 12472 
2 31-8-2014 11987 110 56.79312101 10 12472 
2 1-9-2014 11977 106 54.20776433 13 12472 
2 2-9-2014 11964 97 52.06752341 9 12472 
2 3-9-2014 11955 93 48.44694511 12 12471 
2 4-9-2014 11943 100 45.97025716 9 12471 
2 5-9-2014 11934 103 47.44033358 10 12471 
2 6-9-2014 11924 99 48.89310841 6 12471 
2 7-9-2014 11918 97 48.06526023 8 12471 
2 8-9-2014 11910 91 47.14620958 5 12469 
2 9-9-2014 11905 87 44.89751811 9 12469 
2 10-9-2014 11896 91 42.86669339 13 12469 
2 11-9-2014 11883 94 43.50667535 13 12469 
2 12-9-2014 11870 94 44.68966949 11 12469 
2 13-9-2014 11859 96 45.07414258 5 12468 
2 14-9-2014 11854 89 45.84909634 34 12468 
2 15-9-2014 11820 113 43.82595631 7 12466 
2 16-9-2014 11813 111 50.9684358 19 12465 
2 17-9-2014 11794 123 52.63974164 15 12463 
2 18-9-2014 11779 130 57.08291603 11 12462 
2 19-9-2014 11768 136 60.80194771 16 12462 
2 20-9-2014 11752 142 63.96063301 4 12461 
2 21-9-2014 11748 133 66.93720573 28 12460 
2 22-9-2014 11720 148 64.97959186 18 12458 
2 23-9-2014 11702 155 69.21836735 9 12457 
2 24-9-2014 11693 160 72.87096939 29 12456 
2 25-9-2014 11664 154 75.68306505 28 12452 
2 26-9-2014 11636 175 74.64699614 13 12451 
2 27-9-2014 11623 170 81.13527375 13 12450 
2 28-9-2014 11610 169 81.61896397 19 12448 
3 29-9-2014 11591 177 81.45116329 12 12447 
98
4 Transmission dynamics of LSD 
 
 
 
 
 
 
3 30-9-2014 11579 173 83.99662807 18 12446 
3 1-10-2014 11561 187 83.52390412 12 12445 
3 2-10-2014 11549 170 87.92026884 12 12444 
3 3-10-2014 11537 162 83.82408737 14 12443 
3 4-10-2014 11523 166 79.8928284 9 12442 
3 5-10-2014 11514 148 79.91516923 13 12442 
3 6-10-2014 11501 133 74.07243 18 12442 
3 7-10-2014 11483 138 67.29853975 24 12442 
3 8-10-2014 11459 149 66.72202542 22 12441 
3 9-10-2014 11437 154 70.10965826 9 12439 
3 10-10-2014 11428 151 72.83563893 6 12439 
3 11-10-2014 11422 139 72.74658265 7 12439 
3 12-10-2014 11415 134 68.81763936 9 12439 
3 13-10-2014 11406 131 65.91573279 3 12439 
3 14-10-2014 11403 120 63.99761316 15 12439 
3 15-10-2014 11388 126 59.79922428 6 12438 
3 16-10-2014 11382 119 60.38474789 5 12438 
3 17-10-2014 11377 106 58.30004306 1 12438 
3 18-10-2014 11376 83 53.397514 2 12438 
3 19-10-2014 11374 62 44.32919205 5 12437 
3 20-10-2014 11369 58 34.55698742 0 12437 
3 21-10-2014 11369 52 30.08102091 13 12437 
3 22-10-2014 11356 57 26.6763318 8 12435 
3 23-10-2014 11348 56 27.19480783 4 12435 
3 24-10-2014 11344 57 27.03831255 8 12435 
3 25-10-2014 11336 51 27.31245158 18 12435 
3 26-10-2014 11318 63 25.45154676 2 12434 
3 27-10-2014 11316 59 28.7467527 3 12433 
3 28-10-2014 11313 61 28.51769463 12 12432 
3 29-10-2014 11301 71 29.09325075 8 12432 
3 30-10-2014 11293 74 32.53030649 6 12432 
3 31-10-2014 11287 80 34.62234961 9 12432 
99
4 Transmission dynamics of LSD 
 
 
 
 
 
3 1-11-2014 11278 76 37.25226362 7 12432 
3 2-11-2014 11271 76 36.80698568 3 12432 
3 3-11-2014 11268 75 36.66227035 2 12432 
3 4-11-2014 11266 70 36.29023786 4 12432 
3 5-11-2014 11262 56 34.54432731 9 12432 
3 6-11-2014 11253 63 29.42690637 5 12432 
3 7-11-2014 11248 65 30.03874457 4 12432 
3 8-11-2014 11244 57 30.88759199 0 12432 
3 9-11-2014 11244 49 28.5634674 1 12432 
3 10-11-2014 11243 44 25.2081269 0 12432 
3 11-11-2014 11243 35 22.49264124 0 12432 
3 12-11-2014 11243 28 18.6851084 0 12432 
3 13-11-2014 11243 25 15.17266023 0 12432 
3 14-11-2014 11243 23 13.05611458 0 12432 
3 15-11-2014 11243 19 11.71823724 0 12432 
3 16-11-2014 11243 10 9.983427102 0 12432 
3 17-11-2014 11243 5 6.494613808 0 12432 
3 18-11-2014 11243 1 3.735749488 0 12432 
3 19-11-2014 11243 1 1.539118583 0 12432 
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Abstract 
  The current study was carried out in central and north-western parts of 
Ethiopia to assess the efficacy of Kenyan sheep pox virus strain vaccine (KS1 O-180) 
against natural lumpy skin disease (LSD) infection under field conditions by 
estimating its effect on the transmission and severity of the disease. For this study, 
an LSD outbreak was defined as the occurrence of at least one LSD case in a specified 
geographical area. An observational study was conducted on a total of 2053 (1304 
vaccinated and 749 unvaccinated) cattle in 339 infected herds located in 10 sub-
kebeles and a questionnaire survey was administered to 224 herd owners. Over 60% 
of the herd owners reported that the vaccine has a low to very low effect in 
protecting animals against clinical LSD; almost all of them indicated that the vaccine 
did not induce any adverse reactions. In the unvaccinated group of animals 31.1% 
were diagnosed with LSD while this was 22.5% in the vaccinated group (P<0.001). 
Severity of the disease was significantly reduced in vaccinated compared to 
unvaccinated animals (OR = 0.68, 95% CI: 0.49; 0.96). Unvaccinated infected animals 
were more likely (predicted fraction = 0.89) to develop moderate and severe disease 
than vaccinated infected animals (predicted fraction = 0.84).  
  LSD vaccine efficacy for susceptibility was estimated to be 0.46 (i.e. a 
susceptibility effect of 0.54) while the infectiousness effect of the vaccine was 1.83. 
In other words, the vaccine reduces the susceptibility by a factor of two and increases 
infectiousness by approximately the same amount. LSD transmission occurred in 
both vaccinated and unvaccinated animals, the estimated reproduction ratio (R) was 
1.21 in unvaccinated animals compared to 1.19 in vaccinated ones, and not 
significantly different. In conclusion, KS1 O-180 vaccination, as applied currently in 
Ethiopia, has poor efficacy in protecting cattle populations against LSD, neither by 
direct clinical protection nor by reducing transmission, and this signifies the urgent 
need to either improve the quality of the vaccine or to develop potent alternative 
vaccines that will confer good protection against LSD. 
 
Key words: Capripoxvirus, Kenyan sheep pox (KS1 O-180) vaccine, Lumpy skin 
disease, Reproduction ratio, Severity, Vaccine efficacy 
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5.1 Introduction 
  Lumpy skin disease (LSD) is a disease of cattle caused by LSD virus, a DNA 
virus, which belongs to the family Poxviridea, subfamily Chordopoxvirinae and it is of 
the genus Capripoxvirus. The disease is characterized by fever, nodular lesions on the 
skin and mucous membranes, inflammatory and oedematous swellings of the limbs 
and brisket, lymphadenopathy, deterioration of body condition and drop in milk 
production (Davies, 1991; Quinn et al., 2002; Radostits et al., 2007). It has spread to 
most African countries, Middle East countries and recently to Europe (Davies, 1991; 
Tuppurainen and Oura, 2012; Tasioudi et al., 2016; WAHID, 2016; Tuppurainen et al., 
2017). LSD is endemic in Ethiopia and is a constant threat to the livestock sector since 
its first occurrence in 1981 (Mebratu et al., 1984; Gari et al., 2010). LSD outbreaks 
occur frequently in various regional states of the country, despite intensive 
vaccination campaigns (APHRD, 2012). It is an economically devastating and 
therefore a notifiable disease as per OIE disease categorization (Gari et al., 2011; 
Tuppurainen and Oura, 2012; OIE, 2016). 
Vaccination, movement control and slaughter of infected and in-contact 
animals are considered as options for the control of LSD. However, it is widely agreed 
that vaccination is the most manageable and realistic approach to control the 
disease in endemic and resource poor countries (Carn, 1993; Tuppurainen et al., 
2014). Live attenuated vaccines based on sheep pox virus (for example, Kenyan 
sheep pox (KS1 O-180), Romanian sheep pox and Yugoslavian RM 65 sheep pox 
vaccines), goat pox virus (Gorgan goat pox vaccine), and LSDV (Neethling strain 
vaccine) have been used for the control of LSD (OIE, 2010; Tuppurainen et al., 2014; 
Gari et al., 2015).  
In general vaccination can exert important effects, both at the individual 
and at the population level. It may help to directly protect vaccinated animals, 
reduce severity of the disease by reducing all or some of its symptoms or it may 
reduce transmission of pathogens by lowering susceptibility and/or infectiousness, 
and thus also indirectly reduce the risk for other vaccinated and unvaccinated 
individuals to become infected (De Jong, 1994; Halloran et al., 1997; Van der Goot et 
al., 2007; Aznar et al., 2011; OIE, 2015). The effect of vaccine intervention on the 
dynamics of infectious diseases, i.e. in the population, can be estimated by the 
reproduction ratio (R) which is the average number of secondary cases arising from 
one typically infected animal during its entire infectious period (Diekmann et al., 
1990; Heffernan et al., 2005). 
LSD vaccine failure has been reported in several countries including 
Ethiopia. During the 2006 outbreak in Israel, 11% (4.2% in dairy and 33.7% in feedlot 
5 Vaccination to control LSD 
 
 
142 
 
cattle) of RM65 (Ramayer strain) vaccinated cattle became infected (Brenner et al., 
2009). In Jordan, Abutarbush (2014) reported an overall LSD morbidity of 4.7% in 
cattle populations vaccinated with RM65 (Jovivac®) and LSD vaccine of unknown 
origin. Kumar (2011) reported a continued LSD outbreak in Oman for more than 
three months after vaccination of cattle herds with Kenyan sheep and goat pox 
vaccine. In Ethiopia, LSD vaccine failure has been reported since 1993 (Carn, 1993). 
Ayelet et al. (2013) estimated morbidity to be 23.8% in the cattle population of 
central Ethiopia after vaccination with KS1 O-180 virus strain vaccine. However, a 
better protection was claimed with Neethling vaccine (1.11% morbidity) and with a 
10 times higher dose of the RM65 vaccine (1.85% morbidity) (Ben-Gera et al., 2015). 
Vaccines in general may give only partial protection (leaky vaccines) or protect only 
some of the individuals (all-or-nothing) (Smith et al., 1984). In addition, further 
immunization failure may arise due to insufficient vaccine coverage or factors related 
to the host, vaccine, or vaccination quality due to handling, reconstitution or 
administration of the vaccine (Quinn et al., 1999).  
Ayelet et al. (2013) and Gari et al. (2015) reported that KS1 O-180 vaccine 
provides incomplete protection in immunized animals. However, the level of 
protection and its effect on the severity of the disease have not been documented 
well under field conditions. KS1 O-180 vaccine is still applied as the sole means of 
LSD control in Ethiopia. Hence, the aims of this study was to assess the efficacy of 
KS1 O-180 virus strain vaccine against natural LSD infections under field conditions 
by estimating its effect on the transmission and severity of the disease.  
 
5.2 Materials and Methods 
5.2.1 Study and study area 
  The study consisted of two parts:  
(1) A questionnaire survey focusing on herd owners’ information regarding several 
aspects of vaccination which was undertaken in central and north-western 
parts of Ethiopia (Figure 5.1). In central Ethiopia, it was undertaken in Ada’a, 
Sebeta Hawas, Ambo, Dendi, Debrelibanos, Kuyu and Hidabu Abote districts in 
Oromia National Regional State. In north-western part, the data were collected 
from Dejen, Gozamen, Hulet Ejju Enessie and Jabitenan districts in Amhara 
National Regional State. The dominant agricultural production system in the 
study areas was mixed crop-livestock system. The grazing practice in almost all 
study areas was open grazing on communal pasture land where animals from 
a village were herded together. 
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(2) A vaccine efficacy follow-up study under field conditions was undertaken in 
the north-western part of Ethiopia in Mota town and the surrounding four 
rural kebeles (the lowest administrative structure in Ethiopia, in which at 
least 500 households (3,500 to 4,000 persons) live and cover on average 
about 53 km2 and 3 km2 land area in rural and urban places, respectively) of 
Hulet Ejju Enessie district, East Gojjam Administrative Zone, Amhara 
National Regional State (Figure 5.2). The rural kebeles were Hibre Selam, 
Debre Gubae, Beza Bizuhan, and Ayen Berhan. Cattle populations of ten 
sub-kebeles were enrolled in the study namely Mota (from Mota town), 
Akobe, Semo, and Shewaber from Hibre Selam, Atetanat and Yerez from 
Beza Bizuhan, Webmariam from Ayen Berhan, and Kesmender, Komma and 
Zenabach from Debre Gubae kebele.  
 
Figure 5.1 Map of Ethiopia showing the area where the questionnaire survey was 
performed. 
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Figure 5.2 Map of Hulet Ejju Enessie district (Ethiopia) showing LSD vaccine efficacy 
observational study site. 
 
5.2.2 Questionnaire survey 
  The study population for the questionnaire survey was about 13,200 cattle 
herd owners living in 33 selected kebeles of 11 districts. These owners were 
smallholder farmers with the main purpose of subsistence farming, that is: draft 
power for crop production, milk for consumption, manure for soil fertility and fuel, 
and cash income. Animals were kept in an extensive management system and most 
of the herds were composed of local Zebu breed cattle. Animals in this system share 
communal grazing and watering resources. The term “herd” in this study designates 
an aggregate of animals kept together day and night and owned by a household.  
 
5.2.2.1 Study design and data collection 
  Eleven districts located in the central and north-western parts of Ethiopia 
were identified for a cross-sectional questionnaire survey. The districts were 
selected based on the recent LSD outbreak occurrence, location and accessibility. For 
this study, an LSD outbreak was considered, if at least one case of LSD occurred in a 
specified geographical area (usually kebele). Three kebeles were randomly selected 
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from each district. From each kebele, five to eight herd owners willing to participate 
were interviewed. The survey data were collected from a total of 224 herd owners 
from January 2015 to May 2015.  
  The data were collected by face to face interview using the local language. 
After getting an informed consent from the herd owners, the interviewer asked 
questions about the vaccination status, vaccination frequency, the vaccination 
service provider, fee of the vaccination, the vaccination date and when the animals 
become infected if there was any infected animal in his herd. Furthermore, the herd 
owners were requested to express their opinion on the effectiveness of the vaccine 
in protecting cattle against LSD and the adverse reactions to the vaccine. The vaccine 
is considered to be protective from day 21 to one year post vaccination. All responses 
were recorded in a predesigned response sheet. 
 
5.2.2.2 Data management and analysis  
  Descriptive statistics were used to summarise the data on vaccination 
coverage at herd level, frequency of vaccination, and owner’s opinion about the 
effectiveness and adverse reactions of the LSD vaccine. 
 
5.2.3 Follow-up study 
  A follow-up study was carried out after the index case of LSD appeared in Beza 
Bizuhan kebele at the specific village called Chech on 29 April 2014. The disease 
stayed restricted in the village for a reasonable period of time but after that it spread 
to other villages and surrounding kebeles. The selected area for follow-up was Mota 
town and its surrounding area, representing 10 sub-kebeles. In the area, animals 
were owned by smallholder farmers with the main purpose of subsistence farming 
except for six dairy farms which kept cattle for commercial purposes. Most of the 
herds were composed of local Zebu breed cattle and managed under extensive 
management. The six dairy herds consisted mainly of Holstein-Zebu cross and were 
managed under semi-intensive or intensive conditions.  
The study population included 7464 heads of cattle grouped in 1203 herds. 
The cattle population in each sub-kebele (considered as ten separate populations as 
they were herded on common pasture land within a sub-kebele) was vaccinated 
partially. This partial coverage was not purposive but due to the failure of the owner 
to get their animals vaccinated. The vaccination campaign was undertaken at least 
one month before the entrance of the disease into a specific sub-kebele. The 
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vaccination was provided by the public veterinary service of the Hulet Ejju Enessie 
district following the index case appearance in the area.  
 
5.2.3.1 Study design and herd selection 
  This study was designed as a prospective cohort study. At the beginning of 
the study, ten cattle populations (i.e. all cattle in a sub-kebele excluding calves less 
than 6 month old) with partial vaccination coverage and LSD free status were 
selected. All herds in the selected populations were inspected on a weekly basis for 
clinical signs of LSD. The herd owners were also asked to report any suspicion of the 
disease. The sub-kebeles were selected based on their partial vaccination status. We 
selected populations with different vaccination coverage because that is a pre-
requisite to estimate both vaccine efficacy for susceptibility and infectiousness 
(Longini et al., 1998; Aznar et al., 2011). The vaccination coverage level in the 
selected 10 sub-kebele cattle populations ranged from 3-95%. Since the vaccine 
coverage was strictly inferior to 100%, a number of infections within the vaccinated 
group was expected to occur. The animals, whether vaccinated or not, were followed 
starting from August 1, 2014 to November 31, 2014, i.e. from the day the first case 
was detected in the sub-kebele until no more new cases were recorded. If an animal 
in a herd was diagnosed with LSD and the owner volunteered to participate, the herd 
was enrolled in the study. Therefore, the main inclusion criteria for a herd were the 
infection status of the herd and the willingness of the owner to participate. A herd 
was considered positive if at least one animal showed LSD-characteristic nodular 
lesions. In total, 448 herds were recorded as being affected and of these, 339 farmers 
(75.7%) were willing to participate and all their bovines (n=2053) enrolled in the 
study.  
 
5.2.3.2 Data collection 
  In the ten sub-kebeles, infected herds were visited twice a week by animal 
health professionals and by the first author, and clinical signs were recorded. The 
severity of LSD was assessed at three levels: mild, moderate and severe. Mild LSD 
was defined as only few nodular lesions (<5) in some part of the body, mild fever (39-
39.50C) and quick recovery (within a week); the moderate level was assigned if fever, 
inappetence, many nodular lesions/swelling on the limb or brisket, and weakness 
was present; severe LSD was scored if high fever (>400C), extensive nodular 
lesions/swellings, anorexia, weakness, emaciation or death was observed.  
Animal data including breed, sex, age and records like vaccination status, 
vaccination date and type of vaccine used were compiled for all animals at the first 
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herd visit. Type of herd and sub-kebele were also recorded. The first visit was made 
by the district veterinary team and the first author. The animal health professionals 
who collected the data from infected animals were blind for the vaccination status 
of the affected animals. 
Biopsy samples of skin nodules were collected from a sample of the affected 
animals in each sub-kebele and analysed by conventional and Snapback Real-time 
PCR (polymerase chain reaction) techniques following the method described by 
Tuppurainen et al. (2005) and Gelaye et al. (2013) to confirm that the clinically 
observed disease truly was LSD. A total of 34 skin samples were collected for LSD 
confirmation. 
 
5.2.3.3 Vaccine used for control and prevention of LSD 
  The live attenuated vaccine of KS1-O180 produced by National Veterinary 
Institute (NVI), Ethiopia was the only vaccine used for prevention and control of LSD 
in Ethiopia. It recently has been reported that the virus used for the production of 
KS1-O180 is not a sheep pox virus but was found to be LSDV (Gelaye et al., 2015). 
The vaccine was prepared in 20 ml vials containing 100 doses and reconstituted by 
100 ml of cool and sterile saline water; 103.5 TCID50 was administered per animal as 
recommended by the manufacturer. A suspension of 1 ml vaccine was injected 
subcutaneously at the neck side (NVI, 2010 ). 
 
5.2.3.4 Data management and analysis  
  Descriptive statistics were used to describe the morbidity and mortality in 
cattle populations with different vaccination coverage.  
  To analyse the association between the occurrence of LSD infections in 
animals (i.e. the cases, which are assumed to be binomial distributed) and 
independent variables (vaccination status, breed, age, sex, herdtype, and location), 
multivariable logistic regression was performed (STATA version 14). Vaccination 
status was the main effect of interest while location, breed, age, sex and herdtype 
were added as additional explanatory variables. All factors were fitted in a 
multivariable regression model and the final model was obtained by a backward 
stepwise elimination procedure while checking for confounding. For that purpose 
confounding was defined as a change of at least 25% in any of the regression 
coefficients after removing a non-significant (p>0.05) variable from the model. 
Interactions were tested for all combinations of the significant main effects. 
Generalised estimating equations (GEE, population averaged model) was run using 
herd as random effect. An exchangeable correlation structure was specified for the 
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random effect and results were expressed as Odds ratio (OR) and its 95% confidence 
interval (CI).  
To estimate the effect of vaccination on the severity (mild, moderate or 
severe) of LSD, first a univariable and then multivariable (backwards elimination 
process) ordered logistic regression analysis was run by incorporating breed, age, 
sex, herdtype, and kebele as potential factor and retaining it in the model as 
confounder when necessary. The probability of a vaccinated or unvaccinated 
infected animal falling in either of the severity categories was computed using 
estimated coefficients and the associated cut points of the ordered logistic 
regression analysis. Proportionality of odds across response categories was tested 
using the approximate likelihood-ratio test (omodel logit command in STATA version 
14). 
Multivariable regression analysis using a generalized linear model (GLM) 
was performed to assess the effect of vaccination on the transmission of LSD by 
setting LSD infection of animals as binomial (yes/no) dependent variable and 
vaccination status (yes/no) and fraction of vaccinated among the infected 
(FracVaccI) as independent variables. The model was fit using the complementary 
loglog (cloglog) link function and log (number of infected animals/total number of 
animals per sub-kebele) as offset (Velthuis et al., 2003) using STATA version 14. The 
susceptibility and infectiousness coefficients obtained from the analysis were used 
to calculate the transmission parameters by inserting them into the formulae 
described in Table 5.1. Note that in this case we observed the total outbreak in the 
sub-kebele and thus the regression coefficient estimates pertain to the final size of 
the outbreak and thus we directly estimate the reproduction ratio R rather than the 
transmission rate parameter β. 
Vaccine efficacy for susceptibility (VEs) and infectiousness (VEi) were 
estimated using formula 1 and 2 as described by Halloran et al. (2010) and Aznar et 
al. (2011) and for this the four transmission parameters with their expression were 
defined (Table 5.1). 
𝑉𝑉𝑉𝑉𝑉𝑉 = 1 − �𝑅𝑅𝑅𝑅𝑅𝑅
𝑅𝑅𝑅𝑅𝑅𝑅
� = 1 − �𝑅𝑅𝑅𝑅𝑅𝑅
𝑅𝑅𝑅𝑅𝑅𝑅
�                                                          (1) 
𝑉𝑉𝑉𝑉𝑉𝑉 = 1 − �𝑅𝑅𝑅𝑅𝑅𝑅
𝑅𝑅𝑅𝑅𝑅𝑅
� =  1 − �𝑅𝑅𝑅𝑅𝑅𝑅
𝑅𝑅𝑅𝑅𝑅𝑅
�                                                          (2) 
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Table 5.1 The fitted model to estimate LSD transmission rates in cattle populations with 
different levels of vaccination coverage in Mota town and Hulet Ejju Enessie district of 
Ethiopia.  
 
Partial R 
value 
Log β = c0 + c1*vaccination + c2*fracVaccIa 
Description 
Expressionb 
Ruu Transmission from an unvaccinated to an 
unvaccinated animal 
 
ec0 
Ruv Transmission from an unvaccinated to a 
vaccinated animal 
 
ec0 + c1 
Rvu Transmission from a vaccinated to an 
unvaccinated animal 
 
ec0 + c2 
Rvv Transmission from a vaccinated to a 
vaccinated animal 
 
ec0 + c1 + c2 
a Fraction of vaccinated among the infected. 
b Relation between infection parameters and estimated coefficients of the model, where c0 is 
the estimated intercept and c1 and c2 are the estimated regression coefficients of the 
variables vaccination and fracVaccI respectively. 
 
A vaccine with an efficacy of 0 was considered as not effective whereas a 
value of 1 was considered fully efficacious. Values of vaccine efficacies above 0.7 are 
considered ‘good’, whereas vaccine efficacies in the range of 0.3 to 0.7 are generally 
considered ‘reasonable’ (Halloran et al., 2010; Lu. et al., 2013). However, this 
interpretation of vaccine efficacy does not correspond to whether vaccination will 
reduce R so that R<1, because whether R<1 also depends on the R in the absence of 
vaccination. 
 The reproduction ratio in vaccinated animals was calculated by multiplying 
the effects of vaccination on susceptibility (exp(coefficient of the independent 
variable Vaccination)), and on infectiousness (exp(coefficient of the fraction of 
vaccinated among the infected)) and the intercept of the regression model. Whereas 
R for unvaccinated was calculated from the exponent of the intercept only. 
 
5.3 Results    
5.3.1 Questionnaire survey 
  Based on the herd owner’s response, the vaccination coverage at herd level 
was estimated to be 56.3%. The public veterinary service vaccinated the majority 
(88.9%) of the herds and more than 95% of the herds did not get routine prophylactic 
vaccination against LSD but were vaccinated just after the LSD index case was 
reported in a neighbouring kebele. More than 60% of the herd owners deemed the 
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vaccine to be of low to very low efficacy in protecting against clinical LSD, however, 
almost all of them responded that the vaccine did not induce any adverse reaction 
after vaccination (Table 5.2). 
 
Table 5.2 Ethiopian herd owners’ opinion on LSD vaccine effectiveness and adverse 
reactions. 
 
Level Vaccine effectiveness Vaccine adverse reactions 
Frequency % Cum. % Frequency % Cum. % 
Very high 0 0 0 1 0.8 0.8 
High 29 23.2 23.2 1 0.8 1.6 
Moderate 20 16.0 39.2 0 0 1.6 
Low 6 4.8 44 0 0 1.6 
Very low 70 56.0 100 123 98.4 100 
Total 125 100 100 125 100 100 
 
5.3.2 Follow-up study 
5.3.2.1 Description of LSD occurrence and vaccination 
  The follow-up study was undertaken in 10 sub-kebeles with 339 infected 
herds comprising a total of 2053 cattle of which 1304 (63.5%) were vaccinated (Table 
5.3). Herd size varied from 1 (n=6) to 37 (n=1) with an average of 6 and a median of 
6 animals. About 95% of the herds had 10 or less animals. The study population 
consisted of 346 (16.8%) calves, 263 (12.8%) heifers, 227 (11.1%) bulls, 490 (23.9%) 
cows and 727 (35.4%) oxen. Of the 2053 animals, 526 (25.6%) were diagnosed with 
LSD, 233 (31.1%) in the unvaccinated group and 293 (22.5%) in the vaccinated group 
(Chi-square test: p<0.001). The PCR results confirmed the LSD infection in all ten sub-
kebeles.  
The multivariable population averaged model showed that herd did not 
contribute significantly to the total variance. Therefore multivariable logistic 
regression without random effects was performed which showed that the estimates 
and their significance were very similar to the random effects model. All variables 
remained significant in the multivariable analysis except herdtype but this variable 
confounded the estimates of location. Results show that vaccination significantly 
decreased the risk of LSD (OR= 0.49, 95% CI: 0.37; 0.64). Crossbreeds, males and 
older age were associated with increased risk to be LSD positive compared to their 
references and the interaction between vaccination and breed was significant. 
Vaccination is more efficient in crossbreed (OR= 0.49*0.43=0.21) than local breed 
(OR=0.49) animals (Table 5.4). 
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5.3.2.2 LSD severity and vaccination 
  The severity of LSD was assessed on a total of 480 clinically infected cattle 
(264 vaccinated and 216 unvaccinated). In unvaccinated animals, the majority of the 
affected animals (50.5%) were categorized as severe and 9.7% fell in the mild 
category whereas in vaccinated animals these figures were 42.8% and 17.1% 
respectively (Table 5.5). The results of the multivariable ordered logistic model 
showed that only vaccination was significantly associated with a different (lower) 
severity score (Odds Ratio (OR) = 0.68, 95% confidence interval (CI): 0.49; 0.96). The 
test for the proportional odds assumption was not significant (p = 0.21) indicating 
that it is valid to report the OR as 0.68. Furthermore, the predicted fraction showed 
that the probability of developing moderate and severe disease was slightly higher 
in unvaccinated animals (0.89) compared to vaccinated animals (0.84). 
 
Table 5.5. LSD severity in vaccinated and unvaccinated cattle population (n= 480) of 
Ethiopia.  
 
Severity 
level 
Vaccinated Unvaccinated 
Number Proportion 
in  % 
Number Proportion 
in % 
Mild 45 17.1 21 9.7 
Moderate 106 40.2 86 39.8 
Severe 113 42.8 109 50.5 
Total 264 100 216 100 
 
 
5.3.2.3 LSD vaccine efficacy with respect to transmission 
  The multivariable GLM analysis showed that both the susceptibility (exp(b) = 
0.54, 95% CI: 0.44; 0.66) and infectiousness (exp(b) = 1.83, 95% CI: 1.28; 2.61) effects 
of the vaccine are significant and thus the effects are a reduction in susceptibility by 
a factor 2 and an increase in infectiousness by a factor 2 (Table 5.6).  
 A 0.46 vaccine efficacy for susceptibility and -0.83 for infectiousness recorded 
in this study were obtained by inserting the corresponding estimated partial 
reproduction ratios (Ruu = 1.21, Ruv = 0.65, Rvu = 2.22 and Rvv = 1.19) into formula 
1 and 2 (Table 5.1 and 5.6).  
 The estimated reproduction ratios for vaccinated and unvaccinated cattle 
were almost equal: 1.19 (95% CI: 1.02-1.39) and 1.21 (95% CI: 1.01-1.46). The 0.98 
(95% CI: 0.73-1.33) reduction in R by vaccination was not significantly different from 
1 (p = 0.92). 
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Table 5.6 Analysis of the effect of vaccination on susceptibility and infectiousness of LSD 
in Mota town and Hulet Ejju Enessie district of Ethiopia (n=2053) using GLM. 
 
 
Variable 
Susceptibility/i
nfectiousness 
Coefficient 
(b) 
Effect 
(exp(b)) 
 
95% CI 
p-
value 
Vaccination Susceptibility -0.62 0.54 0.44- 0.66 0.000 
FracVaccIa Infectiousness 0.60 1.83 1.28-2.61 0.001 
Constant  0.19 1.21 1.00-1.46 0.045 
aFraction of vaccinated among the infected in each population (= sub-kebele). 
 
 
5.4 Discussion 
  LSD vaccine breakdown and a concomitant morbidity are reported in 
Ethiopian cattle since 1993 (Carn, 1993) while vaccination with KS1 O-180 vaccine is 
the major control method in the country. However, the efficacy of KS1 O-180 virus 
strain vaccine against natural LSD infections under field conditions and its impact on 
the transmission and severity of the disease is largely unknown and both are 
estimated in this paper. 
 
5.4.1 Questionnaire survey 
  The questionnaire survey shows that in almost all study districts no regular 
vaccination program for LSD is applied. This is related to the long time (5 or more 
years) interval between LSD epidemics (Woods, 1988) and resource limitation. LSD 
vaccination is usually initiated by the appearance of an index case in an area. 
Therefore, vaccination for LSD is commonly carried out at the face of the outbreak 
to control the disease occurrence. However, vaccinating animals during an outbreak 
may aggravate the transmission of LSD due to iatrogenic transmission from healthy 
looking, incubating animals to susceptible animals (Hunter and Wallace, 2001). The 
survey also showed that most of the vaccinations were provided by the public 
veterinary service. This clears out the suspect that the vaccine failure might be 
related to the administration of the vaccine by incompetent practitioners (and that 
apply LSD vaccination illegally).  
Vaccination coverage is an important issue in disease control. Cattle 
populations with low vaccination coverage are assumed to remain at higher risk for 
the disease. The 56.3% vaccination coverage at herd level estimated in this study is 
low given that the vaccine is provided free of charge. The reason for low coverage 
might be related to owner’s belief that the vaccine is not protective. More than 60% 
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of the herd owners interviewed in the questionnaire survey reported low 
effectiveness of KS1 O-180 vaccine in protecting cattle against clinical LSD confirming 
the estimated poor performance of the vaccine (Ayelet et al., 2013; Gelaye et al., 
2015). However, the low vaccination coverage is not related to vaccine adverse 
effects as almost all respondents did not indicate any adverse effect. This is in 
agreement with what Gelaye et al. (2015) reported for the vaccine. However, in 
other countries adverse reactions in cattle vaccinated with sheep pox and Neethling 
virus based vaccine have been reported like swelling on the injection site and 
developing active LSD (Weiss, 1968; Yeruham et al., 1994; Ben-Gera et al., 2015; 
Abutarbush et al., 2016). 
 
5.4.2 Follow-up study 
  The 22.5% morbidity in vaccinated animals recorded in the follow-up study is 
comparable to 23.8% morbidity reported in central Ethiopia in cattle vaccinated with 
Kenyan sheep pox vaccine strain (Ayelet et al., 2013). However, a much lower 
morbidity of 4.7% (Abutarbush, 2014), 11% (Brenner et al., 2009) and 1.6% (Ben-
Gera et al., 2015) were recorded in vaccinated cattle of Jordan and Israel. This 
difference might be attributed to the difference in the quality of the vaccine used, 
vaccination coverage, management system, environment or climate difference of 
the areas where the animals are kept. 
The factors age group, breed, sex, herdtype and location were included into 
the logistic regression model to adjust the estimate of vaccination. The adjusted 
odds ratio for vaccination was 0.49 which indicates that vaccination is protective for 
LSD. Unvaccinated animals have 2.04 (1/0.49) times higher odds to acquire LSD than 
vaccinated ones. The interaction between vaccination and breed was significant and 
it revealed that vaccination was more efficient in crossbreed (OR = 0.21) than local 
breed (OR = 0.49) animals. This might be related with the more susceptibility nature 
of Holstein-Zebu cross to LSD than pure local Zebu animals (Davies 1991; OIE, 2010). 
Possible confounding factors which are not measured in this study include 
movement of animals and vector density. No animal movement restriction was 
applied in the study area; animals move freely from area to area. This practice was 
similar in all study kebeles and for both vaccinated and unvaccinated animals. Vector 
density is also assumed to be similar in all study kebeles because they are located in 
the same geographical area with similar weather conditions and altitude and on top 
of that they are all within the range of the insect flight zone.  
Vaccination was associated with less severe LSD symptoms. This finding is 
in agreement with the observation of Abutarbush (2014) who reported a 
considerable change in feed intake and milk production, fever, and a longer duration 
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of illness in the majority of unvaccinated cattle as compared to vaccinated cattle. 
Hence, LSD vaccination reduces disease severity and as consequence it may prevent 
part of the production loss due to LSD. Increased vaccine dose is claimed to improve 
the protective efficacy of the vaccine. Ben-Gera et al. (2015) reported a low incidence 
(1.85%) in cattle vaccinated with a 10 fold increased dose of RM65 vaccine. The 
regular vaccine dose used to immunize cattle against LSD in Ethiopia is 10 fold 
compared what used to immunize sheep and goat. For cattle, LSD vaccine contains 
103.5 TCID50 attenuated virus per field dose while for sheep and goat it is, 102.5 TCID50 
per dose (NVI, 2010). 
The vaccine efficacy of 0.46 as estimated for susceptibility is within the 
‘reasonable’ efficacy range of 0.3 to 0.7 (Halloran et al., 2010; Lu et al., 2013).This 
indicates that vaccination reduces susceptibility to LSD 1.85 times (1/(1-0.46)). 
However, vaccinated infected animals are 1.83 times more infectious than 
unvaccinated infected ones. This is contradictory from what is expected from a 
vaccine. The increased infectiousness might be related with disease management 
practices. In the usual management practice, diseased animals are isolated and 
penned separately from healthy animals. However, the situation in vaccinated LSD 
affected animals is different, they are less diseased (not easily noticed) and thus 
remain longer in the herd (not isolated or removed) while they are infectious. This 
condition might be favourable for the transmission of the virus. Therefore, in this 
regard, animal disease management might contribute to increased infectiousness. 
However, this finding needs further investigation because the disease management 
and other factors which can influence the infectiousness were not under control. In 
general, the gain in decreasing susceptibility in vaccinated cattle is cancelled out by 
almost the same increment of infectiousness and this indicates that KS1 O-180 
vaccine is not effective in controlling LSD in cattle populations. The overall low 
efficacy of the vaccine substantiates the previous findings that vaccination against 
LSD does not provide protection from clinical disease (Ayelet et al., 2013; 
Abutarbush, 2014; Gari et al., 2015). Most LSD vaccines currently available, except 
the homologous Neethling vaccine, provide poor protection against LSD 
transmission (Brenner et al., 2009; Somasundaram, 2011; Tuppurainen et al., 2014; 
Ben-Gera et al., 2015), which is a challenge for the control of the disease. 
Although vaccinating cattle against LSD is considered the main control 
option in resource poor countries like Ethiopia, little is known about the effect of 
vaccination on the disease dynamics. In the current study, the estimated 
reproduction ratios were 1.21 and 1.19 for unvaccinated and vaccinated cattle, 
respectively. In both cases R is greater than 1 and confirms that LSD virus can spread 
in cattle populations, regardless of their vaccination status, and can cause a major 
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outbreak. This shows that vaccination with KS1 O-180 vaccine alone cannot eliminate 
the disease from a cattle population. Thus, a more competent LSD vaccine and other 
additional measures, like movement control, detection and removal of infected 
animals, are needed to bring the reproduction ratio to below 1.0. 
An observational study was chosen for this study because it is less costly 
and enables to assess the performance of the vaccine under real-life circumstances, 
including the complex and not easily controllable exposure to LSDV due to the insect 
vectors involved. Important confounders were measured and equal exposure risk of 
vaccinated and unvaccinated animals were assumed. Furthermore, the study design 
avoids the ethical problem of using a placebo when an approved vaccine is available 
(Torvaldsen and McIntyre, 2002).  
 Observational studies are prone to potential biases due to its uncontrolled 
nature. The biases may be related to selection, misclassification of cases, 
confounding factors, dealing with the impact of unknown or unmeasured factors 
(Dohoo et al., 2003), missing information, and non-comparability of groups. The 
distribution of potentially confounding variables among the study groups and other 
variables which were not considered might also be a source of bias. Another 
limitation to this study is related to the severity assessment; subjectivity might be 
somehow involved in allocating affected animals into different categories and on few 
occasions the observer might have been unblinded for the vaccination status of the 
animal because the owner might have complained about the poor efficacy of the 
vaccine. We assumed that exposure to infection was equal in both vaccinated and 
unvaccinated animals, that all important confounders were measured and adjusted 
for by the model used. Considering these limitations, the results reported here 
should be interpreted carefully.  
 
5.5 Conclusion 
  The results of our study showed that KS1 O-180 strain vaccine reduces 
susceptibility of cattle to LSD but it also increases infectiousness by about the same 
amount, partially because animals with less severe disease signs may remain 
undetected in the herd for longer periods. Generally, the vaccine has poor efficacy 
in protecting cattle populations against LSD, neither by direct clinical protection nor 
by reducing transmission. Therefore, the prevailing situation dictates the urgent 
need of a competent LSD vaccines development to control LSD in endemic countries 
and to halt its current spread to free countries and continents.  
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Abstract 
Lumpy skin disease (LSD), an infectious viral disease of cattle, causes 
considerable financial losses in livestock industry of affected countries. A 
questionnaire survey with the objectives of determining direct economic losses of 
LSD (mortality loss, milk loss, draft loss) and treatment costs (medication and labour 
cost) per affected herd, and assessing the cost effectiveness of vaccination as a 
means for LSD control was carried out in the central and north-western parts of 
Ethiopia. From a total of 4430 cattle (in 243 herds) surveyed, 941 animals (in 200 
herds) were reported to be infected. The overall morbidity and mortality at animal 
level were 21.2% and 4.5%, and at herd level these were 82.3% and 24.3%. There 
was a significant difference in animal level morbidity and mortality between 
categories of animals. Over 94% of the herd owners ranked LSD as a big or very big 
problem for cattle production. A large proportion (92.2%) of the herd owners 
indicated that LSD affects cattle marketing. A median loss of USD 375 (USD 325 in 
local Zebu and USD 1250 in Holstein-Friesian local Zebu cross cattle) was estimated 
per dead animal. Median losses per affected lactating cow were USD 141 (USD 63 in 
local Zebu cows and USD 216 in Holstein-Friesian local Zebu cross cows) and, USD 36 
per affected ox. Diagnosis and medication cost per affected animal were estimated 
at USD 5. The median total economic loss of an LSD outbreak at herd level was USD 
1176 (USD 489 in subsistence farm and USD 2735 in commercial farm). At herd level, 
the largest component of the economic loss was due to mortality (USD 1000) 
followed by milk loss (USD 120). LSD control costs were the least contributor to herd 
level losses. The total herd level economic losses in the commercial farm type were 
significantly higher than in the subsistence farm type. The financial analysis showed 
a positive net profit of USD 136 (USD 56 for subsistence farm herds and USD 283 for 
commercial herds) per herd due to LSD vaccine investment. It should be noted that 
only the noticeable direct costs and treatment costs associated with the disease 
were considered in the study. Generally, vaccination is economically effective and 
should be encouraged.  
 
Key words: LSD outbreak, Morbidity, Mortality, Economic loss, Vaccination, Ethiopia  
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6.1 Introduction 
Lumpy skin disease (LSD) is a severe systemic disease of cattle caused by the 
lumpy skin disease virus, which belongs to the genus Capripoxvirus, family 
Poxviridae. It is characterized by fever, nodular lesions on the skin and mucous 
membranes and lymphadenopathy (Murphy et al., 1999; Radostits et al., 2007). The 
morbidity during LSD outbreaks varies greatly from 5% to 100% depending on the 
immune status of the host and the abundance of arthropod vectors (Woods, 1988; 
Tuppurainen and Oura, 2012). LSD mortality is generally low (usually less than 5%) 
but occasionally may reach 20% (Woods, 1988; Babiuk et al., 2008; OIE, 2010). LSD 
is associated with reduction in milk production, temporary or permanent sterility in 
bulls and cows, weight loss, draft power loss, abortion, damage to hides and death. 
Disease control and eradication measures such as vaccination campaigns, removal 
of affected animals, biosecurity are costly (Woods, 1988; Radostits et al., 2007; 
Babiuk et al., 2008; OIE, 2010; Tuppurainen and Oura, 2012). For example in Israel 
the control of the initial LSD outbreak costed USD 750,000, and the indirect financial 
loss associated with compulsory animal movement restrictions was also significant 
(AU-IBAR, 2013). The economic importance of the disease is also due to 
convalescence of several months (Murphy et al., 1999). The World Organization for 
Animal Health (OIE) categorized LSD as a notifiable disease because of its substantial 
economic impact (Tuppurainen and Oura, 2012; OIE, 2015). Because of these 
considerable financial losses and the international trade restrictions on live animals 
and their products, LSD is one of the most important infectious diseases in countries 
where it is endemic. 
Livestock is an important sector in Ethiopia’s economy as it contributes 
35.6% to the agricultural Gross Domestic Product (GDP), equivalent to 16.5% of the 
national GDP (Metaferia et al., 2011), and 37 to 87% to the household incomes 
(GebreMariam et al., 2010). The contribution of livestock to the annual foreign 
exchange earnings amounts to 12% (NBE, 2014). Households keep cattle for multiple 
purposes: milk production, draft power, beef production, manure for fuel and 
fertilizer, and breeding (GebreMariam et al., 2010; Negassa et al., 2011). The total 
cattle population of Ethiopia is estimated to be about 57 million heads (CSA, 2015). 
The benefit that cattle could have for the country is not attained for several reasons 
and one important reason is animal disease. LSD stands among the major diseases 
that limit the productivity of the cattle population (Gari et al., 2011; APHRD, 2012). 
LSD was restricted to Africa and Middle East countries for decades, but recently it is 
spreading unusually beyond its territory into Europe and other Asian countries and 
increasingly becomes a risk for the livestock industry in these continents 
6 Economic impact of lumpy skin disease 
 
 
166 
 
(Tuppurainen et al., 2015; Tasioudi et al., 2016; WAHIS, 2016). In Ethiopia, LSD was 
first observed in 1981 in the north-western part of the country (Mebratu et al., 
1984). However, it has now spread to almost all regions and agro-ecological zones of 
the nation with seroprevalence ranging from 23-31% at animal level and 26-64% at 
herd level (Gari et al., 2010, 2012). The infection was reported to cause 33.93% and 
13.41% morbidity and 7.43% and 1.25% mortality in Holstein-Friesian cross bred and 
local Zebu cattle, respectively (Gari et al., 2011). 
Knowledge of disease impact is essential when deciding on the level of 
expenditure that can be justified for a disease control programme (Knight-Jones and 
Rushton, 2013). The economic impact of LSD can be largely influenced by the 
methods used to control and eradicate outbreaks. In general, LSD prevention and 
control programmes are based on one or more of the following three elements: 
routine vaccination, stamping-out and movement restriction (Davies, 1991; Carn, 
1993; Horst et al., 1999). The main LSD prevention and control scheme in Ethiopia is 
through vaccination. Vaccination costs depend on the number of animals vaccinated, 
vaccine cost, vaccination frequency, and labour and distribution costs (Horst et al., 
1999). In Ethiopia, vaccination cost is borne by the government, i.e. vaccines are 
provided free of charge to the livestock owners. 
Disease impacts are generally easy to identify but may be difficult to 
quantify. Disease outbreaks often have broad, long-term effects on livestock 
industry. The costs of animal disease can roughly be divided into direct costs, which 
include losses related to animal illness, death and less immediate impacts such as 
reduced fertility, and indirect costs, which encompass control costs, losses in trade 
and other revenues (Rushton, 2009; Oxford-Analytica, 2012). Understanding the 
impact of animal disease and assessing its losses is useful for policy makers and 
farmers who may weigh the losses against the costs of disease control each at their 
own level (Pritchett et al., 2005). There has been very limited work carried out on 
the financial analysis of herd-level control of LSD. Therefore, the objectives of this 
study were to determine the direct financial losses of LSD related to milk loss, draft 
power loss, mortality and indirect losses due to treatment, and to assess the cost 
effectiveness of vaccination as a means of LSD control. 
 
6.2 Materials and methods 
6.2.1 Study design and population 
A questionnaire survey targeted to assess the economic impact of LSD was 
carried out in the central and north-western parts of Ethiopia (Figure 6.1). In central 
part, it was undertaken in Ada’a, Sebeta Hawas, Ambo, Dendi, Debrelibanos, Kuyu 
and Hidabu Abote districts in Oromia National Regional State. In north-western part, 
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the data were collected from Dejen, Gozamen, Hulet Ejju Enessie and Jabitenan 
districts in Amhara National Regional State. Furthermore, another five commercial 
dairy farms (Selale Dairy Development PLC at Muketuri, Aser at Ecoefobabo, Sululta; 
Selam Children Village in Addis Ababa, Holeta dairy cattle genetic improvement 
nucleus farm and Holeta agricultural research centre farm at Holeta) were included 
in the study.  
 
 
Figure 6.1. Map of Ethiopia showing the area and the location of 243 cattle farms included in 
the study of the economic impact of lumpy skin disease (2014/15). 
 
The livestock production systems in the study area can be classified into two 
broad categories: subsistence crop-livestock production and commercial dairy 
production. In the subsistence production system the small holding farms are mainly 
kept for draft power, milk and meat production (Mengistu, 2003) and the 
composition of the herd is dominated by local Zebu cattle. The commercial dairy 
farms are market oriented and include medium (10-50 animals) to large-scale (>50 
animals) farms of crossbred Zebu with Holstein-Friesian. They are mostly located 
around peri-urban and urban areas practicing intensive and semi-intensive 
production (Mengistu, 2003). Milk and calf production are the main source of 
income. 
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6.2.2 Data collection 
The questionnaire survey was undertaken from October 2014 to May 2015. 
The time span for the financial analysis was one year i.e. May 2014 to April 2015. A 
total of 243 herd owners from 15 districts (comprising 34 kebeles and 5 farms) 
enrolled in the study, a number close to numbers used in comparable studies 
(Jemberu et al., 2014; Jibat et al., 2016; Chenais et al., 2017). Kebele is the smallest 
administrative division in Ethiopia. The districts were selected based on the 
occurrence of an LSD outbreak and three kebeles were randomly selected from each 
of 10 districts, four kebeles from one district, 2 farms from 1 district and 1 farm each 
from the other 3 districts. From each kebele, five to eight herd owners that were 
willing to participate were interviewed. The data were collected by face to face 
interview using the local language. An oral consent to use the data for scientific 
research was obtained from each participating herd owner before the interview 
started. 
The questionnaire was designed primarily to record the magnitude of 
production losses, mortality, and cost of control for LSD in several categories of 
bovines in a herd (a group of cattle owned by a household or an organization), and 
perception of farmers on livelihood impact and its influence on cattle marketing 
during the outbreak period. The farmer’s ability to identify LSD infection was cross-
checked by enquiring about the main epidemiological and clinical features of LSD. If 
the herd owner’s description was consistent with the classical clinical signs and 
epidemiologic features of LSD (nodular lesions on skin and mucosal surface, 
enlargement of superficial lymph nodes, swelling of the limb or the lower body, 
discharge from eyes, nostrils and mouth, reduced milk production in lactating cows, 
depression, morbidity varying from 5-45% and mortality less than 10%) (FAO, 2010), 
they were considered to know the disease and the interview was continued. Farmers 
were also asked to estimate the daily milk production of their cattle before and after 
infection, the duration of infection, the milk price per litre, the renting price of an ox, 
the market value of animal, labour time lost for an animal getting treated and wage 
of a daily labourer. Commercial farms and some of subsistence herd owners 
estimated the volume of the daily milk produced in litres. However, the majority of 
subsistence herd owners estimated the volume of milk produced by each LSD 
affected cow using the local container (gourds or bucket) which normally is used for 
milking. This was later converted to litre after filling the container with water to the 
level indicated by the owner and measured using a graduated jug. Additional 
information such as treatment and vaccination cost were collected from veterinary 
practitioners. Financial information was collected first in Ethiopian currency (Birr) 
and later converted to USD at an exchange rate of 20 Birr = USD 1 (8 October, 2014). 
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6.2.3 Estimation of economic losses 
The economic impact of LSD was determined by an estimation of the direct 
(visible) production losses such as milk loss, mortality loss, and draft power loss, and 
indirect impacts like control costs (Knight-Jones and Rushton, 2013) using the 
method described in Jemberu et al. (2014). However, due to information paucity, 
impacts of the other direct losses due to reduced bodyweight, abortion, infertility, 
culling, and poorer hide quality were not considered in this study. Only affected 
herds were included in the calculations. All costs are expressed as median costs as 
the distribution is not Normal. 
 
6.2.3.1 Mortality loss 
The mortality loss was set equal to the market value of the animal that died. 
Thus, the economic loss due to mortality per herd was calculated by considering the 
seven categories of animals (calf, bull, heifer, dry cow, pregnant cow, lactating cow, 
and ox) that died and their corresponding market price (Formula 1).  
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 = �𝑁𝑁𝑀𝑀𝑁𝑁𝑖𝑖𝑖𝑖 ∗7
𝑖𝑖=1
𝑃𝑃𝑁𝑁𝑖𝑖𝑖𝑖        [1] 
Where MLSDi represents the economic losses due to LSD induced death of herd i; 
NMCij is the number of animals that died in each category j of herd i and PCij is the 
price of that animal. 
 
6.2.3.2 Milk loss 
LSDV infections in lactating cows cause milk yield reduction or cessation of 
milking for the duration of the illness and sometimes beyond. The economic loss per 
herd due to loss of milk production was estimated based on Formula 2.  
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 = 𝑁𝑁𝑀𝑀𝑀𝑀𝑀𝑀𝑐𝑐𝑐𝑐𝑐𝑐𝑖𝑖 ∗ 𝑀𝑀𝑖𝑖 ∗ 𝑄𝑄𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 ∗ 𝑃𝑃𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖      [2] 
where MilkLSDi represents the economic losses due to milk loss for herd i; NLSDcowi 
the number of LSD infected lactating cows in herd i; Di the average duration of illness 
in days of affected lactating cows; QMilkLi the average quantity of milk lost in litres 
per affected cow per day, and PMilki the price of milk per litre for herd i.  
 
6.2.3.3 Draft power loss 
In Ethiopia, the traditional agricultural system depends heavily on animal 
draft power to cultivate crops. A diseased draft ox cannot plough or provides less 
draft power. The loss from draft power reduction can be captured from effective 
working days lost (Formula 3). 
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𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 = 𝑁𝑁𝑐𝑐𝑁𝑁𝑁𝑁𝑁𝑁𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 ∗ 𝑀𝑀𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖 ∗ 𝑃𝑃𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖 ∗ 65365    [3] 
where DraftLSDi represents the economic loss due to draft power loss for herd i; 
NoxenLSDi the number of oxen affected in herd i, DDrafti the average duration of 
illness in days of an affected ox, PDrafti the price of draft power rent of an ox per day 
and 65/365 is an adjustment factor for effective working days - a draft ox in Ethiopia 
works for about 65 days in a year (Goe, 1987). Farmers whose draft oxen are affected 
with LSD have to rent, purchase a replacement ox or borrow animals for cultivation. 
An ox can be rented from a farmer owning surplus oxen on cash or grain basis. 
 
6.2.3.4 LSD control costs  
LSD control costs were considered to consist of vaccination, diagnosis and 
medication costs and extra labour costs for seeking treatment for sick animals. Many 
herd owners in Ethiopia use public veterinary services to get their animals vaccinated 
which is free of charge for contagious and transboundary animal diseases like LSD. 
However, clinical treatment of LSD affected animals was at the farmers’ own 
expense. Hence, the economic cost of LSD treatment is calculated as per Formula 4. 
𝑇𝑇𝐷𝐷𝑁𝑁𝑐𝑐𝑇𝑇𝐷𝐷𝑖𝑖 = (𝑁𝑁𝑇𝑇𝐷𝐷𝑖𝑖 ∗ 𝑃𝑃𝑇𝑇𝐷𝐷𝑖𝑖) + (𝑁𝑁ℎ𝑐𝑐𝑜𝑜𝐷𝐷𝑇𝑇𝑀𝑀𝑖𝑖 ∗ 𝑃𝑃𝑃𝑃𝑀𝑀𝑖𝑖)  [4] 
where TrCosti represents the treatment cost for affected herd i; NTri the number of 
animals treated; PTri the average per head expenditure to LSD treatment; NhoursLi 
the average number of working hours lost for seeking treatment for sick animals, and 
Pdli the average payment rate of a replacement labourer per hour in the locality of 
herd i.  
  
6.2.3.5 Total economic losses 
The total economic costs (TEC) due to LSD infection per affected herd were 
obtained by adding losses arising from draft power loss, milk production loss, 
mortality and treatment expenditure (Formula 5).  
𝑇𝑇𝑇𝑇𝑁𝑁𝑖𝑖 = 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 + 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 + 𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑀𝑀𝑀𝑀𝑀𝑀𝑖𝑖 + 𝑇𝑇𝐷𝐷𝑁𝑁𝑐𝑐𝑇𝑇𝐷𝐷𝑖𝑖   [5] 
 
6.2.4 Partial budget analysis for LSD vaccine use  
The cost effectiveness of LSD control through vaccination was evaluated 
using partial budgeting analysis technique, which quantifies the economic 
consequences of a specific change in farm procedures (Dijkhuizen et al., 1995). The 
economic concept of partial budgeting is important for cost–benefit analysis of 
disease control measures (Rushton, 2009). A partial budget format with four parts 
(additional returns gained, reduced costs, returns foregone, and extra costs 
experienced as a consequence of the change) was employed as described by 
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Dijkhuizen et al. (1995) and Dijkhuizen and Morris (1997). Costs were estimated in 
scenarios with and without vaccination. The base plan was no vaccine use by the 
herd owners, and the alternative plan was LSD vaccine use. The cost for purchase 
and administration of the LSD vaccine was considered the extra cost of the 
alternative plan, though it is borne by the government. The profitability of vaccine 
use in LSD control was calculated on a herd basis using Formula 6. 
𝑁𝑁𝑁𝑁𝐷𝐷 𝑃𝑃𝐷𝐷𝑐𝑐𝐷𝐷𝑀𝑀𝐷𝐷 = (𝐴𝐴𝑃𝑃𝑃𝑃𝑀𝑀𝐷𝐷𝑀𝑀𝑐𝑐𝑁𝑁𝐷𝐷𝑀𝑀 𝐷𝐷𝑁𝑁𝐷𝐷𝑜𝑜𝐷𝐷𝑁𝑁𝑇𝑇 + 𝑅𝑅𝑁𝑁𝑃𝑃𝑜𝑜𝑐𝑐𝑁𝑁𝑃𝑃 𝑐𝑐𝑐𝑐𝑇𝑇𝐷𝐷𝑇𝑇)
− (𝑅𝑅𝑁𝑁𝐷𝐷𝑜𝑜𝐷𝐷𝑁𝑁𝑇𝑇 𝐷𝐷𝑐𝑐𝐷𝐷𝑁𝑁𝑓𝑓𝑐𝑐𝑁𝑁𝑁𝑁 + 𝑇𝑇𝑁𝑁𝐷𝐷𝐷𝐷𝐷𝐷 𝑐𝑐𝑐𝑐𝑇𝑇𝐷𝐷𝑇𝑇)[6] 
A positive net result indicates that LSD vaccination is desirable from an economic 
point of view (Dijkhuizen et al., 1995; Dijkhuizen and Morris, 1997; Young et al., 
2013). Moreover, the marginal rate of return (MRR) was calculated as the net benefit 
divided by the total cost incurred due to vaccine use to further scrutinize the 
adoption of the change (Gari et al., 2011). 
 
6.2.5 Statistical analysis 
Descriptive statistics were used to calculate the morbidity and mortality at 
animal and herd level. A Chi-square test was used to evaluate the differences in 
morbidity and mortality between categories of animals and between districts. 
Kruskal–Wallis equality-of-populations rank test was used, as the economic losses 
were not normally distributed, to compare the differences in herd level economic 
losses among districts and between farm types. A p-value less than 0.05 was 
considered as significant. Stata version 14 was used for all analyses. 
 
6.3 Results 
6.3.1 Herd size and structure 
A total of 243 herds with 4430 heads enrolled in the study. The study 
population comprised 18.4% calves, 22.7% heifers, 8.9% bulls, 37.1% cows and 12.9% 
oxen. Herd size varied from 1 (n = 3) to 643 (n = 1) animals. About 90% of the herds 
consisted of less than 25 animals. The mean herd size in commercial farms was 56 
heads and 10 heads in the subsistence farms. The majority of the farms (81.9%) 
involved in the study were small holder subsistence farms, but they hold only 44.3% 
of the study animals; 78.6% of the herds were managed extensively.  
 
6.3.2 LSD morbidity and mortality 
All herd owners approached were able to describe LSD in terms of its key 
epidemiologic features and symptoms. Based on the farmer’s response, a total of 
941 out of 4430 (21.2%) animals and 200 out of 243 (82.3%) herds were declared 
affected by LSD (i.e. they had at least one LSD positive animal) in the period May 
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2014 to April 2015. Mortalities at animal and herd level were 4.5% (198/4430) and 
24.3% (59/243), respectively. Case fatality amounted to 21.0% (198/941). In most 
herds in which animals died it was restricted to 1 (n = 36 out of 59) or 2 (9 out of 59) 
dead animals, however in one large herd (331 heads) 40 animals died. Differences in 
morbidity and mortality between study districts, at both animal level and herd level, 
were statistically significant (P<0.05). The highest animal level morbidity (37.9%) and 
mortality (12.1%) were recorded in Jabitenan district and Selale dairy Dev. PLC, 
respectively (Table 6.1). The morbidity per animal category varied from lowest 15.0% 
in dry cows to 26.9% in oxen, whereas the mortality varied from 2.2% in dry cows to 
6.0% in pregnant cows (Table 6.2). The difference in animal level morbidity and 
mortality between categories was significant (P<0.05).  
 
6.3.3 Perception of herd owners on LSD impact 
From 243 herd owners interviewed in this study, 229 (94.2%) ranked LSD as 
a serious or very serious disease. Economic losses most frequently mentioned were 
death, milk loss, draft power loss, weight loss, abortion and hide quality loss (Figure 
6.2). 224 (92.2%) of the herd owners indicated that LSD outbreaks affect cattle 
marketing. A large proportion (n = 217, 89.3%) of them witnessed that cattle selling 
is practiced during LSD outbreaks. Almost all herd owners do not sell sick animals 
and 32 (13.2%) of them would like to sell unaffected animals from their herds during 
LSD outbreaks mainly due to fear of the disease (n = 30, 93.8%).  
 
6.3.4 Financial losses of LSD outbreaks 
The financial losses related to mortality, milk reduction, draft power loss, 
and control cost per affected individual animal are presented in Appendixes 6.1–6.4, 
respectively. The overall median financial loss per dead animal was estimated at USD 
375; however, it was USD 325 for local Zebu and USD 1250 for Holstein-Friesian local 
Zebu cross cattle. Category wise, the median loss per head varied from USD 150 for 
calves to USD 1181 for milking cows, whereas from breed perspective the highest 
loss (USD 2250) was recorded in cross breed cows and the lowest (USD 59) in local 
Zebu calves. District wise, the median loss per dead animal varied from USD 125 in 
local Zebu in Debrelibanos district to USD 1966 in cross breed cattle in Holeta 
(Appendix 6.1). Besides to the mortality loss, additional costs were incurred for 
carcass disposal. For this a cost of USD 11.9 (ranging USD 5-20) per carcass was 
required, but this was not included in the economic loss estimation due to the fact 
that expenditure for this purpose is required in rare occasions as usually the 
carcasses are disposed or buried by the villagers.  
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Almost all (n = 240, 98.8%) of the herd owners knew the effect of LSD on 
milk production. According to the information obtained from the herd owners, milk 
production reduced by 74% for a period of about 2.5 months. The overall daily milk 
loss per affected milking cow was 4.0 litres. Breed wise, it was 1.7 litres in local and 
7.2 litres in cross bred cows. Financially, the overall median milk production loss per 
affected milking cow was USD 141, which was USD 63 in local Zebu cow and USD 216 
in Holstein-Friesian local cross cow. The lowest and the highest milk loss per milking 
cow reported were USD 27 in local cattle and USD 906 in cross cow in Hulet Ejju 
Enessie and Debrelibanos districts, respectively (Appendix 6.2).  
Almost all (n = 241, 99.2%) interviewees responded that LSD affects the 
traction power of animals. The median number of effective working days lost per 
affected ox was 10 days (range 1–32 days) resulting in an overall median loss of USD 
36 per affected ox (Appendix 6.3).  
More than 80% of LSD affected cattle got treated for secondary 
complications. The overall median diagnosis and medication cost per affected animal 
was USD 5 (Appendix 6.4). The cost of time lost for seeking treatment per affected 
animal could not be estimated as it was common practice that a herd owner took 
several animals to a veterinary clinic at a time to seek treatment and this complicated 
the estimation of per head cost.  
The median total economic loss of an LSD outbreak at herd level was USD 
1176. This figure is based on 193 herds as in 7 herds the LSD positive animal(s) were 
not productive and were not treated. A statistical analysis with Kruskal–Wallis 
equality-of-populations rank test revealed significant differences (P < 0.05) in total 
economic loss among districts. The highest and lowest economic losses were 
recorded in Selale dairy farm and in Sebeta Hawas district, respectively (Table 6.3). 
At herd level, the largest component of the economic loss was due to mortality (USD 
1000) followed by milk loss (USD 120) and draft loss (USD 48). LSD control costs were 
the least contributor to herd level losses (Table 6.3). The median economic loss by 
farm type was USD 489 and USD 2735 in subsistence and commercial farms 
respectively per affected herd (P < 0.05; Table 6.3). 
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Figure 6.2. Major losses induced by lumpy skin disease as listed by cattle herd owners (n 
= 243) in Ethiopia (2014/15). 
 
 
6.3.5 Partial budgeting 
The majority of the input parameters for the partial budget analysis were 
obtained from data collected in this study; however, the remaining key parameters 
were taken from other sources (Appendix 6.5). 
The results of the partial budget analysis indicated a positive net profit of 
USD 136 (USD 56 for subsistence farm herds and USD 283 for commercial herds) and 
marginal rate of return (MRR) of 15.14 (11.29 in subsistence and 10.10 in commercial 
herd) per herd by vaccinating the animals for LSD (Table 6.4). Thus, investment in 
vaccination to control LSD would reduce the overall financial loss due to the disease 
by 11.6% per herd.
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6.4 Discussion 
  The animal level morbidity (21.2%) and mortality (4.5%) recorded in this study 
is close to the 22.9% and 26% morbidity and 2.3 and 1.9% mortality reported in 
central Ethiopia (Ayelet et al., 2013) and Jordan (Abutarbush et al., 2015), 
respectively. However, it is much higher than the 7.4% animal level morbidity 
reported in north-eastern Ethiopia (Hailu et al., 2014), 8.7% in Greece (Tasioudi et 
al., 2016), 11% in Israel (Brenner et al., 2009), and 0.65% in Turkey (Ince et al., 20016 
). Significantly different morbidity and mortality was observed between animal 
categories with oxen showing the highest level of morbidity (26.9%). This might be 
attributable to the stress and fatigue created during ploughing. The highest mortality 
was observed in pregnant cows (6%) which might be related to physiological 
conditions of pregnancy that make the animal more susceptible to disease (Kehrli et 
al., 2009). Generally, LSD morbidity varies from as low as 5% to 100% (Woods, 1988) 
and mortality is generally low (usually less than 5%) but may sometimes reach 20% 
(Woods, 1988; OIE, 2010). Thus, the animal level as well as the LSD morbidity and 
mortality levels per animal category reported in this study are within the limits 
reported in previous works. Furthermore, a significantly different morbidity and 
mortality was present between districts with highest morbidity in Jabitenan district 
(37.9%). This might be related to the presence of many rivers, irrigated areas and 
higher temperature, making the conditions in the district suitable for the replication 
of arthropods and propagation of LSD (Davies, 1991).  
  Interview results indicated that LSD is a serious problem for cattle producers 
in the study area as more than 94% of the interviewees considered LSD as a threat 
for their cattle. According to the herd owners, the disease induces weight loss, 
reduced milk production, draft power loss, mortality, market instability, infertility, 
abortion, culling, and hides quality losses. These observations are in line with the 
impacts of LSD described in previous works (Woods, 1988; Davies, 1991; Kumar, 
2011; Abutarbush et al., 2015). The impacts of LSD in domestic as well as 
international cattle market is complex and generally go beyond the immediate 
effects on affected producers (Otte et al., 2004). In this study, more than 92% of the 
herd owners reported that LSD outbreaks affects cattle marketing at domestic 
market in numerous ways including lowering the demand and price of cattle during 
the outbreak period. 
  An overall median financial loss of USD 375 per dead animal recorded in this 
study is a big loss for a farmer whose livelihood depends on crop-livestock or 
livestock production. The mortality loss per head was highly variable between 
breeds, animal categories and districts. The per head mortality loss of local Zebu 
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cattle was low (USD 325) as compared to Holstein-Friesian local cross cattle (USD 
1250). The median loss per head categories varied from USD 150 for calves to USD 
1181 for milking cows. These differences can be mainly attributed to the high 
production potential of cross bred animals and animal’s purpose. 
  The milk production loss of 74% for the period of about 2.5 months recorded 
in this study is almost comparable to what has been reported in previous studies 
(Woods, 1988; Kumar, 2011; Abutarbush et al., 2015). The median daily milk loss of 
4.0 litres per affected animal is a big loss for a nation that is an importer of dairy 
products (Negassa et al., 2011) by aggravating the product scarcity. In most cases the 
affected milking cows did not produce milk for months. For cows restarting milk 
production, it took months to regain their normal production level while in some 
cases, especially for local cows, LSD caused complete drying off. LSD caused an 
overall median loss of USD 141 per affected cow, being USD 216 in Holstein-Friesian 
local cross and reduced to USD 63 in local Zebu. The loss indicated here is greater 
than the loss induced by foot and mouth disease (FMD), which was USD 29 per 
affected cow in crop-livestock production system and USD 26 in pastoral system 
(Jemberu et al., 2014). 
  In the current study the herd owners reported that LSD affected draft animals 
were not available for field work for an average period of 59 days (ranging 7-180 
days) which resulted in a median loss of about 10 (ranging 1-32) effective working 
days. The lost working days, in turn, lead to reduced crop production, either through 
reduced area that can be cultivated, or through lower yields due to late planting 
(McDermott et al., 1999). The effective working days lost estimated in this study is 
smaller than the 16 days reported by Gari et al. (2011). A farmer whose ox is affected 
by LSD has to borrow, rent, or purchase replacement ox or request assistance from 
relatives for cultivation. The translation of the effective working days lost into 
financial loss by considering the daily renting price (cash basis) of an ox gave an 
overall median loss of USD 36 per affected ox, which is greater than the loss reported 
due to FMD (Jemberu et al., 2014). This loss would have been larger if we had used 
100/365 as adjustment factor (Yilma et al., 2011) instead of 65/365.  
  The median total economic loss of USD 1176 per LSD affected herd recorded 
in this study is a huge loss for a producer in a country with a gross domestic product 
per capita of USD 316 (Trading-Economics, 2015) and per capita income of USD 550 
(World-Bank, 2015). Even the median loss per affected herd in subsistence crop-
livestock system (USD 489) is six times higher than what Jemberu et al. (2014) 
reported for FMD, a disease which is on the top list for its devastating economic 
impact worldwide (Knight-Jones and Rushton, 2013; Junker et al., 2009). This 
supports the reports stating that LSD is economically more important than FMD in 
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some countries such as South Africa (Murphy et al., 1999). The reason for this is that 
mortality in FMD is low and it occurs mainly in young age categories while LSD 
mortality is relatively high compared to FMD and occurs in all age categories. Of all 
costs, 85% is due to mortality although LSD induced mortality is low in cattle 
population as a whole (Woods, 1988). The median total economic losses per affected 
herd of USD 2735 for the commercial farm were significantly higher than the loss of 
USD 489 for the subsistence farm type. The higher loss in affected commercial herds 
is the reflection of larger herd size, higher market value and productivity potential of 
cross-bred animals.  
  As the study is undertaken retrospectively after certain months of LSD 
occurrence in the herd, recall bias in relation to the duration of infection, the amount 
of milk produced during sickness, working days lost and others might happened. 
Furthermore, the number of animals and herds affected were reported based on the 
owners declaration and this might also lead to biased number of cases. The recall 
bias and the diagnosis bias might have influenced the estimation of the financial 
losses reported to some extent and can be taken as the weakness of the study. 
  Routine vaccination, stamping-out and movement restriction are important 
methods in LSD control (Davies, 1991; Carn, 1993). Each control measure acts by 
reducing the transmission of the agent in the population. However, Ethiopia is 
applying mainly vaccination to control the disease. The economic benefit gained 
from controlling LSD with vaccination was measured by taking the reduction in 
economic loss from the disease into account by comparison with the level of 
expenditure for its vaccination. The result of the cost benefit analysis showed that a 
net loss of about USD 136 per herd would be avoided and marginal rate of return 
(MMR) of 15.14 gained by using LSD vaccination. The estimates revealed that LSD 
control with vaccination is economically beneficial by reducing the loss by 11.6% per 
herd. This result is less cost effective as compared to the findings of Gari et al. (2011) 
who reported a positive net benefit of USD 680.71 and a MRR of 34 for LSD vaccine 
intervention. However, the existing LSD vaccine provides incomplete protection 
against the disease (Ayelet et al., 2013). The vaccine is efficacious in only 28% of the 
vaccinated animals (unpublished data) which was taken into account in the partial 
budget analysis. More effective vaccines are needed to gain more from the 
intervention. The partial budget analysis was restricted to the direct benefits arising 
from the mortality and morbidity losses avoided and savings in the cost of LSD 
treatment. We did not consider other control options like movement control due to 
their practical limitation in Ethiopian situations.  
  It should be noted that only the noticeable direct costs and treatment costs 
associated with the disease were considered in the study. The indirect impacts of the 
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disease such as under exploitation of the animal potential, animal welfare, 
international trade etc., were not considered. Also the visible direct costs were not 
fully captured mainly due to information paucity and difficulty to measure the loss 
in precise economic terms. Thus, the economic loss estimation presented here 
should be seen as a conservative estimate of the loss due to LSD.  
 
6.5 Conclusion 
  The LSD impact in terms of production losses and control costs was high, a 
median total economic loss of USD 1176 (USD 2735 in commercial and USD 489 in 
subsistence herd) per LSD affected herd. The losses were mainly from morbidity and 
mortality of cattle and were the greatest in highly productive animals. The largest 
component of the economic losses was due to mortality loss followed by milk loss 
and draft loss at both animal level and herd level losses. LSD control costs were the 
least contributor for the herd level losses. Commercial farms which hold more 
productive and more susceptible animals were more severely affected economically 
than the subsistence crop related farms. Vaccination was found to be economically 
and practically feasible choice to control LSD. The cost benefit analysis was restricted 
to the direct benefits arising from the mortality and morbidity losses avoided and 
savings in the cost of LSD treatment. Generally, vaccination is economically beneficial 
and should be encouraged.  
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7.1 Introduction 
The main aim of the studies described in this thesis was to generate 
knowledge on lumpy skin disease (epidemiology, financial consequences and effect 
of vaccination) in cattle that can be used to formulate and optimize a control strategy 
in Ethiopia. LSD is one of the top ranked diseases that affects the livelihood of many 
Ethiopians as approximately 70% of them, directly or indirectly, depend on the 
livestock sector (GebreMariam et al., 2010). In Ethiopia, cattle are kept for multiple 
purposes: meat and milk production, draft power, manure for fuel and fertilizer, cash 
storage for those that have no bank access and for social status. Farmers’ livelihoods 
are often threatened by diseases that lead to death of their animals, reduce 
production and productivity or cause a drop of demands (Perry and Grace, 2009). 
The African Union-Inter African Bureau for Animal Resources (AU-IBAR, 2014) 
records indicate that LSD is the fourth most widely distributed transboundary animal 
disease in Africa following Newcastle disease, foot and mouth disease (FMD) and 
peste des petis ruminants (PPR). Hence, it is the second after FMD if only cattle 
diseases are considered. 
The motivation for the research described in this thesis was the (ongoing) 
extensive LSD outbreak having a significant economic impact on the country for the 
past decades. The specific aims can be found in Chapter 1. In this final chapter, 
research findings are discussed and the practical implications of the results towards 
control of LSD, future research directions and the main conclusions are presented. 
 
7. 2 Amalgamation of the findings 
7.2.1 LSD geographical distribution and level of occurrence  
Understanding the epidemiology of a disease such as geographical 
distribution, its morbidity, mortality, and risk factors is very important for designing 
and justifying an effective control program (OIE, 2014). The epidemiological 
information described in Chapter 2, 3, 4 and 6 revealed the importance of LSD in 
Ethiopia and therefore will help to formulate a control strategy for the disease in the 
country. 
LSD has been spreading into several parts of Ethiopia following its first 
introduction in the north-western part in 1981 (Mebratu et al., 1984; Gari et al., 
2010). A number of reports describe the occurrence of LSD in several parts of 
Ethiopia (Gari et al., 2010; APHRD, 2012; Ayelet et al., 2014; Hailu et al., 2014; Abera 
et al., 2015; Gelaye et al., 2015). The spatiotemporal study described in Chapter 2 
clearly indicates that LSD is now a well-established endemic disease in Ethiopia 
because all of the regional states and city administrations reported at least one LSD 
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outbreak in the period 2000 to 2015. At local level, LSD occurs as an epidemic for a 
certain period and spreads throughout a regional state over a period of several years 
(Chapter 2). The prevalence study (Chapter 3) confirmed that LSD is widespread in 
central and north-western parts of Ethiopia, with all investigated kebeles (n = 30) 
having at least one LSD seropositive herd. LSD has been reported to occur in all agro-
climatic zones of Ethiopia, from the hot arid lowland, warm wet midland to cool 
highlands (Chapter 2, Chapter 3) showing the potential of LSDV to spread in a range 
of climatic zones, in accordance with Gari et al. ( 2010). 
Furthermore, the spatiotemporal study showed that, at district level, on 
average more than one seventh of the districts in the nation is stricken by LSD 
outbreaks every year (Chapter 2). LSD outbreak incidence varied over space with the 
lowest incidence (over the period 2000-2015) observed in the eastern lowland (Afar 
and Somali), southern lowland (Liben), south west (Benchi Maji) and North (north-
western zone of Tigray). This might be attributed to the less favourable 
environmental conditions for the transmission and circulation of LSDV. Most of these 
areas are characterized as dry (Ecotravelworldwide) which may not be conducive for 
the replication and survival of arthropods that are considered the major vector for 
the transmission of the disease (OIE, 2013; Tuppurainen et al., 2017). The highest 
number of outbreaks over the 16 years were documented in the north-west, central, 
west and south-western parts of the country, which receive relatively high rainfall 
for a reasonable period. This creates favourable conditions for the replication and 
survival of blood feeding arthropods assumed responsible for transmission of LSD 
(Ecotravelworldwide; Woods, 1990; Gari et al., 2010; Ayelet et al., 2014). However, 
the low disease reporting rate (< 47%) in Ethiopia should be taken as a limitation in 
relation to these findings. The reporting rate can be improved through establishing 
a national disease reporting system based on information technology and capacity 
building training.  
Knowledge of the level of LSD morbidity and mortality is also important for 
estimating its impact. Morbidities vary across geographical regions (Chapter 3, 4, 6) 
and they are moderate at individual animal level (10.1%-26.5%) but high at herd level 
(51.0%-82.3%). In central and north-western Ethiopia, the true sero-prevalence of 
LSD at animal level was 26.5% and at herd level 51.0% (Chapter 3). A morbidity of 
21.2% at individual animal level was estimated based on a questionnaire survey 
(Chapter 6). In dominantly crop-livestock system, the animal level morbidity was 
10.1% while in intensive infected herds it was 17.5% (Chapter 4). These morbidity 
levels are in agreement with previous research findings (Woods, 1988; Ahmed and 
Zaher, 2008; Gari et al., 2012; Ayelet et al., 2013; OIE, 2013; Tuppurainen et al., 
2017). The regional variation in morbidity might be related to differences in 
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geographic location and climate, breed of animals, herd immunity level, 
management system, and distribution, abundance and efficiency in transmitting 
LSDV of vector populations (FAO; Davies, 1991; Tuppurainen and Oura, 2012; FAO, 
2013; Al-Salihi, 2014). Morbidity of 100% may occur when LSDV is introduced in a 
very susceptible cattle population and as low as 2% in resistant populations (Davies, 
1991; Murphy et al., 1999; Tuppurainen et al., 2017). Davies (1991) reported both 
low and high morbidity in different herds during the same epidemic. The 82.3% herd 
morbidity level (Chapter 6) is higher than previously reported levels in Ethiopia. This 
may be related to the way herds were selected for the study being based on the herd 
owner’s capability to describe the main epidemiological and clinical features of LSD. 
Hence, owners’ that had experienced an LSD outbreak in their herd were more likely 
to be included in the questionnaire survey than owners of unaffected herds were. 
This selection bias, therefore, might lead to an inflated herd level morbidity.  
LSD mortality is generally low: 0.7% and 4.0% at animal level in dominantly 
crop-livestock herds and in intensive infected herds, respectively (Chapter 4); 4.5% 
and 24.3% at animal and herd level, respectively (Chapter 6); and 1.4% in a partly 
vaccinated cattle population (Chapter 5). These outcomes are within the range of 
previous reports (Woods, 1990; Murphy et al., 1999; Babiuk et al., 2008; Gari et al., 
2008; Ayelet et al., 2013; Ayelet et al., 2014). The observed variation in mortality 
between different study herds might be explained by the health, physiological and 
nutritional status of the affected animals, susceptibility of the breed and secondary 
bacterial infections (Davies, 1991; Babiuk et al., 2008). In Ethiopia, previous research 
reports indicate LSD mortality variation from 0.5% in the north-western, western and 
central parts of the country (Mebratu et al., 1984), 1.8% in southern and 2.8% 
northern (Gari et al., 2008) to 5.4% in central (Ayelet et al., 2014) parts of Ethiopia.  
A number of factors affect the occurrence and spread of LSDV (Woods, 
1990). Age group, contact with other animals and presence of water bodies were 
identified as important risk factors in relation to LSD occurrence (Chapter 3). Cattle 
in low laying wet areas suffer from the largest morbidity (Chapter 3), most likely 
related to more abundant vector populations. Previous research findings indicate 
that breed is associated with LSD occurrence (Davies, 1991; Gari et al., 2011; OIE, 
2013; Abera et al., 2015) and this is in line with the current vaccine efficacy study 
(Chapter 5). However, the sero-prevalence and risk factor study indicate that breed 
was not associated with LSD occurrence (Chapter 3); this might be potentially due to 
the distribution of the breeds among study areas. Most of the crossbred animals 
were in less affected districts. Adult animals were more frequently affected by LSDV 
than young animals and calves (Chapter 3). This corroborates what Abera et al. 
(2015) and Elhaige et al. (2017) who also reported that LSD is more prevalent in adult 
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cattle than younger animals. Contrary to what Gari et al. (2010) reported, altitude is 
not identified as a risk factor in the current study which is in agreement with Abera 
et al. (2015) who described a non-significant association between agro-climatic 
zones (midland and highland) and LSDV antibodies. In other studies, factors such as 
herd size (Hailu et al., 2014), introduction of new cattle to the herd, and use of 
communal grazing or watering points have been reported as a risk for LSD 
occurrence in a herd (Gari et al., 2010; Hailu et al., 2014).  
 
7.2.2 LSD outbreak seasonality and transmission dynamics  
LSD epidemics show a clear seasonal pattern. The number of LSD outbreaks 
was higher in the months after the long rainy season compared to other seasons 
(Chapter 2). It was above average for the months September-January and below 
average for February to August. The highest, and significant, correlation (r = 0.55) 
between monthly number of LSD outbreaks and monthly rainfall at lag 3 indicates 
that the rainfall from June to September might be responsible for the increased 
number of outbreaks from September to January. Other research also shows the 
seasonality of LSD epidemics following the commencement of rains and the 
subsequent emergence of large numbers of vectors (Woods, 1988; Davies, 1991; 
Carn, 1993). The rapid spread of LSD with increased activity of potential vectors was 
observed in several African countries following the seasonal rains (Davies, 1991). 
Abundant blood-feeding arthropod populations in association with wet and warm 
weather conditions were noticed in LSD outbreaks in South Africa and Middle East 
countries (Weiss, 1968; Tuppurainen and Oura, 2012). Gari et al. (2010) reported a 
positive and significant association between LSD occurrence and increased biting-
flies activity in various agro-climatic zones of Ethiopia and they indicate that the 
biting fly population starts to build up from April and reaching a maximum in 
September. In Israel, LSD outbreaks were associated with abundant Stomoxys 
calcitrans populations (Kahana-Sutin et al., 2016). Heavy seasonal rainfall combined 
with high temperature is a suitable condition for build-up of a blood-feeding 
arthropod population that in turn increases the probability of LSDV transmission 
(Tuppurainen and Oura, 2012).  
The average length between two LSD outbreak episodes was 4.5 years 
(Chapter 2). This is close to the estimated 4.6 years reoccurrence time assuming a 
major outbreak size of 67% for an epidemic with a reproduction ratio (R) of 1.2 (as 
estimated in the vaccine efficacy study for unvaccinated animals, Chapter 5) and an 
annual replacement rate of 25%. At the threshold level (R=1), the corresponding 
reoccurrence time equals 4.6 years (Figure 7.1). The outbreak cycle of 4.5 year is 
shorter compared to Woods (1988) who reported 5 or 6 year intervals. This might be 
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related to censoring of districts not reporting reoccurrence of the disease at the end 
of 2015, as their period without LSD outbreaks might go further beyond the study 
period. The pattern of recurrence of LSD epidemics may vary between regions 
depending on herd susceptibility, and extent and frequency of vaccination (Woods, 
1990). This corroborates the observation that some districts reported outbreaks 
after one year of quiescence, whereas others reported an outbreak after a relatively 
long period (13 years) without LSDV (Chapter 2).  
 
 
Figure 7.1. Waiting time for the reoccurrence of LSD in a district/area in Ethiopia in relation to 
reproduction ratio (red line) and the fraction of positives in the population (blue line). The 
horizontal line (green) indicates the threshold level of R =1, and the vertical line (black) shows 
the average recurrence time.  
 
Knowledge of transmission rate parameters is very important to design 
effective sets of measures that help to control the disease. For LSD, the transmission 
rates were low, 0.072 and 0.076 per day between animals in dominantly crop-
livestock area and intensive farms, respectively (Chapter 4). Furthermore, the 
reproduction ratios of 1.07 and 1.09 between animals in dominantly crop-livestock 
area and in intensive farms, respectively, are low. This indicates that an affected 
animal is responsible for transmission of LSD only to one other animal in most of the 
cases during its infectious period. This might be the reason why in most of the LSD 
epidemics usually only 5-45% of the animals are affected (OIE, 2013). Woods (1988) 
describe the very slow spread nature of the disease by coining it “a creeping 
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pandemic” and that the disease took more than half a century to spread in most 
African countries (Woods, 1988). The low transmission rate finding might urge to 
reconsider a claim that transmission of LSDV via direct contact is negligible (Carn and 
Kitching, 1995; Magori-Cohen et al., 2012). The low R value might explain why 
susceptible animals that had close contact with infected animals do not get readily 
infected.  
The transmission study showed that transmission rate was highest in the 
wet season, period 2 (Chapter 4), but the highest number of LSD outbreaks was 
reported in October (the beginning of the dry season, period 3) (Chapter 2). This 
discrepancy might be attributed to the reporting period. In Ethiopia, the monthly 
disease occurrence is reported at the end of each month or at the beginning of the 
next month, this might be the reason for the highest number of outbreaks at the 
beginning of the dry season. 
 
7.2.3 LSD economic impacts 
In general, disease affects the benefits obtained from livestock either by 
reducing production and productivity, killing animals or by causing consumer 
demand drops which may lead to collapse of communities depending on them (Perry 
and Grace, 2009). Chapter 6 presents the economic impact assessment of LSD in both 
subsistence crop-livestock and commercial farming systems. Financial losses of USD 
325 (local Zebu) and USD 1250 (Holstein-Friesian local cross cattle) per dead animal, 
USD 63 (local Zebu cow) and USD 216 (Holstein-Friesian local cross cow) per lactating 
cow, USD 36 per affected ox and USD 5 diagnostic and medication cost per affected 
animal were estimated. Besides, total economic losses of USD 489 in subsistence 
herds and USD 2735 in commercial farms were estimated at herd level for an LSD 
outbreak. Recall bias was potentially present at the time of data collection and 
therefore these estimates can be under- or overestimated. These losses are larger 
than the loss reported earlier for LSD as well as for other contagious and 
transboundary disease including FMD in Ethiopia (Gari et al., 2011; Alemayehu et al., 
2013; Jemberu et al., 2014). Gari et al. (2011) estimated the financial loss in LSD 
infected herds at USD 6.43 per head for local Zebu and USD 58 per head for crossbred 
cattle. Alemayehu et al. (2013) reported a total loss of USD 667,786 in feedlots in 
and around Adama where 18,864 bulls were at risk during the outbreak. The loss 
reported in this study is, however, less than what Abutarbush (2014) reported: £486 
(about USD 800) per animal.  
The estimated loss due to LSD in both subsistence and commercial farms 
are huge for producers in a developing country like Ethiopia. In subsistence farms 
the burden was 40.2% of the total annual expenditure (USD 1216) of an average 
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household for the system (CSA, 2012) which is taken as a proxy of income, whereas 
in commercial farms the burden was 143.7% of the total annual expenditure (USD 
1903) estimated (CSA, 2012). The loss in both cases is over 10% of the income which 
is set as a benchmark for a catastrophic shock (Shankar et al., 2012).  
It is obvious that LSD epidemics have huge economic consequences for 
farmers and other stakeholders (for example traders). Apart from the direct losses 
due to the morbidity and mortality of animals and the indirect losses related to the 
costs of disease control and prevention, losses are caused by long-term 
consequences due to market disruption, production interruption, additional 
repopulation costs, animal welfare and price effects (Meuwissen et al., 1999; Otte 
and Chilonda, 2001). The consequential losses related to trade restrictions could be 
even more important for Ethiopia because livestock sector contributes 12% of the 
annual foreign exchange earnings (NBE, 2014). Control measures, therefore, should 
be put in place to mitigate LSD burdens on the economy.  
 
7.2.4 LSD control opportunities 
Experiences from other affected countries showed that control of LSD 
depends on early detection of the index case, immediate stamping-out of all infected 
and in-contact animals, quarantine, strict movement control, and vaccination 
(Tuppurainen et al., 2017). Vaccination with a live attenuated vaccine is reported as 
the effective way to control the spread of LSDV (Tuppurainen et al., 2017). The KS1 
O-180 vaccine confers some level of protection to LSD by reducing the susceptibility 
of vaccinated cattle (Chapter 5). Vaccination was also associated with less severe LSD 
symptoms. However, the estimated reproduction ratio in both vaccinated and 
unvaccinated cattle indicate that LSD virus does transmit in cattle populations, 
regardless of their vaccination status, and a major outbreak may occur (Chapter 5). 
This shows that immunizing animals with KS1 O-180 vaccine will not help much to 
control and eliminate LSD by bringing the reproduction ratio below the threshold 
level. To the worst, some people associate the occurrence of the disease in 
vaccinated animals with vaccination. However, previous research findings clearly 
indicate that the isolates causing LSD in Ethiopia are different from the vaccine strain 
(Gelaye et al., 2015) and the current vaccine efficacy study supports this, meaning 
that the vaccine is not responsible for the occurrence of LSD in vaccinated cattle. 
Furthermore, the vaccine has been successfully used in Kenya against LSDV without 
adverse reactions (Davies and Mbugwa, 1985; Tuppurainen et al., 2014).  
Despite the KS1 O-180 vaccine is not competent enough to give full 
protection against LSDV infection, it currently is being used as the main control 
method in Ethiopia (Ayelet et al., 2013; Gari et al., 2015). The partial budget analysis 
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indicated a positive net profit of USD 136 (USD 56 for subsistence farm herds and 
USD 283 for commercial herds) and a marginal rate of return (MRR) of 15.14 (11.29 
in subsistence and 10.10 in commercial herds) per herd by vaccinating the animals 
against LSD (Chapter 6). This shows that LSD control with vaccination is economically 
beneficial by reducing losses via decreasing susceptibility of vaccinated animals to 
the disease and reducing its severity in infected animals. The benefit from 
vaccination could be more if a vaccine like the Neethling virus vaccine, which is 
claimed to reduce morbidity (Ben-Gera et al., 2015), is used. The low estimates for 
transmission rates and reproduction ratios (Chapter 4) also indicate the possibility of 
controlling the disease with moderate level of vaccination coverage by efficacious 
LSD vaccine. Vaccination complemented with other methods such as movement 
control and removing severely affected animals is presumed effective to control LSD 
epidemics (Ben-Gera et al., 2015; EFSA AHAW Panel, 2015). 
  It is now clear that the occurrence of LSD in areas/districts is cyclic which 
explains its endemicity in the country (Chapter 2). Once the epidemic is over in a 
certain area that area may remain free from LSD for some years. A carrier state of 
LSD recovered animals has not been observed. Therefore, resurgence of an LSD 
epidemic into a free area occurs either by introduction of infected animals or by 
blood feeding insects. Thus, new animals should be quarantined before they enter 
to a free area and banning free and unauthorized animal movement could be taken 
as an option for the control of LSD in Ethiopia. Stamping out of infected animals and 
insect control options might not be feasible in resource poor countries. In other parts 
of the world, insecticides are frequently used to control LSD outbreaks, even though 
their effectiveness in controlling LSD spread is not yet proven (EFSA AHAW Panel, 
2015). Stamping out infected and in contact animals is considered as best option 
when LSD occurs for the first time in a free country.  
Currently, Ethiopia lacks a well-designed control strategy for LSD. Thus, 
based on the findings presented in Chapter 2 to 6, it is possible to formulate a control 
program, which encompasses vaccination, isolation and removing of infected 
animals, and movement control. Vaccination should be undertaken regularly ahead 
of the onset of the main rainy season, starting in the most risky geographical areas. 
Susceptible adult cattle should be vaccinated annually and calves of six months and 
older, born from immunized dams, should be vaccinated as soon as possible to 
ensure adequate protection against LSD. Calves over 10 days of age may be 
vaccinated, if they born from unimmunized cows. However, a more competent 
vaccine should replace the incompetent KS1 O-180 vaccine, which is currently in use 
for the control of LSD. Movement of animals from infected to free areas should be 
banned and live cattle open-air local markets should be closed during LSD outbreaks.  
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7.3 Practical implications 
In Chapter 2, the geographical distribution and seasonal pattern of LSD in 
Ethiopia has been described using the outbreak reports from 2000-2015. A better 
understanding of the spatiotemporal distribution of an infectious disease is likely to 
result in a formulation of better disease control and prevention strategies (Grassly 
and Fraser, 2006; Alkhamis and VanderWaal, 2016) by specifying where and when 
particular attention should be paid to control the disease. Furthermore, the 
forecasted results (Chapter 2) are useful in alerting and helping policy makers to 
formulate epidemic preparedness plans to prevent and control the occurrence of the 
disease.  
LSD occurrence varies from place to place within the country depending on 
the risk factors. Areas endowed with surface water bodies (rivers, lakes, ponds, 
dams, irrigated and swampy areas) and that receive high amount of rainfall are more 
affected by LSD (Chapter 2 and 3). This suggests that these high-risk areas should get 
priority in the application of control measures to reduce LSD transmission and 
economic losses. Risk maps can be drawn based on the findings on potential risk 
factors that can help in undertaking targeted disease surveillance and control 
activities (Chapter 2 and 3). Thus, understanding the risk factors and occurrence of 
LSD may assist in the control and prevention of the diseases in cattle population.  
Knowledge of within herd transmission is necessary in disease controlling. 
The per day transmission rate of the disease between animals was higher at the 
beginning of the epidemic compared to the later stage of the epidemic (Chapter 4). 
This result might give a clue that starting implementation of control measures at an 
early stage of the outbreak or ahead of the outbreak is necessary to halt the spread 
of the disease. The reproduction ratio, being a parameter that reflects the 
transmission dynamics of the disease, estimated in dominantly crop-livestock area 
and intensive farm animals was low in magnitude but above the threshold level 
(Chapter 4). The reproduction ratios estimated in unvaccinated and vaccinated 
animals were also above the threshold level but low (Chapter 5). This indicates that 
the epidemic would spread and affect susceptible cattle, but implementation of 
appropriate control measures might bring R to below 1 and the disease under 
control. If a 100% effective vaccine is being used, the disease can be brought under 
control by vaccinating at least 18% (based on the R of 1.21 for an unvaccinated 
population) of the susceptible cattle population (Chapter 5). This means that herd 
immunity can be achieved by vaccinating a moderate number of animals against LSD. 
This critical vaccination coverage is on the assumption of 100% vaccine efficacy, but 
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in reality the vaccine efficacy is usually less than 100%, so that a vaccination coverage 
of more than what indicated here might needed to control the disease. 
Though livestock contributes a significant portion to the national economy 
and the fulfilment of the livelihood needs of the poor farmers, the sector often is 
under-appreciated and inappropriately funded when public resources are being 
allocated (Perry and Grace, 2009). This discrepancy might be related to lack of 
understanding of the contribution of livestock. In relation to this, the huge per head 
and per herd financial loss caused by LSD (Chapter 6) might be helpful in alerting and 
changing the attitude of the policy makers towards the sector and LSD control. The 
role of livestock should not be seen only as an issue of food security and income, but 
rather encompasses nutrition security which is closely linked to the wellbeing of the 
producers and the general population. 
The economic impact of LSD, which is greater than many of the endemic 
transboundary animal diseases including FMD in Ethiopia, urges to design an 
effective LSD control strategy, which is non-existent to date in the country. Being 
well aware of the economic impact of LSD, the herd owners are expected to be fully 
cooperative for the implementation of control measures; particularly for 
vaccination, if a competent vaccine is available and the vaccination costs continues 
to be borne by the government. 
The study in Chapter 6 also showed that cattle selling is practiced during LSD 
outbreaks in open-air local markets. This has an implication in the spread of the 
disease between areas. To halt the progress of the disease epidemics it will be 
necessary to close the local market and implement some degree of animal 
movement restriction at least during the outbreak. A strong extension work, 
however, is needed as subsistence farmers have high resistance against animal 
movement control and closure of a local market.  
Results from previous researches indicate that the KS1 O-180 vaccine has 
shortcomings in protecting vaccinated animals (Ayelet et al., 2013; Gari et al., 2015; 
Gelaye et al., 2015) which was confirmed by results described in Chapter 5. The 
reproduction ratio estimated in unvaccinated and vaccinated cattle populations also 
gave additional insight in the effect of the vaccine on the disease dynamics at 
population level and emphasises the necessity of a more competent vaccine to 
control the disease. 
 
7.4 Future research recommendations 
The geographic distribution of vector-borne diseases tends to be influenced 
by climate whereas disease transmission dynamics, the timing and intensity of 
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outbreaks by variations in weather such as temperature, rainfall, and humidity 
(Institute of Medicine, 2008; Tuppurainen et al., 2017). However, due to information 
constraints, the influence of temperature and humidity on the LSD outbreak 
occurrences could not be assessed in the spatiotemporal study (Chapter 2). Hence, 
future study in the area should address this. 
Circumstantial evidence observed in the previous and the current studies 
indicate that the occurrence of LSD is associated with increased abundance of 
arthropod vectors. However, little information is available on the specific vectors 
responsible for the transmission of LSD. Field observations suggest that insects like 
mosquitoes, Culicoides, Tabanids, and Glossina spp. may transmit the virus 
mechanically (Davies, 1991). Weiss (1968) reported the isolation of LSD virus from 
Stomoxys calcitrans and Biomyia fasciata caught on infected cattle and Chihota et al. 
(2001) demonstrated female Aedes aegypti mosquitoes to transmit LSD virus for 2–
6 days post-feeding on experimentally infected animals. Tuppurainen et al. (2011; 
2013a,b) and Lubinga et al. (2015) have reported a possible role of hard ticks in the 
transmission of LSDV. Vectors responsible for transmission may vary between 
affected regions depending on the geographic location and climate of the region 
(Davies, 1982; Tuppurainen et al., 2017). So, research on the candidate vectors 
responsible for the transmission of LSD in a region is needed to enhance the control 
efforts. Furthermore, the use of insecticides and insect repellents as a means for the 
LSD control should be assessed for their applicability, effectiveness and safety.  
The reproduction ratio is a key parameter determining the level of disease 
transmission and disease persistence in a population (Velthuis et al., 2003). It is of 
value in assessing in real time whether interventions have effect in controlling the 
disease. The reproduction ratio is a composite measure of infectiousness and 
susceptibility, but to date the infectious period of cattle infected with LSDV and the 
role of the virus in the environment towards the transmission is not known. Further 
research into these, preferentially under experimental conditions, will lead to a 
better understanding of LSD transmission dynamics and estimates of LSD 
transmission parameters, and thus to a better control strategy.  
Assessing the impact of diseases is necessary but not sufficient to proceed 
directly to their control. It is not automatic that a disease with high economic impact 
should be tackled, different factors such as availability of effective control methods, 
technical feasibility, economical benefit, political willingness and the like, determine 
the move to action (Perry and Grace, 2009). Control measures such as vaccination, 
movement control, stamping out, and vector control can be employed separately or 
in combination to control LSD (Tuppurainen et al., 2017), but before applying them, 
their effectiveness, technical feasibility and cost effectiveness in controlling the 
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disease should analysed. Transmission experiments could be useful in estimating the 
effect of (combinations of) interventions measures. Besides, development of a new 
effective and safe vaccine should get priority in future research undertakings. 
  
7.5 Main conclusions of the thesis 
With the research described in the thesis, insight in LSD epidemiology, 
financial consequence and effect of vaccination as a control means has increased. 
The insight is crucial in order to better prevent and control the disease in the future. 
Based on the findings of this thesis, the following conclusions can be drawn: 
• Lumpy skin disease is endemic in Ethiopia. Districts are hit by an outbreak 
on average each 4.5 years (Chapter 2).  
• LSD outbreak incidence varies over space and time and shows an increasing 
trend over time (Chapter 2). Outbreaks are high at the end of the long rainy 
season (from September to January) and more numerous in areas receiving 
relatively high rainfall (north-west, central, west and south-western parts 
of the country) for a reasonable period of time (Chapter 2). 
• LSD sero-prevalence varies across districts and it is moderate at individual 
animal level (26.5%) but high at herd level (51.0%) (Chapter 3).  
• Animals at adult age and that live in an area endowed with abundant 
surface water bodies are at relatively higher risk for LSD infection (Chapter 
3). Cattle populations exposed to these risks should get priority in LSD 
control programs.  
• The 0.325 per day survival rate of the infectious virus in the environment 
increases the infectivity of LSD affected animals by 50%. The daily LSDV 
transmission rate between animals is higher at the beginning of the 
outbreak compared to the later stage of the outbreak. Thus, 
implementation of control measures at early stage of the outbreak is helpful 
to halt the spread of the disease (Chapter 4).  
• The estimated reproduction ratio of LSD is about 1.1 and thus above the 
threshold level but low in magnitude which implies that every affected 
animals transmit the disease only almost to one other animal (Chapter 4). 
• KS1 O-180 vaccine has poor efficacy in protecting cattle populations with 
partial vaccination coverage against clinical LSD, but it significantly reduces 
severity of the disease (Chapter 5).  
• LSD’s impact in terms of production losses and control costs is high. The 
losses are mainly from morbidity and mortality of cattle and are the greatest 
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in highly productive animals. Commercial farmers are more affected 
economically than subsistence crop related farmers (Chapter 6). 
• Vaccination is economically beneficial as it reduces losses by decreasing 
susceptibility to LSDV and severity in vaccinated infected animals (Chapter 
6) despite a poor efficacy of KS1 O-180 vaccine in protecting cattle against 
clinical LSD. 
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Summary 
Lumpy skin disease (LSD) is an economically important viral disease of cattle 
caused by lumpy skin disease (Neethling) virus of the genus Capripoxvirus. Morbidity 
of the disease varies from as low as 2% to 100% while mortality is generally 
considered low (usually less than 5%). The disease is endemic in Africa and Middle 
East countries. In recent times, the disease has also spread into Europe and West 
Asia.  
LSD is an endemic transboundary animal disease that has a significant 
economic impact on livestock sector. In Ethiopia, the disease causes major economic 
loss since its introduction in 1981. This loss is associated with low production and 
productivity, high control and prevention costs and international trade restrictions 
on cattle and their products. Although the disease is endemic and presumed to have 
huge economic consequences, little was known about its spatiotemporal 
distribution, transmission dynamics, predisposing factors, financial loss and 
efficiency of prevention and control strategies practiced in Ethiopia. The main aim of 
this study was, therefore, to generate information on LSD epidemiology, its financial 
consequences and the effect of vaccination as a control means. This information 
then can be used to formulate a LSD control strategy policy, which currently is lacking 
in Ethiopia. 
The spatiotemporal distribution of LSD in Ethiopia (Chapter 2) was assessed 
using data extracted from LSD outbreak reports over 16 years (2000-2015) with the 
objectives to determine the spatial and temporal distribution, and to forecast the 
future pattern of LSD outbreaks. For this study, LSD outbreak data were obtained 
from the Federal Veterinary Services Directorate of Ethiopia for the period 2000-
2015 and the monthly mean precipitations for the period 1999-2013 from the Global 
weather data for SWAT website. The national LSD outbreak incidence was 
established at district level and its geographical distribution was mapped by 
administrative zones. Time series analysis was used for depicting temporal patterns 
of LSD outbreaks. An ARIMA (1, 1, 1) x (1, 1, 1)12 model was used to forecast the 
number of LSD outbreaks that are expected to occur between January 2016 to 
December 2018 (Chapter 2). A total of 3811 LSD outbreaks were reported in Ethiopia 
between 2000 and 2015, an outbreak being defined as the occurrence of one or 
more LSD case in a specified geographical area (usually Kebele). LSD was reported at 
least once over the period in all regional states and city administrations. The national 
average incidence of district level LSD outbreaks was 5.58 per 16 district years. The 
incidence varied over space, being the lowest in hot dry lowlands and highest in 
warm moist highland areas. The occurrence of LSD outbreaks appeared to be 
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seasonal, it peaks in October and become lowest in May. In general, the number of 
LSD outbreaks was above average for the months September-January and below 
average for February to August. The trend of LSD outbreaks increased over the 
period 2000-2015. Based on the forecast for the period 2016-2018 the highest 
number of LSD outbreaks (about 36 outbreaks) will occur in October for all the three 
years and the lowest in April for the year 2016 and in May for 2017 and 2018 
(Chapter 2). 
Chapter 3 describes a cross-sectional study that was undertaken in central 
and north-western parts of Ethiopia to estimate the sero-prevalence and identify the 
associated risk factors of LSD. Multistage cluster sampling was chosen because the 
population studied had a nested structure and lists of individual animals were lacking 
in the study area. Nesting was due to sampling several herds/animals in a kebele (the 
smallest administrative division in Ethiopia). A total of 2386 cattle serum samples 
were collected in 30 kebeles and tested for antibodies against LSDV using a virus 
neutralization test. Data on putative environmental and animal risk factors were 
collected by interviewing the farmers at the time of blood sample collection. 
Multivariable mixed effect logistic regression with kebele as random effect was 
applied to assess the association between LSD sero-positivity and potential risk 
factors. LSDV antibodies were detected in all study kebeles. The overall animal level 
and herd level apparent sero-prevalences recorded were 25.4% and 48.9%, 
respectively. The true animal level and herd level prevalences were estimated as 
26.5% and 51.0%, respectively. Adult age, contact with other animals and presence 
of water bodies in the area were identified as the most important risk factors in 
relation to LSD infection. The intracluster correlation coefficient was 0.104, the 
design effect 9.2 and the standard error of the apparent prevalence (animal level) 
was 2.7% (Chapter 3).  
The transmission study described in Chapter 4 was carried out in central and 
north-western parts of Ethiopia with the aims to understand LSD outbreak dynamics, 
to quantify the transmission between animals, and to estimate the disease 
reproduction ratio in dominantly crop-livestock mixed and commercial herd types. 
Animals in the crop-livestock area (Mota area) were considered as one large herd 
due to continuous mixing of animals, whereas commercial herds were separate herd 
with no or little contact with animals of other herds. The infection chain in the herd 
was monitored by recording the number of susceptible, infected, recovered and 
newly infected animals (with the date of onset of the infection) at regular visits. The 
infected animals were assumed to stay infectious for ten days. The transmission of 
LSD virus between animals was estimated from the relationship between the 
number of animals newly infected at the end of each observation time interval and 
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the number of infectious animals during that same time interval using a SIR epidemic 
model including a factor for environmental transmission. A generalized linear model 
was employed for the estimation of transmission parameters. A survival rate of 0.325 
per day in the environment for LSDV was used to estimate the transmission 
parameters. The estimated transmission rate between animals was 0.072 per day in 
dominantly crop-livestock production system and 0.076 per day in commercial 
herds. In dominantly crop-livestock system, transmission rates were higher at the 
beginning of the outbreaks. The reproduction ratios (R) estimated for dominantly 
crop-livestock production system and commercial production system were 1.07 and 
1.09, respectively. Though these R’s are greater than 1, their magnitude is low and 
implementation of appropriate control measures might reduce R to below 1. 
The vaccine impact study described in Chapter 5 was carried out in central 
and north-western parts of Ethiopia with the objectives to assess the efficacy of KS1 
O-180 vaccine against natural LSD occurrence and its impact on the transmission and 
severity of the disease. The study was based on a questionnaire survey and an 
observational field study. The latter included a total of 2053 cattle (1304 vaccinated 
and 749 unvaccinated) in 339 infected herds located in 10 sub-kebeles; the 
questionnaire survey was administered to 224 herd owners. A live attenuated KS1 
O-180 vaccine produced by National Veterinary Institute (NVI) of Ethiopia was used 
for vaccination. Multivariable ordered logistic regression and generalized linear 
regression were applied to estimate the effect of vaccination on the severity level 
and on transmission of LSD at sub-kebele level, respectively. Over 60% of the herd 
owners reported that the vaccine has a low to very low effect in protecting animals 
against clinical LSD; almost all of them indicated that the vaccine did not induce any 
adverse reactions after vaccination. Severity of the disease was significantly reduced 
in vaccinated compared to unvaccinated animals. Vaccinated animals were more 
likely to develop less severe disease than unvaccinated animals (OR = 0.68, 95% CI: 
0.49-0.96). LSD vaccine efficacy for susceptibility was estimated as 0.46 (i.e. the 
susceptibility effect equals 1-0.46 = 0.54) while the effect of the vaccine on infectivity 
was estimated as 1.83. This indicates that vaccinated animals are half as susceptible 
to get the disease but once infected the infectivity is almost doubled compared to 
unvaccinated animals. LSD transmission occurred in both vaccinated and 
unvaccinated animals, the estimated reproduction ratios were very similar: 1.21 in 
unvaccinated animals and 1.19 in vaccinated ones. Generally, KS1 O-180 vaccine has 
poor efficacy in protecting cattle populations with partial vaccination status against 
clinical LSD, neither by direct clinical protection nor by reducing transmission, and 
this signifies the urgent need either to improve the quality of the vaccine or to 
develop potent alternative vaccines that will confer good protection. 
Summary 
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Chapter 6 describes the results of a questionnaire survey targeting to 
determine the direct financial losses of LSD related to milk loss, draft power loss, 
mortality and indirect losses due to treatment and vaccination as a means of LSD 
control in central and north-western parts of Ethiopia. The production systems in the 
study area were subsistence crop-livestock and commercial dairy production. A total 
of 243 herd owners from 15 districts (34 kebeles and 5 farms) were enrolled in the 
study. The economic impact of LSD was determined by an estimation of the direct 
(visible) production losses such as milk loss, mortality loss, and draft power loss, and 
indirect impacts like control costs. Impacts of the other direct losses such as reduced 
bodyweight, abortion, infertility, culling, and poorer hide quality were not 
considered in the study due to lack of information. The losses were estimated per 
head and per herd. The cost effectiveness of LSD control through vaccination was 
evaluated using partial budgeting analysis technique. From a total of 4430 cattle 
(within 243 herds) surveyed, 941 animals (in 200 herds) were reported to be 
infected. The overall morbidity and mortality at animal level were 21.2% and 4.5%, 
and at herd level, these were 82.3% and 24.3%. LSD is a top ranked disease for cattle 
producers in Ethiopia. Almost all of the herd owners knew its effect on production 
and productivity of animals and marketing. They reported that the disease induces 
weight loss, reduced milk production, draft power loss, death of animals, market 
instability, infertility, abortion, culling, and hides quality losses (Chapter 6). An 
overall median loss of USD 375 (USD 325 in local Zebu and USD 1250 in Holstein-
Friesian local cross cattle) was estimated per dead animal. The median losses per 
affected lactating cow were USD 141 (USD 63 in local Zebu cow and USD 216 in 
Holstein-Friesian local cross cow) and, USD 36 per affected ox. Diagnosis and 
medication cost per affected animal were estimated at USD 5. The median total 
economic losses of LSD outbreaks at herd level were USD 1176. The median total 
herd level economic losses in the subsistence and commercial farm types were USD 
489 and 2735, respectively. A positive net profit of USD 136 (USD 56 for subsistence 
farm herds and USD 283 for commercial herds) per herd was observed in return to 
LSD vaccine investment. 
In Chapter 7, the outcomes of all chapters are linked and discussed. First, 
the importance of LSD in livestock industry of Ethiopia was emphasised. Next, the 
findings of the research were organized and discussed. The practical implications, 
future research outlook and main conclusions of the thesis were also highlighted in 
Chapter 7. 
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